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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to day affairs of surgery.

The Journal Comes of Age

The Canadian Journal of Surgery com
mences its 21st year with a new and
enlarged format.
Not only has the Journal increased
its size to the more popular 814 x 1114,
but because of smaller type size there
is a substantial increase in the amount
of editorial content even though the
number of pages has not increased.
More editorial material was received
during 1977 than at any time in the
Journal’s past. While the rejection rate
has increased, the number of accepted
manuscripts, panel discussions, sym
posia, review articles and other sub
missions requires far more space than
was available in the “old journal”. The
result has been that there is almost
a year between acceptance of a manscript and its publication.

This issue presents subjects of in
terest to general surgeons, the panels
and symposia of the inaugural meeting
of the Canadian Association of General
Surgeons. Short papers by experts on
peptic ulcer disease, carcinoma of the
colon and rectum, pancreatitis and in
tensive care are all followed by a panel
discussion recorded at the time of the
meeting. These presentations are de
signed to meet the needs of the sur
geons in practice who were not able
to attend the meeting, but those who
did attend may wish to organize their
thoughts on management in these four
important areas. The panel discussions
are valuable additions to the papers and
help to place each topic in perspective.
The objectives of the Journal are:
a) to serve in the effective continuing

education of Canadian surgical fellows,
b) to provide an effective vehicle
for documentation of their clinical and
scientific observations and c) to up
grade the international image of Cana
dian surgery. This issue serves a and b
and, while designed for the readership
rather than the author, we think will
gain international approval as well.
If the receipt of editorial material is
a measure of interest in this form of
continuing medical education, the Jour
nal appeals to general surgeons, cardio
vascular and thoracic surgeons, and
orthopedists. We hope other surgical
specialists will also use the Journal to
record their efforts in continuing med
ical education.
L loyd D. M acL ean , md, frcs [c]
C. B arber M ueller , md , frcs [c ]

Physician Manpower Planning: An Urgent Problem

There is concern among medical edu mittee suggested an overall physician/
cators and health-care organizers that population ratio of 1:665. In June 1977,
Canada may soon have an excess of the federal/provincial advisory commit
physicians. A planning document pre tee on health manpower planning ac
pared by the health economics and cepted this ratio. However, since the
statistics division of Health and Wel graduating class of 1980 had already
fare Canada provides data to support been enrolled, the Department of
these concerns.1 When the requirements Health and Welfare projected physician
committee of the physicians manpower requirements based on the anticipated
planning committee submitted its final situation for the period 1982 to 1986.
The current physician/population ra
report in April 1976, it contained rec
ommendations for optimal 1981 physi tio in Canada is 1:679 (excluding in
cian requirements based on the reports terns and residents) — rich, in the light
of 32 working parties representing the of world requirements. The medical
medical specialties in Canada.2 Al schools of Canada will produce 1717
though the possibility of maldistribu physicians in 1978; the number will
tion is obvious, the requirements com increase from 1839 students in 1984
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to 1869 students in 1986. If our pres
ent immigration policies maintain the
number of immigrating physicians at
400/yr, in 1981 there will be 915
physicians too many; this figure will
increase to 2096 in 1984, and the ex
cess by 1986 will be 2807 (a ratio of
1:621). These projections assume an
intermediate growth rate in population
and that the number of intern and
resident positions remains at 6500/yr.
An alternative proposal is that if
the immigration of physicians be lim
ited to 1 for every 665 immigrants, and
immigration remain at about 100 000/
yr, then 150 more physicians would
enter Canada each year than would
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leave the country. If medical school
output reached the goal of 1869 stu
dents, there would be, by 1986, 807
too many physicians.
The planning document is admittedly
a statistician’s concept. However, it is
based on realistic estimates and its im
plications must be seriously considered.
If immigration is not controlled, then
medical schools should produce fewer
physicians if we are to avoid the pre
dicted excess. There are some obvious
difficulties to this policy. While some
“have-not” provincial governments
might accept this as an excuse to reduce
the amount of money spent on health
education, to reduce the number of
available positions in the local medical
school might not be politically palatable
at the constituency level. Further, there
is the problem of reducing the size of
medical school staff, and who is to
decide which schools should, in fact,
reduce their student intake? Controlled
immigration seems the most feasible
step. If one were assured that the 150
immigrating physicians would be se
lected to restore our current defi
ciencies, that is, to fill positions where
there is immediate need but in which
we are not yet sufficiently productive
(e.g., anesthesiologists, radiation ther
apists and microbiologists), medicine
might be in a healthy and vigorous
state in 1984. This solution, however,
is unlikely to happen since many coun
tries have shortages similar to our own.
However, these calculations ignore the
problem of distribution. Politicians are
concerned with the availability of pri
mary physicians in remote areas, but
postgraduate teachers are concerned
with the inappropriate overproduction
of specialists. To have completed one’s
medical course at the age of 25 and
find oneself redundant is a problem,
but to have accepted the challenge of
another 4 or 5 years of study to become
a specialist only to find that there are
no openings in one’s field is a catas
trophe! True, general surgeons may
locate in smaller towns to provide a
first-class service to their community,
but if an ophthalmologist or neurosur
geon cannot locate in a community of
adequate size in Canada, the only op
tion would be to emigrate or practise
in circumstances that limit the potential
as well as the quality of practice.
The class of 1982 is already becom
ing acquainted with the rigours of 1st
year medicine. Some forthright plan
ning is therefore necessary and accurate
statistics are required. The physician
requirements committee recommended
that a registry be established to docu
ment the major areas of practice of
each physician in Canada. It is under
stood that federal and provincial gov
ernments are instituting a “national
8

grid” to document disparities in dis
tribution (Lang OE: Personal com
munication, 1977). This is encouraging,
but such data must be available to
directors of residency programs so that
they can advise postgraduate students
of the potential openings in their spe
cialty when they complete their train
ing. Admittedly, some of the data may
be “soft”, but surely they constitute a
more sensible guide than the current
“market-place pressures”, which influ
ence many residents when they select
their specialties.
Some training programs should be
reduced and others increased within the
limits of the 6500 resident/intern posi
tions per year. These decisions should
be made by responsible medical educa
tors rather than imposed by provincial
governments (on the basis of fiscal ex
pediency), lest we find, once again,
that the government solution to a prob
lem has itself become the problem!
We must note the concern of the
Association of Canadian Medical Col
leges of Canada3 at the “possible bal
kanization of the country, creating in
ternal restrictions on the movement of
physicians from province to province,
even though they may be graduates
of Canadian schools. Self-sufficiency
should be considered in the national
context, not in provincial aspirations.”
Parochial interests, therefore, must be
made subservient to national needs by
responsible cooperation between educa
tors and government so that residency
programs are modified nationally rather
than provincially to meet the predicted
needs in each specialty. Eventually
Canadian graduates from whatever
province may locate with the assurance
that their newly acquired expertise will
be a valuable contribution to the med
ical needs of their communities.

Prescribing Information
INDICATIONS: For the relief of chronic, atonic,
spastic and rectal constipation and for the
constipation accompanying pregnancy,
convalescence and advanced age. For use
in special diets lacking in residue and as
adjunctive therapy in the constipation of
mucous and ulcerative colitis and diverticulitis.
Also useful in the management of hemorrhoids
and following anorectal surgery.

CONTRAINDICATIONS: Presence of nausea,
vomiting, abdominal pain or symptoms of
an acute abdomen or fecal impaction.
Metamucil Instant Mix is contraindicated
in patients who must severely restrict their
dietary sodium intake.

PRECAUTIONS: For patients, such as those
suffering from diabetes mellitus. where rigid
dietary calorie control is required:
Powder— 1 dose furnishes 14 calories.
Instant Mix— 1 dose furnishes 3 calories.

DOSAGE: Powder—one rounded teaspoonful
of powder 1 to 3 times daily depending on the
condition being treated, its severity and indi
vidual responsiveness. The teaspoonful of
powder is stirred into an 8 oz. glass of cool
water or other suitable liquid and should be
taken immediately.

Instant M ix -o n e packet 1 to 3 times daily
depending on the condition being treated, its
severity and individual responsiveness. The
contents of the packet are poured into an 8 oz.
glass to which cool water is then slowly added.
The resulting effervescent mixture should be
taken immediately.

SUPPLIED: Pow der- a refined, purified and
concentrated vegetable mucilloid, prepared
from the mucilaginous portion of Plantago
ovata, combined with dextrose as a dispersing
agent. Each rounded teaspoonful contains
approximately 3.1 g of psyllium hydrophilic
mucilloid per dose, a negligible amount of
sodium, and furnishes 14 calories.
Available in 6 and 12 oz. plastic bottles.

In s ta n t M i x —p re m e a su re d u n it-d o se
packets. Each unit-dose packet contains
3.6 g of psyllium hydrophilic mucilloid with ef
fervescent and flavouring excipients, 0.25 g
of sodium as bicarbonate, and furnishes 3
calories.
Available in boxes of 15 unit-dose packets.

F.G. INGLIS, M D , FRCS[c]
Professor and chairman,
Department of surgery,
University of Saskatchewan,
Saskatoon, Sask.

Natural bowel management that
benefits many kinds of patients.
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• Metamucil is made from grain,
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• Metamucil promotes regular
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without straining, cramping
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• Metamucil will not cause
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lacking in many diets
Available as Metamucil powder,
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flavoured Metamucil Instant Mix,
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treatment and successful
bowel management,
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kinds of patients.

The laxative most
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physicians.

I

>

SEARLE

Searle Pharmaceuticals
Oakville, Ontario
L6H 1M 5

Visualizing the Spectrum of Parameters

The standard of medical writing and
speaking must have improved over the
last generation, because so many books
and courses have been made available
to remedy the ineffective usage of Eng
lish by educated people. Then why is
sloppy, incorrect and cliche-ridden
prose still a conspicuous feature of
medical communication? Doctors often
are hurt and resentful if authorities on
speaking and writing group them in a
class of educated illiterates; the individ
ual doctor’s response is that it may
apply to many, but certainly not to
him. Many are unaware that hackneyed
expressions and barbarisms can be just
as distracting as any other unpleasant
mannerism of speech or writing. Words
and phrases have their times of fashion,
and doctors can be as trendy as poli
ticians.
I would like to cite a few examples
of effete fashions in medical writing.
“Parameter” is defined in various
dictionaries as an arbitrary constant
or an independent variable through
functions of which other functions may
be expressed. “Dorland’s Illustrated
Medical Dictionary” describes it as “a
variable whose measure is indicative of
a quantity or function that cannot itself
be precisely determined by direct meth
ods”. Wilson Follett, in “Modern
American Usage”, says, “parameter,
in mathematics, is a quantity that varies
with the conditions under which it
occurs. Hence in ordinary life a pedan
tic substitute for the task before us,
the limits of our problems.” In medical
communication it is most often used
as a fashionable word to mean vari
ables, dimensions, factors, size, scope,
measurement, features, findings, but
the vogue seems to be to put it into the
text somewhere, and it scarcely matters
where it is inserted.
“Spectrum” originally meant the dis
tribution of a physical system or phe
nomenon, and came from the Latin
spectere, to look at. In medical usage
it has now almost entirely replaced
range, distribution, variation, gamut,
extent.
“Emergent”, the adjective, has two
meanings defined in dictionaries: a)
coming to attention or into existence;
b) demanding prompt action. The dif
ficulty in medical communication is in
10

understanding which of the two defini
tions is meant by the writer at all times.
Every emergent condition does not
necessarily require prompt action, and
some emergent situations have been in
existence and recognized for some time.
It would be helpful if writers would
reserve the word for its original pur
pose, to mean “appearing”, or “coming
out of”, or “coming to one’s attention”,
and use the noun emergency to denote
anything demanding immediate atten
tion.
The radiologists have gradually cor
rupted a large segment of the profes
sion into preferring “visualize” to see,
demonstrate, define, observe. Now
when we form a mental image we can
not use visualize to express the idea
lest our meaning be mistaken. Similarly
they have persuaded many of us that
“image” used as a verb is superior to
copy, portray, or record.
We are often told by a speaker that
there was no “mortality” in a series
he is presenting, when really he means
that there were no deaths, or that the
mortality was zero. In expressing re
sults in medical reporting the term
mortality should be used to express the
death rate. One cannot expect immortal
prose from those who use “mortality”
to mean “death”.
Most surgeons would never think of
using an osteotome as a screwdriver,
yet some see no incongruity in blunting
our tools of communication and think
it pedantry to be concerned with pre
cision in speech or writing. We must
look to editors of professional journals
to give us guidance and insist upon
better standards. Would it really matter
if some articles were rejected because
the authors refused to have their manu
scripts edited?
In addition to knowing and insisting
upon good English usage, editors also
could help us eliminate the tiresome
cliches that were once colourful or
expressive of ideas but have become
distracting repetitions.
“A high index of suspicion” has
become one of the most jaded phrases
in medical literature, when all the
writer is trying to say is “keep this
condition in mind”. We should compile
an index of suspicion to include the
names of all writers found associating
with this jade.
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“Meticulous attention to detail” is
another favourite banality. The speaker
merely recommends conscientious or
precise care, or exacting measures, or
punctilious attention, or scrupulous
care, or just close attention. Better still,
the phrase could be left out entirely;
it is gratuitous as it suggests, obliquely,
that “most of you clods had better
watch out, this has to be done care
fully”.
When a medical author reports a
series of instances of some unusual con
dition that he has collected from an
intensive search of the medical litera
ture and added a case or two of his
own, he often becomes impressed with
the number he has collected and warns
us “this condition is commoner than
usually acknowledged”. When one con
siders the number of items that have
borne this saturnine message, we can
count ourselves lucky that we have not
been afflicted with more strange mal
adies that few can recognize.
One can expect some bias in the
reports of results of treatment. An
author has a point to make, and it is
difficult to be completely detached in
reporting one’s own work. None the
less, to state that “there were only two
deaths in the series” does beg the
question. At best this is not being ob
jective and at worst presumptuous.
There are many other faults in med
ical writing, so many indeed that we
are delighted when we encounter an
author who chooses his words with an
understanding of their meaning and
only uses clever words or phrases when
he has coined them himself, before
they have become tedious. But such
authors are uncommon, and as com
pensation one can still obtain enjoy
ment from some of the most pedestrian
presentations by keeping count of re
dundancies, cliches and solecisms. I
have mentioned here a few of the
common irritants, but each of us has
his own anathemas with respect to
speaking and writing, and keeping a
tally of them during an uninspiring
paper can be pleasantly diverting.

J.E. M ullens , md , ms , frcs [c]
Department of surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
THE CANADIAN JOURNAL OF SURGERY

SELF - ASSESSMENT
SESAP II Question

600. Fatalities in intensive care units resulting from pseudomonas infections are most often associated with the use of

(A)
(B)
(C)
(D)

central venous pressure catheters
urethral catheters
intravenous hyperalimentation
mechanical ventilators for respiratory assistance

For this incomplete statement select the one completion that is BEST from those noted above.

For the critique of Item 600 see page 74 of this issue.

(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education and Selfassessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program No. 2 please apply
to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)

Kidney Foundation
Research FellowshipsAlberta,
Canada 1978-79

REVIEWERS, 1977
The coeditors and members of the Editorial Board of the Journal wish
to acknowledge, with thanks, the services of the following reviewers of
manuscripts for the year 1977.

Applicants invited for two
post D o c t o r a l Medi cal
Fellowships in Nephrology or
Urology to run concurrently
from July 1, 1978 at University
of Alberta, in Edmonton or
University of Calgary (Faculty of
Medicine).

H.W. Beattie
G.W. Bethune
P.E. Blundell
K.D. Bury
G.S. Cameron
J. Cantin
S.E. Carroll
W.B. Chung
B.
L. Clark
F. M. Cole
R.L. Cruess

Salary concordant with the
qualifications and prior training
to maximum of $20,000. p.a.
Each Fellowship is for one year
but application for second year
anticipated.

R.K. Daniel
M. Deitel
M.C. Devlin
A.R.C. Dobell
J.H. Duff

Application form s available
from Kidney Foundation of

G. Evans
C. C. Ferguson
J.B. Freeman

Canada (Alberta Branch), No.
301 - 836 — 5th Avenue S.W.,
Calgary, Alta., Can. T2P ON5.

D.
A. Gibson
G.J. Gill

No application accepted after
February 28, 1978.
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R.C. Harrison
H.S. Himal
E.
J. Hinchey
F.

G. Inglis

L.M. Kahana
G. Karu
R.A. Kinch
W.H. Kirkaldy-Willis
B. Langer
P.G. Lavoie
G.J. Legros
L.
J. Levasseur
R.B. Lynn
M. Martin
P.B. McCulloch
R.M. McFarlane
M. J. Meakins
J.E. Miller
N. S. Mitchell
P.J. Moloney
J.
E. Morin
K.
S. Morton
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F. Moseley
B.M. Mount
D. S. Mulder
J.E. Mullens
H.O.L. Murray
F.G. Pearson
M.J. Phillips
H. Richardson
H.J. Scott
H.R. Shibata
H.M. Shizgal
J.F. Symes
E.J. Tabah
A. Talalla
E.J. Thomas
O.G. Thurston
A. Toi
W.E. Waterfall
M.J. Wexler
H.B. Williams
C.J. Wright
R.H. Yabsley
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Trasylol
• increases the chances

CORRESPONDENCE
Carcinoma of the Esophagus

To the coeditors: I have read with in
terest Dr. Mulder’s editorial comment
on carcinoma of the esophagus (Can J
Sitrg 20: 400, 1977). I believe that it is
of great importance that some centres
adopt an individual approach to this
problem although the weight of evi
dence favours another direction. After
all, the rest of us may be totally wrong.
Certainly I will await with' interest the
final presentation of the figures from
McGill University teaching hospitals;
however, though I appreciate that the
figures quoted by Dr. Mulder are pre
liminary and incomplete, it looks as if
those for 5-year survival will be little
different from the figures in other pub
lished series. Of greater interest is the
outcome for the remaining 50 patients
who did not complete the “curative”
phase of his protocol. It is my con
tention that the answer to this question
is extremely important and can only be

obtained through a prospective grading
system as I outlined in my paper (Can
J Surg 20: 454, 1977). Dr. Mulder is,
of course, absolutely correct in pointing
out that the grading score is timerelated and changes quickly with recur
rence of disease. This is as I would
have expected since I believe that this
disease has an inexorable course and
one’s palliative efforts can be expected
to fail sooner or later.

J u l iu s L. S t o l l e r , m b , f r c s , f r c s [ c ]
Laurel Medical Centre,
316 - 888 West 8th Ave.,
Vancouver, BC

To the coeditors: Dr. Stoller has cor
rectly pointed out that the final results
of carcinoma of the esophagus protocol
at McGill University are very prelimin
ary, and at the present time it is im
possible to predict a 5-year survival
figure. The most striking finding to
date in the small group of patients is
that it is possible to use radical surgical
treatment in selected patients with an
acceptable operative mortality. This is
in contrast with the experience of the
previous 10 years when the operative
mortality was high and case selection
was poor.
The patients who did not complete
the curative phase of the protocol usu
ally received a course of radiotherapy
if their general condition warranted it.
The preliminary results would suggest
that their mean survival was under
5 months, the same as reported in the
surgical literature for cases in which
celiac axis or supraclavicular lymph
nodes are involved by tumour.
I cannot comment on the degree of
palliation provided for this group of
patients. We are at present in the pro
cess of re-evaluating this group and it
would be interesting to apply Dr.
Stoller’s grading system.
It is only through a prospective treat
ment protocol, whether palliative or
curative, that our effectiveness in man
aging this difficult disease can be as
sessed.
D.S. M u l d e r , m d , f r c s [ c ]
Surgeon-in-chief,
The Montreal General Hospital,
1650 Cedar Ave.,
Montreal, PQ
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conditions, such as in abruptio
placentae.
Initial dosage: 200,000 — 500,000
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sary by slow infusion. Administra
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Initial dosage: 100,000 — 200,000
K.I.U. to be followed by 100,000
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tered either by intravenous injec
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Trasylol is a polypeptide and thus
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allergic reactions should be
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tion of Trasylol.
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CAGS PAPERS

Symposium on Peptic Ulcer Disease
1. Medical Treatment of Peptic Ulcer*
K.N. J eejeebhoy ,

The conventional treatment of peptic
ulcer disease with special dietary
regimens, antacids or anticholinergics
has been found wanting. Recently
introduced agents show considerable
promise in the benefit they can render.
Carbenoxolone accelerates the healing
of gastric ulcers by increasing gastric
mucosal resistance. Cimetidine, a
histamine H2-receptor antagonist, is an
effective suppressant of acid secretion
and therefore promotes healing of
duodenal ulcers. Metoclopramide
hastens gastric emptying and increases
the tone of the gastroesophageal
sphincter, and is valuable in cases of
reflux esophagitis and gastric ulcer.
Le traitement classique de I'ulcere
gastrique a I’aide de regimes alimentaires
speciaux, d'anti-acides ou d'anticholinergiques s'est avere insatisfaisant.
Certains medicaments nouvellement
lances se montrent fort prometteurs
en ce qui a trait aux benefices
escomptes. La carbenoxolone accelere
la cicatrisation des ulceres gastriques
par augmentation de la resistance de la
muqueuse gastrique. La cimetidine,
un antagoniste des recepteurs histaminiques H2, est un inhibiteur efficace
de la secretion d'acide et, de la sorte,
favorise la cicatrisation des ulceres
duodenaux. Le metoclopramide accelere
la vidange gastrique et augmente le
tonus du sphincter gastro-oesophagien;
il est utile dans les cas d’oesophagite
de reflux et d'ulcere gastrique.

The conventional treatment of peptic
ulcer disease has consisted of diet and
antacids. Traditionally the diet has been
a so-called “low residue bland diet” and
'"From the clinical sciences division,
University of Toronto, Toronto, Ont.
Presented at the inaugural meeting of
the Canadian Association o f General
Surgeons, Toronto, M ay 11 and 12,
1977

the patient has been instructed to take
antacids usually before or with meals.
During episodes of acute pain frequent
small feeds have been advocated. Milk
has been considered especially useful
in treating ulcers. However, none of
these regimens has received critical
study until recently. In addition to these
measures new drugs have appeared on
the market that can alter profoundly
the metabolism of gastric mucosal
cells, reducing acid secretion and affect
ing gastric motility. These drugs have
shown greater promise for healing pep
tic ulcer than the plethora of antacid
or antacid-anticholinergic compounds.
Their efficacy has been demonstrated
by rigorously controlled trials.
The average physician has now to
choose from a variety of different regi
mens claimed to cure ulcer disease. This
paper will attempt to place the role of
such regimens in proper perspective
on the basis of currently available
evidence.
Diet

Doll, Friedlander and Pygott1 showed
that the healing of gastric ulcers was
unaffected by the administration of socalled gastric diets. Likewise, the use
of belladonna and antacids, while per
haps relieving pain, did not influence
the rate of healing of gastric ulcers.
Other investigators2-5 showed that fre
quent feedings with milk and cream did
not reduce gastric acidity and might
even increase the mean acidity above
values obtained with three meals a day.
Various diets such as “gastric II diets”
did not reduce acid below the value
observed while taking three normal
meals. More recently Ippoliti, Maxwell
and Isenberg6 have shown that milk
actually increases acid output in pa
tients with duodenal ulcer and that the
calcium in the milk appears to be re
sponsible for stimulating acid secretion.
Antacids

Reprint requests to: Dr. K.N. Jeejeebhoy,
Professor o f medicine, University of
Toronto, Rm. 6352, Medical Sciences
Building, Toronto, Ont. M5S 1A8
VOLUME 21, NO. 1, JA N U A R Y 1978

m b , bs , ph d, f r c p ( edin ), frcp [c]

Antacids in vitro will neutralize
gastric acid, but when given according
/

to a random schedule they do not aid
the healing of peptic ulcers.7 In the
studies from which these conclusions
were drawn, the effect of buffers in a
meal, to aid and prolong the effect of
antacids, was not investigated.
Fordtran, Morawski and Richardson8
showed that antacids have to be given
in doses of 80 meq (e.g., Maalox, 30
mL) 1 and 3 hours after a meal and
at bedtime to suppress acid secretion
continuously. When given in this dos
age antacids have improved significant
ly the rate of ulcer healing.9 However,
to attain this objective the patient must
ingest the equivalent of 240 to 300 mL
of Maalox daily. Such a dose often
causes diarrhea and is inconvenient for
ambulatory patients.
Anticholinergic Medications

These agents are effective in reduc
ing acid secretion, but the doses re
quired often result in side effects such
as dry mouth, cycloplegia and urinary
retention, which may be intolerable to
the patient. It has been claimed that
Robinul (glycopyrrolate) may suppress
acid secretion preferentially10 and may
improve the rate of healing of gastric
ulcer.11 Other studies have not shown
unequivocally that anticholinergic drugs
aid the healing of duodenal ulcers.12,13
It is quite clear from the above evid
ence that peptic ulcer disease has not
been favourably influenced by conven
tional medical means unless the drugs
are used in such a way as to be incon
venient or associated with side effects.
New Therapeutic Agents

Recently there have become avail
able three new agents (carbenoxolone
sodium, cimetidine and metoclopra
mide), which are clearly effective in the
healing of peptic ulcers.
C a rb en o x o lo n e Sodium

This drug is a derivative of glycyrrhizic acid, itself a derivative of lico
rice.14 It reduces the turnover of gastric
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mucosal cells,15 increases mucous secre
tions,16 protects the gastric mucosa
from the injurious effects of bile salts17
and seems in general to act by increas
ing gastric mucosal resistance. In clin
ical trials it has been shown to ac
celerate the healing of gastric and duo
denal ulcer.18'19 Its effect is especially
evident in ambulatory patients. It is of
interest that this drug requires the pres
ence of aldosterone to be effective so
that the use of aldosterone antagonists,
such as spironolactone, will inhibit its
healing action on gastric ulcers.20
The main side effects are related to
the retention of sodium, which causes
edema, weight gain and congestive fail
ure in patients with cardiac disease.
These effects can be avoided by care
ful monitoring of the patient, using
lower doses of the drug (e.g., 50 mg
tid), avoiding its use in patients with
cardiac disease and by using thiazide
diuretics.
The regimen recommended is 100
mg tid for 1 week and then 50 mg tid
for 6 to 8 weeks. After that period it
is not clear if maintenance doses will
prevent recurrence. Should there be a
relapse after discontinuing the drug,
the recurrent ulcer will heal at the same
rate as the initial ulcer.
Cimetidine
Cimetidine21 is the latest compound
in a series of agents called histamine
H2-receptor antagonists, developed to
block the stimulating effect of hista
mine on gastric acid secretion. The first
in the series of drugs, burimamide and
metiamide, were not satisfactory, espe
cially since metiamide caused agranulo
cytosis.
Cimetidine in a single 300-mg dose
will completely suppress acid secretion
in response to food and pentagastrin
for a 3-hour period; the gastric pH
tends to remain high for up to 6 hours
after ingestion of the drug. This effect
is noted when the agent is given either
orally or intravenously. Its use is not
associated with serious side effects.
A slight rise in serum creatinine is
noted, not due to any demonstrable
kidney damage. A few instances of
gynecomastia have been reported.
Given in doses of 300 mg qid (after
meals and at bedtime), it significantly
accelerates the healing of duodenal
ulcers,22 and by continuing to admin
ister one dose at night the physician
may reduce the incidence of recurrence.
Cimetidine is likely to be of value also
in the treatment of bleeding stress ul
cers and the bleeding duodenal ulcers
seen in patients following renal trans
plantation.
Metoclopramide
This drug hastens gastric emptying
and reduces the flow of bile into the
18

duodenum. It also increases the tone
of the gastroesophageal sphincter23 and
reduces bile reflux significantly. Clin
ical trials have indicated that it also
helps reflux esophagitis appreciably24
and hence is of value in treating peptic
ulceration of the esophagus. It favour
ably influences the course of gastric
ulcer disease25 and gastritis. Uncon
trolled observations suggest that it is
useful in the management of postsurgical bile reflux gastritis with gastric
ulceration (by contrast with its effect
on stomal ulcers involving the anastom
osed intestine). Possible side effects are
depression, lethargy and parkinsonism,
which may be unacceptable to some
patients. The dose recommended is 10
mg after meals and at bedtime, but
in thin subjects it is not advisable to
exceed a total dose of 0.5 mg/kg*d.
In conclusion the drug of choice for
gastric ulcer is carbenoxolone sodium
and for duodenal ulcer, cimetidine. An
tacids should be given in large doses if
they are used in an attempt to heal
ulcers. A dose of 30 mL, 1 and 3 hours
after food and at bedtime, is the only
logical way to use these agents.
While the results of controlled trials
are not yet available, it may be prac
tical in some situations to combine
drugs to treat special situations. For
example, where esophageal reflux is a
major problem or where there is gas
tric retention, as with pyloric channel
ulcer, as well as hypersecretion, a com
bination of cimetidine and metoclo
pramide will afford symptomatic relief.
Finally, it should be recognized that
there is no place for restricted and
unpalatable diets in the treatment of
peptic ulcer disease. These are more
therapeutic for the psyche of the physi
cian (? surgeon) than for the patient.
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2. Vagotomy and Its Variations*
P e t e r J. D o r is , m d , m sc , f r c s [ c ]

All the forms of vagotomy that are used
in the treatment of peptic ulcer disease
lower the acid secretion by the gastric
parietal ceils. The preferred operation
is the proximal selective vagotomy in
which the innervation to the antrum
and pylorus is undisturbed. Therefore
the necessity for any type of drainage
procedure is obviated. The results of a
number of clinical trials can be
considered highly satisfactory. The
undue rate of ulcer recurrence
sometimes reported after the operation
is possibly attributable to its incorrect
performance.
Toutes les formes de vagotomie qui
sont utiiisees dans le traitement de
I’ulcere de I'estomac abaissent la
secretion d'acide par les cellules
parietales de I'estomac. L'operation de
choix est la vagotomie proximale
selective qui permet de conserver
I'innervation de I'antre et du pylore. On
evite de la sorte la necessity de toute
forme de drainage. Les resultats d'un
bon nombre d'etudes peuvent etre
consideres comme tres satisfaisants.
Le taux indu de recidives ulcereuses
parfois signale apres l'operation est
possiblement attribuable a son execution
imparfaite.

Currently there are three forms of
vagotomy that are recommended for
the surgical treatment of peptic ulcera
tion. 1-4 The rationale for each type is
the lowering of acid secretion by the
gastric parietal cells subsequent to their
denervation, thereby allowing ulcers to
heal and preventing their recurrence.
The various forms of vagotomy differ
from each other only in the extent of
the denervation of the other abdominal
organs.
A truncal vagotomy (TV) involves a
denervation of all intra-abdominal
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In testin e

The motor activity of the small in
testine is disturbed following vagal de
nervation in experimental animals. The
characteristic normal wave of motor
activity beginning in the antrum and
sweeping down the whole of the small
intestine has been demonstrated to be
disorganized by vagotomy of the small
intestine. 1112 The role of this interdi
gestive myoelectrical complex has yet
to be determined in man. It is pre
served by SV and PSV and altered by
TV.
Clinical Trials

Acid Secretion

All three forms of vagotomy, TV, SV
and PSV, reduce acid secretion to an
equivalent degree provided a technically
adequate operation has been per
formed. 6 The retention of innervation
to the antrum by PSV might be thought
to be associated with vagal release of
gastrin and higher acid production, but
this has not been borne out in clinical
studies and must be considered only a
theoretical objection to PSV. 7' 8
Motility

The major differences between the
forms of vagotomy are to be found in
the alterations caused in motor function
of the abdominal viscera.
P roxim al Stom ach

Denervation of the proximal portion
of the stomach, produced by TV, SV
and PSV, results in a failure of recep
tive relaxation of this part of the organ
leading to higher intragastric pressures9
and causing a more rapid emptying of
liquids from the stomach. 10 In addition,
the decreased distensibility may result
in the symptom of early satiety.
D istal Stom ach

Denervation of the distal portion of
the stomach, brought about by SV and
TV, impairs the antral mill leading to
incomplete mixing of solids and by its
effect on the pylorus retards the empty
ing from the stomach of solid foods. 10
As a consequence a drainage procedure
is necessary, which is not the case
when PSV is performed since it pre
serves innervation to the distal stomach. 6

■fFrom the department of surgery, Queen’s
University, Hotel-Dieu Hospital,
Kingston, Ont.
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structures innervated by the vagus
nerve, whereas a selective vagotomy
(SV) denervates only the stomach. A
new type of vagotomy introduced by
Holle, Johnston and Amdrup brings
about denervation of only the proximal
portion of the stomach, so that the
innervation to the antrum and pylorus
as well as the other abdominal organs
is preserved. 2 This last operation is
variously referred to as highly selective
vagotomy, parietal cell vagotomy, prox
imal gastric vagotomy or, the term I
propose to use, proximal selective vago
tomy (PSV) . 3

In clinical practice it would be ex
pected from consideration of the func
tional effects of the various types of
vagotomy that PSV would cause the
least number of postoperative side ef
fects. There are now several reports of
randomized clinical trials comparing
the various operations that have justi
fied this premise. 7,13 Sawyers, 14 in a
study comparing PSV with SV com
bined with pyloroplasty, found a sig
nificantly decreased incidence of the
early dumping syndrome following
PSV. Devries and colleagues13 recently
reported on a randomized clinical trial
comparing PSV with TV plus antrec
tomy; in the PSV group there was a
significant increase in the number of
patients in the “excellent to good”
category postoperatively.
In summary, all forms of vagotomy
lower acid secretion and, in the short
term, control duodenal ulceration to an
equal degree if the operation is tech
nically adequate. Likewise all forms of
vagotomy lead to loss of receptive re
laxation in the proximal stomach and
more rapid emptying of liquids from
the stomach. The operations that denervate the antrum and pylorus must
be accompanied by either a drainage
procedure or a pyloroplasty. PSV is
associated with the lowest incidence of
postvagotomy side effects and avoids
the complications that may be asso
ciated with pyloroplasty or gastroen
terostomy.
Discussion

Proximal selective vagotomy appears
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to have many advantages in its favour.
Nevertheless this is not the most com
mon operation for peptic ulcer disease
in Canada or in North America. The
main argument against its adoption is
the relatively short duration of follow
up in the studies that compare it with
other forms of vagotomy, so that there
is a possibility that the true incidence
of ulcer recurrence may be unaccept
ably high. The high rates of recurrence
after PSV in some reports have led to
scepticism concerning the value of this
type of vagotomy.13 Since the main
reason for recurrence is related to tech
nical aspects of the operation, it is
obvious that if the operation is not
performed correctly, the initial rate of
recurrence will be unacceptably high.
At the moment, the incidence of de
layed recurrence appears not to differ
from that for other forms of vagotomy
although it may be slightly higher than
for vagotomy and antrectomy.6
Another concern regarding PSV
(without pyloroplasty) relates to gastric
emptying. Although inadequate gastric
emptying occasionally may be present
after PSV and either gastric retention
or gastric ulceration may develop, if
the innervation to the antrum has been
preserved, the distal stomach in most
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patients retains the normal mechanism
of emptying,16 a drainage procedure is
not required and tests for gastric empty
ing show normal indices.17
A specific complication of PSV has
been lesser curve necrosis with per
foration, presumably due to the ex
tensive devascularization of this area
of the stomach.1,4 Although it is un
common, this possibility must receive
attention in the postoperative period
and the complication recognized so that
reoperation may be performed as soon
as it is suspected.
The final objection to PSV has refer
ence to the technical aspects of the
operation and in particular the length
of time required for its performance.
On average a PSV takes longer than a
truncal vagotomy and antrectomy and
certainly much longer than TV plus
drainage.18 When done as an elective
procedure a longer operative time is
not an important consideration, but if
required as an emergency operation or
when done for a poor-risk patient, then
an alternative operation to PSV should
be considered.
On the other hand there are cogent
arguments in favour of PSV, particu
larly that this operation has the lowest
operative mortality to date.7'19 In
randomized clinical trials, as well as
in numerous reports of retrospective
analyses, it has been found that PSV
is effective in preventing recurrence of
duodenal ulceration and is associated
with a significantly lower incidence of
postoperative side effects than the al
ternatives,1,2'6'7 Continued investigation
into the role of the vagus nerve in af
fecting motility, endocrine activity and
extragastric secretion may reveal un
expected benefits from reducing the
extent of intra-abdominal vagal de
nervation.
Recommendations

Proximal selective vagotomy has ad
vantages over other forms of vagotomy
and should be introduced as routine
surgical practice in Canada. However,
unless this operation is performed to
adequate technical standards an unac
ceptably high rate of ulcer recurrence
will follow. Therefore PSV should be
performed only by surgeons who have
received instruction in its performance,
and some form of either intraoperative
or postoperative testing is required.
Vagotomy and drainage retains an
important role in the treatment of ulcer
disease in that the operation can be
performed quickly and it is the safest
operation in the hands of a surgeon not
trained in the performance of PSV.
Vagotomy and antrectomy should be
performed when the rate of recurrence
must be kept as low as possible. Of
the various operations that have been
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devised, it has the highest potential
mortality. Also it has a higher post
operative morbidity than PSV.
For any individual patient the data
are still insufficient to indicate in ob
jective terms which operation is most
appropriate. The continued process of
randomized clinical trials is required to
determine the answer to the question,
“Which operation for which patient?”
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3. Practical Management of Recurrent Peptic Ulcer*
M ax M. Cohen,

Recurrent peptic ulcer usually develops
as the result of an ill-advised or
poorly executed operation. The
commonest surgical error is an
incomplete vagotomy. Diagnosis is
made best by endoscopy. Mandatory
investigation includes determination
of serum gastrin and calcium, and
measurement of basal and maximal acid
output. Management is surgical and
depends on the initial ulcer operation.
Decision-making is aided by the
Hollander insulin test, the secretin
infusion test and occasionally by a
technetium scan. There is no place
for procedures that do not reduce
acid output. Emergency treatment of a
complication should be followed by
full investigation and the appropriate
operation. Recurrent gastric ulcer
should be treated by gastrectomy and
excision of the ulcer.
La recidive d’un ulcere de I'estomac
est souvent le resultat d'une operation
peu judicieuse ou mal executee.
L'erreur chirurgicale la plus frequente
est une vagotomie incomplete.
L'endoscopie est le meilleur moyen de
diagnostic. Les examens obligatoires
comprennent la determination de la
gastrine et du calcium seriques, et la
mesure du debit basal et maximal
d'acidite. Le traitement est chirurgical
et depend de I'operation initiate. La
prise de decision est aidee par le test a
I'insuline de Hollander, le test de
perfusion a la secretine et,
occasionnellement, par une scintigraphie
au technetium. Toute intervention
qui ne vise pas a reduire la secretion
d'acide est a proscrire. Le traitement
d'urgence d’une complication doit
etre suivi d’un examen complet et de
I'operation appropriee. L'ulcere gastrique
recidivant doit etre traite par la
gastrectomie et I'excision de l'ulcere.

mb , frcs ( edin ), frcs [c], facs

Recurrent peptic ulcer is probably the
best term to describe the development
of an ulcer following primary peptic
ulcer surgery and is preferable to the
common synonyms, stomal, anastomotic
and marginal ulcer. It is a serious con
dition, carrying a much greater com
plication rate and mortality than the
primary ulcer. While the incidence
appears to be declining it still poses
a difficult problem in management.
This review focuses on recurrence after
treatment of duodenal ulcer with the
intention of offering the surgeon a
practical guide to the management of
what is often a complex problem.
The incidence and timing of recur
rent ulcer varies considerably depend
ing on the initial surgical procedure
(Fig. 1). Unquestionably the most suc
cessful operation in terms of the pre
vention of recurrence is vagotomy and
antrectomy. There is no single correct
treatment for recurrent ulcer. This will
depend on the etiology of the lesion,
which in turn is usually determined by
the nature of surgery for the primary
ulcer.
E tio lo g ic F a c to rs

Responsibility for the development

of a recurrent ulcer can almost always
be attributed to the surgeon who per
formed the initial operation. Either the
decision to operate was ill-advised be
cause the patient was, for example,
drug dependent or severely neurotic,
and an “albatross” results,' or because
the operation was badly executed (Ta
ble I). Gastroenterostomy alone has
now been overtaken by incomplete
vagotomy as the commonest cause of
recurrent ulcer. Gastroenterostomy is
unsatisfactory because it does not re
duce gastric acid secretion. An inade
quate vagotomy means there is con
tinued vagal stimulation of acid
secretion, continued potentiation of
gastrin release and unimpaired parietal
cell responsiveness.
Less than a two-thirds gastrectomy
without vagotomy is inadequate and
was once a common cause of recurrent
ulcer. This is becoming an increasingly
rare cause as this operation gradually
disappears from the surgical scene. Re
current ulcer is rare after vagotomy
and antrectomy and then is usually due
to incomplete vagotomy, since even a
40% resection will successfully remove
the antrum.
Poor gastric drainage is another con-
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F IG . 1— Incidence of recurrent ulcer follow ing each of fo u r main ulcer operations
and m ean tim e interval between first and second operation.
/
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Table I— Recurrent Ulcer: Etiologic Factors
Inadequate operation
Gastroenterostomy
Incomplete vagotomy
Inadequate gastric resection
Inadequate gastric drainage
Retained antrum
Nonabsorbable sutures
Endocrine factors
Zollinger-Ellison syndrome
Hyperparathyroidism
P ituitary-ad renal tumours
Ulcerogenicdrugs

tributory factor since gastric retention
stimulates acid secretion. It is more
likely to follow pyloroplasty than gas
troenterostomy and probably explains
the slightly higher rate of recurrent ul
cer after the former.2
While antrum retained in continuity
with the duodenum after a Billroth I
gastrectomy is not hazardous, the
arrangement effected by Billroth II
gastrectomy is highly ulcerogenic.3 The
continuous bathing of the antral mu
cosa in alkaline duodenal juice produces
a continuous gastrin hypersecretion
and a clinical situation resembling the
Zollinger-Ellison syndrome (ZES).4 For
tunately, there appears to be a decline
in the prevalence of this complication
of Billroth II gastrectomy.
Extruded nonabsorbable suture ma
terial at the anastomosis is a rarely
reported but important cause of recur
rent ulceration and can be readily
dealt with by endoscopic removal of
the suture material.
Although endocrine abnormalities
are rarely the cause of recurrent ulcer5
it is essential that this possibility be
considered in every case and actively
ruled out. Gastrinomas (ZES) are usual
ly not recognized until recurrent ul
ceration occurs and such ulceration is
classically of a fulminating variety.6
Less than 2% of recurrent ulcers are
due to gastrinomas.7
There is a well-established relation
between hypercalcemia and peptic ul
cer.8 Treatment of an underlying hyper
parathyroidism will often cure the
ulcer.9 There is also an association be
tween multiglandular endocrine adeno
matosis and recurrent ulcer.10

quadrant pain relieved by antacid is
highly suggestive of recurrent ulcera
tion. However, many patients with
proven recurrence deny pain11 and
present with frank hemorrhage or,
more usually, chronic anemia due to
occult blood loss.12 Weight loss, diar
rhea and feculent vomiting should sug
gest the diagnosis of gastrojejunocolic
fistula.13
Roentgenography after ingestion of
barium is usually the initial investiga
tion and will provide the diagnosis in
rather more than half the cases.14 How
ever, it is notoriously difficult to inter
pret the findings in the region of the
anastomosis, and endoscopy must be
performed on all patients in whom the
findings are negative or equivocal. In
our experience an ulcer previously
suspected but missed will often then
be clearly visualized.
It has recently been suggested that
it may be possible to diagnose recurrent
ulceration by detecting an increase in
serum pepsinogen group I values in
response to betazole,15 but this is a
difficult determination, and the ob
servation requires confirmation.
Management

In every case of proven recurrent
ulcer it is essential to exclude the use
of ulcerogenic drugs and an underlying
endocrine abnormality. A meticulous
inquiry should be made into the use
of drugs such as acetylsalicylic acid,
indomethacin, phenylbutazone and ste
roids. These agents must be scrupulous
ly avoided while the remainder of the
investigation is completed and if the
ulcer heals nothing further need be
done. The 1-hour basal acid output
(BAO) and
pentagastrin-stimulated
maximal acid output (MAO) are meas
ured. If the patient is achlorhydric the
diagnosis of recurrent ulcer is almost
certainly incorrect and alkaline reflux
gastritis should be considered. If the
BAO is more than 5 m m ol/h and the
ratio BAO/MAO is greater than 0.6,
ZES is suspected.16 In any event, in all
cases of recurrent ulcer, fasting serum
gastrin should be determined on 3 con
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Recurrent Ulcer after
Gastroenterostomy
No additional investigation is re
quired. While the logical treatment is
vagotomy alone — and indeed this has
a very low mortality — the rate of
second recurrence is prohibitive (24%).
The combination of vagotomy and
antrectomy has been performed very
infrequently and carries an unaccept
able operative mortality (9%). The
operation of choice therefore is partial
(two thirds) gastrectomy, after which
the recurrence rate is 11%. Vagotomy
alone should be reserved for patients

Table I I — O verall Results of Surgical Treatm ent for R ecurrent U lcer

Diagnosis

The diagnosis of recurrent ulcer is
made from the history, by roentgeno
graphy and especially by endoscopy.
While secretory and other studies are
of enormous value in the management
of individual proven cases, the opinion
that these investigations are of diag
nostic value should be abandoned. Re
currence of epigastric or left upper

secutive days. If the values for acid
secretion and serum gastrin are equivo
cal the diagnosis can be established by
means of the secretin infusion test.17
In ZES there is an immediate increase
in serum gastrin in response to intra
venous secretin whereas in other pa
tients with recurrent ulcer, including
those with retained antrum, there will
be the expected fall in gastrin concen
tration.18
Serum calcium is measured in all
patients with recurrent ulcer to rule
out the rare parathyroid adenoma.
If the ulcer is not drug-induced,
medical treatment is usually unsatis
factory7 and should be reserved for
patients in whom the risk of operation
is too great. If ZES is proved, the cor
rect treatment is total gastrectomy. A
retained antrum should be excised. Hy
perparathyroidism should be treated
surgically before surgical treatment of
recurrent ulcer is considered.
An excellent review of the literature7
from 1950 to 1974 yielded reports of
over 3400 surgically treated cases of
recurrent ulcer; the important results
are summarized in Table II. The authors
make the valuable observation that any
operation that does not reduce acid out
put will fail in an unacceptably high
proportion of cases.
There is, however, no single correct
surgical treatment of recurrent ulcer.
Surgical management depends entirely
on the nature of the initial operation
(Table III).

Operation
Vagotomy or repeat vagotomy
Resection
Repeat resection
Vagotomy or repeat vagotomy and
resection
Vagotomy or repeat vagotomy and
repeat resection
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No. of
patients

Operative
m ortality, %

Second
recurrence, %

888
957
387

1.1
2.9
6.5

15
12
21

76

7.9

8

241

5.4

8

2549

3.2
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who are poor risks or hyposecretors
and in whom the ulcer is uncompli
cated.
Recurrent Ulcer after Partial
Gastrectomy
The first step is to exclude the pos
sibility of retained antrum if the
anastomosis is of a Billroth II type.
This will usually have been achieved
by the essential investigations noted
above. In addition, it may be useful to
obtain a technetium pertechnate scan,
which will identify a “hot spot” to the
right of the main stomach uptake if as
little as 1 cm of antrum is present.19
Direct proof is theoretically possible
by endoscopic visualization and biopsy
of antral mucosa by way of the af
ferent limb of the stoma. If retained
antrum is identified it should be ex
cised, but if it can be ruled out then
vagotomy alone is sufficient. Vagotomy
carries a low mortality (1.0%) and an
acceptable recurrence rate (12%). Re
peat resection is accompanied by a
prohibitive mortality (7%) and is much
less likely to provide a permanent
cure.20
Recurrent Ulcer after Vagotomy
and Drainage
The underlying cause is always an
incomplete vagotomy (if ZES has been
excluded). There are only three case
reports in the literature of properly
performed insulin tests giving persist
ently negative results and it is not
known if these patients with recurrent
ulcer after vagotomy were using ul
cerogenic agents.21'22 It can therefore be
argued that an insulin test is unneces
sary as its result can be predicted. Most
investigators nevertheless continue to
use the insulin test to assess complete
ness of vagotomy in this situation.
Certainly, if the MAO data obtained
before the initial operation are avail
able, a repeat MAO study is simpler
and quite adequate — a reduction in
acid output of less than 50% and a
BAO of more than 2 m m ol/h are in
dicative of incomplete vagotomy.23 The
converse does not follow. It cannot be

assumed that in the patient with an
incomplete vagotomy as determined by
tests of acid secretion a recurrent ulcer
has developed, or inevitably will de
velop. It is quite wrong to reoperate
on an asymptomatic patient to com
plete a vagotomy.
The approach we have adopted in
recurrences following vagotomy is to
explore the hiatus abdominally. If a
substantial vagal trunk is found (and
there is usually a large posterior trunk)
we perform vagotomy alone, provided
there is no stomal stenosis. If no vagal
trunk can be identified we employ
antrectomy. There is insufficient re
ported experience of this approach to
provide data on its results. It must
carry a lower morbidity and mortality
than the alternative of antrectomy in
all cases.
Recurrent Ulcer after Vagotomy
and Antrectomy
As this occurs much less frequently
than recurrence after vagotomy and
drainage the reported experience is
even more limited. Again, the cause is
almost always incomplete vagotomy,
and the insulin test will be positive. In
this event the patient should be man
aged in the same way as after vagotomy
and drainage. The hiatus should be
explored and if a vagal trunk is found
vagotomy alone is performed; if no
significant nerve is identified, repeat
resection should be undertaken. In the
rare event of the insulin test being
negative on two occasions (and assum
ing that drug and hormonal factors
have been excluded) there is little al
ternative but to perform subtotal gas
trectomy.
Emergency Management of
Recurrent Ulcer

Hemorrhage
This is a common presenting symp
tom of recurrent ulcer, and massive
bleeding is more likely to require sur
gical control than bleeding from a
primary duodenal ulcer. If at laparo
tomy the surgeon is astute enough to

T a b le I I I — In v e s t ig a t io n o f P r o v e n
In d ic a t io n
M a n d a t o r y t e s ts

O p t io n a l t e s ts

R e c u r r e n t U lc e r

Test
—

A b n o rm a l o r e q u iv o c a l
s e r u m g a s t r in a n d
BA0/M A0
P r e v io u s v a g o t o m y
P r e v io u s B illr o t h II
re s e c tio n

D ia g n o s is

S e r u m g a s t r in
S e ru m c a lc iu m
BA0/M A0

Z E S o r re ta in e d a n t r u m
H y p e r p a r a t h y r o id is m
Z E S o r re ta in e d a n t r u m

S e c r e t in in f u s io n te s t
H o lla n d e r in s u lin te s t

ZE S
In c o m p le te v a g o t o m y

T e c h n e t iu m sc a n

R e ta in e d a n tru m

Z E S = Z o ll in g e r - E l lis o n s y n d r o m e ; B A 0 / M A 0 = b a sa l a c id o u tp u t/ m a x im a l a c id o u tp u t.
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recognize an ulcerogenic tumour of the
pancreas then unquestionably the cor
rect treatment is immediate total gas
trectomy.24 Fortunately, this lesion is
rare.
Under normal circumstances the first
step will be to obtain control of the
bleeding vessel by direct suture using
a large needle mounted with nonab
sorbable material. If the patient’s con
dition is still unstable, a pause at this
stage while blood is replaced often pays
dividends. In the very poor-risk patient
the operation can be terminated at this
point with a view to elective reopera
tion. Otherwise, the next step is deter
mined by the nature of the previous
operation. If vagotomy has not pre
viously been performed, or is found
to be incomplete, vagotomy alone is
added. If there has been what appears
to be a complete vagotomy, resection
or repeat resection is performed.
Perforation
Unlike hemorrhage this is quite rare,
representing only 1% of all perfora
tions.25 Experience is meagre and sug
gests that this complication should be
handled like any other perforation,
namely by simple patching. If the pa
tient is young and otherwise healthy,
if it is less than 8 hours from the time
of perforation, and if contamination is
minimal, definitive surgery can he con
sidered. Rarely, a large perforation will
demand immediate gastrectomy. If
there is concern about gastric emptying
it is advisable to fashion a gastrostomy
for long-term gastric suction, and a
jejunostomy for enteral feeding. Pa
tients who have been treated by patch
ing should be fully investigated in the
convalescent period and managed sur
gically, exactly as any other case of
recurrent ulcer.
Gastrojejunocolic Fistula

This condition should be suspected
in any patient who presents with diar
rhea, steatorrhea and weight loss after
gastric surgery,13 and especially after a
gastroenterostomy. The diagnosis is
confirmed by barium enema and by
endoscopy. With the advent of safe
total parenteral nutrition there should
be no need for the former staged pro
cedures. Once the metabolic disorders
have been resolved and the bowel pre
pared, the surgeon should proceed to
a one-stage resection of the fistula and
en-bloc revision gastrectomy.26
Recurrent Gastric Ulcer

This is quite uncommon unless the
initial gastric ulcer was treated by vago
tomy and drainage.27 As with a recur
rence after surgery for duodenal ulcer,
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it is first mandatory to exclude ulcero
genic agents, retained antrum and hor
monal causes such as hyperparathyroid
ism and ZES. The surgical treatment
will then depend on the initial opera
tive procedure. If the first operation
was vagotom y and drainage, partial
gastrectomy should be performed; if
it was vagotomy and antrectomy, then
repeat vagotomy and revision gastrec
tomy are undertaken; and if the initial
operation was partial gastrectomy, the
operation of choice is vagotomy and
subtotal gastrectomy. In every instance
the gastric ulcer should be excised
along with the gastrectomy specimen.
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AMINOSYN INDICATIONS AND CLINICAL USES
Aminosyn 5% Injection is indicated for peripheral vein infusion as
a source of nitrogen in the intravenous treatment of acute surgical
patients with adequate stores of body fat, in whom, for short
periods of time, oral nutrition cannot be tolerated or is not desira
ble. In such instances, the patient's caloric needs are met from
their own fat stores.
Amino acids when administered with concentrated dextrose solu
tions also are indicated for central vein infusion as an adjunct in
the prevention of nitrogen loss or in the treatment of negative
nitrogen balance in patients where: (1) the alimentary tract, by the
oral, gastrostomy or jejunostomy route, cannot or snould not be
used, (2) gastrointestinal absorption of protein is impaired, or
(3) metabolic requirements for protein are substantially increased,
as with extensive burns. In such usage, intravenous feeding for
prolonged periods, up to 100 days or more, has been success
fully employed7 .

CONTRAINDICATIONS
This preparation should not be used in patients with hepatic coma
or anuria or metabolic disorders involving impaired nitrogen utili
zation. Patients with azotemia from any cause should not be in
fused with amino acids without regard to total nitrogen intake.

WARNINGS
Peripheral intravenous infusion of amino acids may induce a rise
in blood urea nitrogen (BUN) especially in patients with impaired
hepatic or renal function. Appropriate laboratory tests should be
performed periodically and infusion discontinued if BUN levels
exceed normal post-prandial limits, and continue to rise. It should
be noted that a modest rise in BUN normally occurs as a result of
increased protein intake.

PRECAUTIONS
Safe use during pregnancy has not been established: therefore,
infusion of amino acids should be undertaken during pregnancy
only when this is deemed essential to the patient s welfare as
judged by the physician.
1 . Protein-sparing (peripheral use)
When amino acids (without dextrose) are infused peripherally,
care should be taken to avoid oral ingestion of carbohydrate or
infusion of carbohydrate-containing solutions if fat mobilization is
desired as the source of energy. Otherwise, full utilization of body
fat may not occur.
Serum electrolytes should be monitored and appropriate electro
lytes added to the daily infusion regimen. Acid-base balance also
should be monitored and disturbances in equilibrium corrected as
needed The amino acid solution as formulated has no potential
for increasing hydrogen ion concentrations.
Do not withdraw venous blood for blood chemistries through the
peripheral infusion site, as interference with estimations of
nitrogen-containing substances may occur.
Intravenously administered amino acids should be used with cau
tion in patients with history of renal disease, pulmonary disease,
or with severe congestive heart failure so as to avoid excessive
fluid replacement. The effect of infusion of amino acids, without
dextrose, upon carbohydrate metabolism of children is not known

24

peptic ulcerations of jejunum asso
on serum gastrin, serum calcium, and
ciated with islet cell tumours of pan
gastric acid secretion in a patient with
creas. Ann Surg 142: 70, 1955
suspected Zollinger-Ellison syndrome.
Stabile BE, P assaro E j r : Recurrent
Gastroenterology 62: 626, 1972
peptic ulcer. Gastroenterology 70:
19. C haudhuri TK, C haudhuri TK,
124, 1976
Shirazi SS, et al: Radioisotopic scan
Barreras RF: Calcium and gastric se
— a possible aid in differentiating
cretion. Gastroenterology 64: 1168,
retained gastric antrum from Zol
1973
linger-Ellison syndrome in patients
Black BM: Primary hyperpara
with recurrent peptic ulcer. Gastro
thyroidism and peptic ulcer. Surg Clin
enterology 65: 697, 1973
North Am 51: 955, 1971
20. Walters W, C hance DP, B erkson J :
W ychulis AR, P riestly JT, F oulk
Comparison of vagotomy and gastric
WT: Study of 360 patients with gasresection for gastrojejunal ulceration:
trojejunal ulceration. Surg Gynecol
follow-up study of 301 cases. Surg
Obstet 122: 89, 1966
Gynecol Obstet 100: 1, 1955
C ondon JR, T anner NC: Retrospec 21. Bachrach WH, Bachrach LB: Retive review of 208 proved cases of
evaluation of the Hollander test. Ann
anastomotic ulcer. Gut 9: 438, 1968
NY Acad Sci 140: 915, 1967
E verson TC, A llen MJ: Gastro22. Kay AW: Memorial lecture: an evalu
jejunal ulceration. Arch Surg 69: 140,
ation of gastric acid secretory tests.
1954
Gastroenterology 53: 834, 1967
Bondar GF, Y akimets WW, W il  23. R uckley CV: Tests for completeness
liams HTG, et al: Diagnosis and
of vagotomy and their clinical signif
management of stomal ulcer. Can J
icance. Clin Gastroenterol 2: 413,
Surg 7: 383, 1964
1973
E llis K: Gastrojejunal ulcer. Radiol 24. Way L, G oldman L, D unphy JE:
ogy 71: 187, 1958
Zollinger-Ellison syndrome. An anal
Samloff IM, Secrist DM, P assaro
ysis of twenty-five cases. Am J Surg
E j r : The effect of betazole on serum
116: 293, 1968
group I pepsinogen levels: studies in 25. C ohen MM: Perforated peptic ulcer
symptomatic patients with and without
in the Vancouver area: r survey of
recurrent ulcer after vagotomy and
852 cases. Can Med Assoc J 104:
gastric resection or drainage. Gastro
201, 1971
enterology 70: 1007, 1976
26. A mlicke JA, P onka JL: Gastrocolic
Baron JH: The clinical application
and gastrojejunocolic fistulas. A report
of gastric secretion measurements.
of sixteen cases. Am J Surg 107: 744,
Clin Gastroenterol 2: 293, 1973
1964
I senberg JI, Walsh JH, G rossman
27. Zahn RL, Stemmer EA, H om LW,
MI: Zollinger-Ellison syndrome. Gas
et al: Delayed recurrence of gastric
troenterology 65: 140, 1973
ulcer following vagotomy and drain
I senberg JI, Walsh JH, P assaro E
age procedures. Am Surg 34: 757,
j r , et al: Unusual effect o f secretin
1968

2.

Adjunctive for total parenteral nutrition
For long-term total nutrition, or if a patient has inadequate fat
stores, it is essential to provide adequate exogenous calories
concurrently, if parenterally administered amino acids are to be
retained by the body and utilized for protein synthesis. Concen
trated dextrose solutions are an effective source of such calories.
Special care must be taken when giving hypertonic glucose to
diabetic or pre-diabetic patients. In such cases crystalline insulin
should be added to the solution8. Such strongly hypertonic nu
trient solutions should be administered through an indwelling in
travenous catheter with the tip located in the superior vena cava.

ADVERSE REACTIONS
See WARNINGS and DOSAGE AND ADMINISTRATION
Peripheral Infusions
Local reactions consisting of a warm sensation, erythema,
phlebitis and thrombosis at the infusion site have occurred with
peripheral intravenous infusion of amino acids particularly if other
substances, such as antibiotics are also administered. In such
cases the infusion site should be changed promptly to another
vein. Use of large peripheral veins and slowing the rate of infusion
may be helpful in decreasing the incidence of local venous irrita
tion. Electrolyte additives should be spread throughout the day.
and irritating additive medications may need to be injected at
another venous site. Generalized flushing, fever and nausea also
have been reported during peripheral infusions of crystalline
amino acids.

_ DOSAGE AND ADMINISTRATION

1 . Protein-sparing (peripheral vein)
This preparation (without dextrose) can be administered by the
peripheral intravenous route. It should not be infused via a central
vein, unless it is admixed with sufficient dextrose to provide full
caloric energy requirements in patients who require prolonged
total parenteral nutrition.
For peripheral intravenous infusion, 1 to 1.5 g/kg/day of total
amino acids will achieve optimal fat mobilization and spare protein
catabolism if no carbohydrate is infused or ingested.
As with all intravenous fluid therapy, the primary aim is to provide
sufficient water to compensate for insensible, urinary and other
(nasogastric suction, fistula drainage, diarrhea) fluid losses.
Those requirements as well as electrolyte and acid/base needs
should be estimated and appropriately prescribed.
Given an amino acid solution of specified total concentration, the
volume required to meet amino acid requirements per 24 hours
can be calculated. Then, after making an estimate of the total daily
fluid (water) requirement, the balance of fluid needed beyond the
volume of amino acid solution required, can be provided as a
non-carbohydrate electrolyte solution. Vitamins and additional
electrolytes (except bicarbonate) as needed to correct imbalances
may be added to the amino acid solution. If desired, one-half of an
estimated daily amino acid requirement of 1.5 g/kg can be given
on the first day. The degree of fat mobilization can be gauged by
the presence and amount of acetonuria Amino acid dosage may
be increased on the second day. Amino acid infusion into a
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peripheral vein can be continued as long as oral nutrition is im
paired. However, if a patient is unable to take oral nourishment at
the end of 5 to 7 days, institution of total parenteral nutrition with
exogenous calories should be considered.
2 . Adjunctive for total parenteral nutrition
For central vein infusion with concentrated dextrose solution, the
total daily dose of the amino acid solution depends on daily pro
tein requirements and on the patient’s metabolic and clinical re
sponse. The determination of nitrogen balance and accurate daily
body weights, corrected for fluid balance, are probably the best
means of assessing individual protein requirements. For patients
in a stable metabolic condition the provision of amino acids as a
3.5% concentration with 20 to 25% dextrose is usually considered
adequate. Vitamins, minerals and electrolytes should be added as
indicated.

DOSAGE FORMS
Aminosyn 5% Injection is supplied in 1000-ml ABBO-VAC*
containers.
A 1000-ml unit provides a total equivalent of 50 g of protein and
7.86 g of nitrogen. Each 100 ml contains crystalline amino acids
5 g and potassium metabisulfite not more than 60 mg (equivalent
to 5.4 mEq K*/litre); pH 5.25 (approx ), adjusted with acetic acid
30 mEq/litre (approx.).
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4. Panel Discussion on Peptic Ulcer Disease*
Chairman: B.J. P erey, md, FRCs[c]f
Panelists: M.M. Cohen , P.J. Doris, J.C. G oligher and K.N. J eejeebhoy

Dr. Perey: I would like to welcome
Professor Goligher of Leeds, who has
agreed to join our panel. Professor
Goligher, we have always been inter
ested in the results of various prospec
tive randomized studies that you have
conducted over the years in the field
of gastrointestinal surgery. Have you
conducted or are you currently con
ducting such a study of this new opera
tion of proximal selective vagotomy,
which allows you to decide how good
an operation it is?
Prof. Goligher: Although we are
very attracted to controlled trials in
gastric surgery, we did not conduct
such a trial of proximal selective vago
tomy. When we began, we couldn’t get
enough surgeons to participate in a
controlled trial of this rather peculiar
operation, but when the trial got under
way and the results seemed so good,
surgeons were so happy with it that
they wouldn’t agree to do any other
operation. So a controlled trial was out
of the question and though we have
performed this operation now in nearly
600 patients (about 400 of them with
duodenal ulcer), we have no properly
controlled data. We have to make re
trospective comparisons with the results
of other operations. Of course we have
been interested in the trials carried out
by other surgeons, like Kennedy. He
has recently found a 10% recurrence
rate following this operation, which is
rather daunting, and I think that’s the
only question that remains. It is safer
than most operations, it has fewer side
effects and gives wonderful functional
results. How often does it prevent re
currences? That’s the thing we want to
know.
Dr. Perey: I would ask Dr. Jeejeebhoy
what he foresees as happening to the
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the Canadian Association o f General
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role of surgery in duodenal ulcer in
years to come in view of the new
drugs now available?
Dr. Jeejeebhoy: I can only guess. I
think that there will continue to be a
place for surgery in the foreseeable
future. There will continue to be ulcer
complications, and patients who do not
tolerate the medication for long periods
of time. Also, we do not know what
are the long-term effects of cimetidine.
Recent reports suggest that low-dosage
prophylaxis with cimetidine probably
is not very effective.
Prof. Goligher: I don’t know to what
extent cimetidine is used in Canada. It
is certainly used a great deal in Britain
at the moment. Many surgeons find
that fewer patients are now referred for
surgery because internists and general
practitioners are now treating ulcers
with cimetidine, so that there has been
a considerable diminution in the num
ber of surgical cases. I have a feeling
that this medical treatment cannot go
on for ever and that persons with
chronic ulcers will eventually require
surgery.
Dr. Perey: Dr. Cohen, would you also
comment on the influence of cimetidine
on the role of surgery?
Dr. Cohen: I think it is irrational to
expect that cimetidine will be the an
swer to the treatment of peptic ulcer
because the patient has to continue
taking the drug for the rest of his
life. Walmsley has reported on seven
patients who were maintained for 1
year on metiamide, which acts like
cimetidine. One of them had bleeding
while taking the drug metiamide. As
soon as treatment was stopped, the
ulcer recurred dramatically in two other
patients and an asymptomatic recur
rence developed in the other four. I
think the only way to cure an ulcer
permanently is by surgery.
Dr. Perey: Dr. Jeejeebhoy, is there any
place for cimetidine in the management
of the Zollinger-Ellison syndrome?
Should it be tried first before resorting
to surgery, and does it work?
Dr. Jeejeebhoy: Reports have suggested
that patients with the Zollinger-Ellison
syndrome will benefit from cimetidine,
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but with time there is a fairly high
incidence of breakthrough. I think that
breakthroughs have occurred because
of the presence of significant metastases. The drug would probably be
useful in cases where preservation of
the stomach is particularly desirable,
as in patients who have difficulty in
gaining weight. However, if a break
through occurs, the necessity for sur
gery is obvious. We have two patients
with proven Zollinger-Ellison syndrome
who currently are taking cimetidine
and they are doing quite well. One of
them had an inadequate operation in
the past and he doesn’t want to have
another one.
Dr. Perey: Let us now go on to some
thing else. Is there any test of gastric
secretion that helps in deciding whether
an operation is indicated, or in choos
ing the best type of procedure? Let us
hear from Dr. Doris.
Dr. Doris: In general terms, secretory
tests do not provide sufficient informa
tion that allows me to select the type
of operation. However, I do use secre
tory tests to detect the rare patients
with the Zollinger-Ellison tumour, al
though serum gastrin determinations
make these tests less necessary. Also,
marked acid hypersecretion is signifi
cant in the case of patients who have
typical ulcer symptoms but no ulcer
visible on roentgenographic or endo
scopic examination. In routine practice,
gastric analysis is of little practical
consequence.
Dr. Perey: So you’re telling us that
secretory tests are important to estab
lish whether or not we are dealing with
a common garden variety of duodenal
ulcer, but beyond that they don’t help
much. Professor Goligher, would you
like to express your view?
Prof. Goligher: I would go along with
Dr. Doris. We’ve done hundreds or
even thousands of these secretory tests
in my department over the last 25
years and they’ve had some academic
interest but they haven’t really helped
us in deciding on the type of operation
to perform or whether operation was
necessary, because we haven’t tried to
tailor the operation to the patient.
We’ve always chosen the smallest
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possible and the safest operation that
would be reasonably effective. So even
if we knew the patient had high acid
secretion we would still do a relatively
limited operation. I haven’t been very
impressed with the efforts of groups
who have tried to select the patients
for different types of operations. I
would also add that it is almost easier
to perform a satisfactory gastric opera
tion than a satisfactory secretory test.
You need a good organization for doing
a satisfactory test.
Dr. Perey: So in these days of financial
and budget constraints, you two gentle
men are suggesting that perhaps we are
wasting the taxpayers’ money on these
tests. But there may be other view
points. I understand, Dr. Cohen, that
you may consider this matter differ
ently.
Dr. Cohen: Yes, in part. I do not be
lieve that you can specifically tailor
the operation on the basis of the acid
secretory data, but I do believe that it
is mandatory to obtain acid secretory
data, in particular the maximal acid
output (MAO), before operating on a
patient with duodenal ulcer. As Dr.
Doris has said, this can prevent you
from doing the wrong operation on a
patient with the Zollinger-Ellison syn
drome. Also, you do not want to oper
ate on a patient who is achlorhydric.
Finally, by measuring the maximal acid
output both pre- and postoperatively,
you can avoid having to do the insulin
test, which is more hazardous. When
vagotomy produces a 70% reduction
in the MAO, it is complete and the
insulin test is not needed. I also think
that the most restricted operation
should be done, and as far as I’m con
cerned, that is truncal vagotomy and
drainage. If, however, the patient is
a really massive hypersecretor — by
that I mean putting out 50 mmol/h
or more — then I think that an antrec
tomy should be done as well.
Dr. Perey: On what basis do you hold
that opinion?
Dr. Cohen: Because the data provided
by Kronborg show that patients who
have acid secretion of more than 45 to
50 mmol/h do badly with vagotomy
and drainage.
Dr. Perey: Are the other members of
the panel aware of studies such as
Kronborg’s that would support Dr.
Cohen’s approach?

Dr. Perey: But Professor Goligher, do
I understand that you have recurrences?
Prof. Goligher: Naturally, we do have
recurrences. But most of our recur
rences after proximal gastric vagotomy
have occurred in the last year. Among
300 male patients we now have 7
proven recurrences and about 10 others
that are dubious. We do not know what
the number will be when our follow-up
period reaches 5 years as for other
operations. I can’t see why the recur
rence rate with this operation should
be any less than after truncal vagotomy
and drainage.
Dr. Perey: We all probably agree on
this. Before we leave the subject of
gastric analysis I would like to ask Dr.
Jeejeebhoy, as a gastroenterologist,
what he thinks about the value of this
test?
Dr. Jeejeebhoy: From what I have
heard from the panel members, I would
say that much of the evidence on which
we have estimated the worth of gastric
analysis is anecdotal. Whether there is
any advantage in modifying the opera
tion according to gastric acid output
remains to be shown by well-controlled
randomized studies. Without that kind
of data it remains unproven at this
time. I would like to enlist surgeons
who would be prepared to cooperate
with me in carrying out clinical trials.
Dr. Perey: Should we select the best
operation and employ it in almost all
patients or is it your opinion that we
should choose from a number of pos
sible procedures the one most appropri
ate for each patient? May we put this
question first to you, Professor Gol
igher?
Prof. Goligher: I have already declared
that I am a believer in the most limited
Operation that is likely to be reasonably
effective, for if this fails you can al
ways reoperate and perform a more
major one. I think that for practical
purposes this is a good doctrine, but
it is not one that is popular in the
United States. You can do 400 of
these new operations with no deaths,
but you cannot do 100 vagotomies and
antrectomies as a rule without at least
one death and perhaps more. It’s a
much more dangerous operation. You
can always operate on a patient again
for recurrent ulcer. That is my philo
sophy, stated quite boldly and un
equivocally.

Prof. Goligher: I’m well aware of this
work. We recently analysed our cases
that were treated by proximal gastric
vagotomy (parietal cell vagotomy).
Using Kronborg’s criteria we did not
find that there was a higher incidence
of recurrence in the patients with very
high acid secretion or a lower incidence
VOLUME 21, NO. 1, JANUARY 1978

in the patients with low acid secretion,
so we regard the verdict as unproven.
I have a high regard for this Danish
surgeon’s work, but I must say our
results haven’t been in agreement with
his.

Dr. Perey: So you’re in favour of the
/

minimal operation, whichever it may
be, for everybody. Dr. Doris?
Dr. Doris: I agree with Professor
Goligher’s statement. This is a matter
of philosophy. I feel that there is a
specific place for each of proximal
selective vagotomy, vagotomy and py
loroplasty, and vagotomy and antrec
tomy in duodenal ulcer disease. But I
know of no way to decide which pa
tient should get which operation.
Therefore, my philosophy is to start off
with a proximal selective vagotomy.
Dr. Perey: But does this mean you are
going to use all the others afterwards
on the same patient?
Dr. Doris: Quite possibly. I have not
had to reoperate on any patient after
my very short follow-up.
Dr. Perey: Dr. Jeejeebhoy, would you
like to venture some comments on this
topic?
Dr. Jeejeebhoy: I think that in the pres
ence of a duodenal ulcer one could first
try cimetidine. You would have no
morbidity and no deaths with that!
If you examine Walmsley’s data, the
recurrence occurred after an interval
of about 7V2 months and I would say
that if it were my ulcer, I would be
prepared to take cimetidine for 6 weeks
every TV?, months. Many diseases re
quire more medication than that, and
I do not consider this to be a major
imposition on most patients. I think
that recurrent ulcer disease can also be
managed with cimetidine — we have
done this in four patients — although
controlled trials will be required in
this regard.
Dr. Perey: Dr. Cohen?
Dr. Cohen: The important point is, can
you keep them healed?
Dr. Perey: If we had eight panelists we
would probably have eight different
opinions. Before closing, I have a few
short questions from the audience. Dr.
Jeejeebhoy, is there any acid rebound
after stopping cimetidine?
Dr. Jeejeebhoy: It is difficult to give
an answer because there are no good
data on which to base it.
Dr. Perey: Are there uses for cime
tidine in other acid peptic conditions
such as reflux esophagitis?
Dr. Jeejeebhoy: Oh yes! We are in the
process of carrying out a controlled
trial ourselves and there is now increas
ing evidence that it is significantly
useful.
Dr. Perey: Thank you gentlemen. On
behalf of the Canadian Association of
General Surgeons, I would like to thank
the panelists for their excellent pre
sentations.
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Current Status of Surgical Treatment for Ulcerative
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In ulcerative colitis surgery is most
often indicated because of frequent
relapses when there is evidence of
total or subtotal colitis. It may be
performed as prophylaxis against the
development of carcinoma of the large
bowel, especially when rectal biopsies
show epithelial dysplasia. The preferred
operation would seem to be colectomy
with ileorectal anastomosis, but the
results obtained by most surgeons
have been unsatisfactory. Therefore
the procedure most favoured is
ileostomy with proctocolectomy.
Ileostomy is now more accepted by
patients because of modern improve
ments in its management. To obviate
the necessity of an external appliance,
a continent or reservoir ileostomy
with a valve mechanism has been
devised, but this requires a highly
intricate operation which should be
performed only when the disease is
in remission.
When surgery is required during a
severe attack that has not responded
to intensive medical treatment, the
mortality rate is much higher than after
an elective procedure.
In Crohn's disease the type of
operation necessary depends on the
extent of the disease. Often an
ileorectal or ileosigmoid anastomosis
is possible, even when the possibility
of a recurrence is recognized, since
the recurrence may be long delayed.
La colite ulcereuse est tres souvent
une indication de chirurgie a cause des
rechutes frequentes lorsqu’il y a signe
de colite totale ou quasi totale.
L’intervention chirurgicale peut etre
effectuee prophylactiquement contre
le carcinome du gros intestin,
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its function by means of an ileorectal
anastomosis would seem an invitation
to further trouble. But what matters
in medicine is not so much what should
happen as what actually does happen,
and it must be admitted that the results
reported by Aylett,1'3 the leading ad
vocate of this operation for ulcerative
colitis, are remarkably good. At one
stage almost 90% of about 300 patients
treated by this method were highly
satisfied with the results of the pro
cedure. No one else seems to have been
able to obtain results quite as good
as these, although Turnbull4 and Watts
and Hughes5 have had up to 60% and
70% rates of success, respectively. On
the other hand Muir,6 Ault,7 Anderson,8
Griffen, Lillehei and Wangensteen,9
Baker,10 Adson, Cooperman and Far
row" and I12 have been much less im
pressed by the results of ileorectal
anastomosis — about half the patients
eventually needed rectal excision and
ileostomy. However, there has been a
revival of interest in this procedure in
Britain recently (Parks AG: Personal
communication, 1975; Hawley PR:
Personal communication, 1975).
One of the difficulties concerning the
controversy over the use of colectomy
with ileorectal anastomosis is the ab
sence in published reports of any clear
guidance as to which patients may do
particularly well after this operation
In this survey of the contemporary role and which will do badly.10 It seems
of surgery in the treatment of ulcerative reasonable to restrict the use of this
colitis and Crohn’s disease of the large method of treatment to patients with
bowel I should like to devote particu relatively mild changes in the rectum.
lar attention to a few of the outstand The ileorectal anastomosis should be
located at the upper end of the rectum
ing controversial issues.
and, because of the considerable risk
of subsequent anastomotic dehiscence,
Ulcerative Colitis
it would appear wise to follow Aylett’s3
Choice o f Operation
advice to establish a temporary covering
One controversial question concern loop ileostomy until the suture line has
ing ulcerative colitis, at least in the healed (Fig. 1).
The operation favoured by most
United Kingdom, is, What is the place
of colectomy with ileorectal anastomosis surgeons is ileostomy with proctocolec
in the management of this disease? It tomy or subtotal colectomy. To those
should be emphasized that the term familiar with the synchronous combined
“ulcerative colitis” is a misnomer; abdominoperineal technique for rectal
the condition ought to be called “ulcer excision, as is widely practised in Brit
ative proctocolitis”, for the rectum ain and many countries of the British
also is almost always involved. Con Commonwealth, it is simple to extend
sequently, to preserve the rectum and this operation upwards to include a

specialement lorsque la biopsie du
rectum revele une dysplasie epitheliale.
L’operation de choix semble etre une
colectomie avec anastomose ileorectale,
mais les resultats obtenus par la
plupart des chirurgiens ont ete peu
satisfaisants. Done, I'intervention qui
Iui est preferee est I’ileostomie avec
rectocolectomie. L'ileostomie est
maintenant mieux acceptee par les
patients grace aux ameliorations
recentes apportees a son maniement.
Pour parer a la necessity d’un dispositif
externe, une ileostomie avec controle
de continence, ou ileostomie avec
reservoir et systeme de soupape, a
ete mise au point; toutefois, celle-ci
exige une operation tres compliquee
qui ne devrait etre effectuee que
lorsque la maladie est en remission.
Ouand on doit recourir a la chirurgie
pendant une crise grave qui n’a pas
cede a un traitement medical intensif,
le taux de mortality est beaucoup
plus eleve qu'apres une intervention
elective.
Dans la maladie de Crohn, le type
d'operation necessaire depend de
I'etendue de la maladie. Souvent, une
anastomose ileorectale ou ileosigmoi'de
est possible, meme lorsque I’on
reconnait la possibility d'une recidive,
puisque celle-ci peut etre longuement
retardee.
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FIG. 1—Diagrammatic representation
of ileorectal anastomosis with proximal
loop ileostomy to protect anastomosis.
Note projecting active opening and reced
ing inactive opening of loop ileostomy.

colectomy and ileostomy. But if the
surgeon lacks this familiarity or is in
experienced in treating patients with
colitis, he should restrict the initial in
tervention to a subtotal colectomy and
ileostomy. In this case the sigmoido
rectal stump is brought out in the
suprapubic region as a mucous fistula
or, if the tissues are considered strong
enough to hold sutures, it is closed
and dropped back into the pelvis. It is
preferable to suture the stump to either
the anterior or posterior abdominal
wall to keep it readily available in case
a secondary ileorectal anastomosis is
ever required. But in most cases, al
though the patient makes a good recov
ery of general health, the persistent
inflammation in the rectal wall makes
an anastomosis unwise. Indeed, the
continued discharge of blood, mucus
and pus from the rectum may cause so
much inconvenience as to necessitate
its excision within a few months. Be
cause of the risk of malignant change,
the likelihood of eventual rectal excision
should always be considered, although
regular sigmoidoscopic review with rec
tal biopsy to confirm the absence of
epithelial dysplasia may permit a more
conservative attitude to this problem
(see below).
What is so daunting to the patient
about a proctocolectomy is the ileo
stomy, which initially impresses the
lay person, particularly a young woman
or teenager, as repulsive and unnatural.
Unquestionably the best way to over
come the patient’s apprehension is to
arrange for a confidential talk with an
ileostomist of similar age and social
background. This plan seldom fails to
secure the patient’s consent for opera
tion.
Ileostomy
The success of the operation depends
mainly on the ability of the surgeon to
provide a good ileostomy and to en
VOLUME 21, NO. 1, JANUARY 1978
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sure that the patient receives proper
instruction on its management.
Operative technique.—The siting of
the stoma is extremely important
because the patient will subsequently
wear an appliance adherent to the skin
immediately surrounding it. The sur
geon should make a separate circular
wound for the ileostomy away from
the main incision and not too close to
the umbilicus, the anterior superior
iliac spine, or the groin in order to
ensure a smooth flat skin surface to
which the bag can be affixed. Popular
sites for this wound are shown in Fig.
2, the lower one being preferable be
cause it is not at the waistline. The
surgeon should choose a tentative site
for the ileostomy before operation,
while the patient is both lying and
standing, and mark this point for his
guidance at the operation.
For ileostomy most surgeons now
use the technique of eversion and
primary mucocutaneous suture, first
described by Brooke13 (Fig. 3), which

FIG. 2— Common sites for circular or
trephine wound for terminal ileostomy in
relation to main laparotomy wound and
anatomical structures of anterior abdom
inal wall. Site A is inconvenient because
it lies on waistline; site B is preferable.

FIG. 3—Ileostomy technique. Ileal
stump is fixed by circumferential row of
3-0 silk sutures between anterior rectus
sheath and superficial layers of ileal wall
and leaf of mesentery, about 7.0 cm from
cut distal edge. End of bowel is then
everted by sutures between it and edges
of skin wound to produce ileal spout
about 3 cm long.

provides a soft, supple, projecting
ileostomy spout that shows no tendency
to stenose. It is probably wise to aim
for a completed ileostomy protrusion
of 2.5 to 3 cm; therefore the ileal
stump should extend 5 to 7.5 cm beyond
the skin before it is everted.
Appliances and care of the stoma.—
One of the great innovations in regard
to ileostomy was the introduction of
the adherent bag by Koenig and
Rutzen.14 The original bag was made
of rubber and was stuck to the skin by
a double-sided adhesive plaster or a
cement, similar to that used for re
pairing bicycle tires. The ileostomy
appliances fashionable today are made
of a plastic, odour-resistant, rustleproof material that is disposable; they
are often fixed to the skin in part by
washers of karaya gum. Many patterns
are available — two of the more popu
lar ones are illustrated in Figs. 4 and 5.
Of the complications that may occur
after an ileostomy, the most common
and troublesome is that of the soreness
of the skin around the stoma. This may
be due to sensitivity to the material
of the appliance or adhesive, or to
leakage of ileal contents with resulting
digestion of the skin. Factors predis
posing to leakage are a poor standard
of care in the fixation of the appliance,
loose watery motions and, occasion
ally, a poorly constructed stoma, for
example, one that does not project
adequately, or protrudes too much, or
is associated with a depressed scar in
the immediate peristomal skin or with
some other structural defect. Whatever
the initial cause of skin soreness, the
difficulty in keeping the appliance
stuck to a raw oozing surface predis
poses to leakage and a vicious circle
is established. The best way to break
this circle is for the patient to wear
karaya gum washers, or Stomahesive
(Squibb) or Reliaseal (Davol Interna
tional) squares between the flange of
the appliance and the abdominal skin.
These are good adhesive agents and at
the same time are nonirritating and
soothing to the raw cutaneous surface.
If the feces are particularly loose, antidiarrheal drugs such as codeine phos
phate (60 to 120 mg qid) or diphe
noxylate hydrochloride and atropine
(Lomotil) (2 tab, qid), may give them
a firmer consistency. Occasionally
severe structural abnormalities of the
stoma may necessitate refashioning or
resiting of the ileostomy.15,16
Although transient skin soreness oc
curs in 10% to 20% of ileostomy pa
tients, it can be eliminated or greatly
reduced with the aid of the measures
mentioned above in all but a small
proportion of the patients. A notable
advance in colorectal surgery in recent
years has been the evolution of ente
rostomal therapy as a recognized aux-
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FIG. 5— Coloplast patterned draining ileostomy bag.

Fig. 4b
FIG. 4— (a) Rear view of Hollister
draining bag. (b) Frilled cloth covering
bag worn by some patients over Hollister
bag to conceal feces.

iliary service for ileostomy and colos
tomy patients. We owe this advance
mainly to the foresight and energy of
Turnbull4 and Gill17 of Cleveland, Ohio.
The availability of a keen enterostomal
therapist can undoubtedly improve the
recognition of stomal difficulties and
help to bring them more quickly under
control.
Reservoir or continent ileostomy.—
K ock
(personal
com m unication,
30

1976)18'20 of Gothenburg has devised
the method of the continent or reser
voir ileostomy, in which a length of
ileum (40 to 50 cm) immediately
proximal to the stoma is folded on
itself, opened and anastomosed to make
a pouch or sump in which the feces
can accumulate and from which they
can be evacuated three or four times
a day by the passage of a tube
through the stoma into the reservoir.
Between intubations, if the operation
has been successful, there is no leak
age from the stoma and no need for
an external appliance, merely a piece
of gauze held in place with strapping.
This is naturally an attractive method
to many patients. Originally Kock18
thought that by constructing such a
reservoir an aperistaltic intestinal bag
would be produced, which would ex
hibit no tendency to expel feces spon
taneously. Experience soon showed
that this was not so, and that to
achieve anything like complete con
tinence, a nipple valve mechanism, in
the form of an intussusception of the
base of the exit conduit into the re
servoir (Figs. 6 and 7) producing a
sort of “unspillable inkwell” effect was
necessary. Then it was discovered that
prolapse of the intussusception valve
could take place (Fig. 8) resulting in
loss of continence and inability to pass
the tube into the reservoir (Kock NG:
Personal communication, 1976).20,21 In
his explanation for this prolapse Kock
(personal communication, 1976)20 drew
attention to the existence of a gap in
Ihe circumferential row of sutures at
the base of the valve, corresponding to
the coinciding mesenteries of the in-
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FIG. 6—Diagram of reservoir ileostomy
with 4- to 5-cm nipple valve on exit con
duit projecting into interior.
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FIG. 7—Completed reservoir fixed to
anterior abdominal wall.
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FIG. 9— Diagrammatic drawing of completed nipple valve demonstrating potential
gap at site of ingoing (A) and outgoing (B) mesentery, through which prolapse of
valve is thought to take place.

Fig. 8a
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Fig. 8b
FIG. 8— Radiograph showing reservoir
ileostomies, (a) Well-formed nipple valve,
indicated by clear area around tube on
upper part of reservoir, (b) Displaced
nipple valve producing sharp kink in exit
conduit.

going and outgoing portions of bowel
(Fig. 9). He believed that the valve
might extrude through this weak spot.
To counter this weakness he proposed
a modified technique for constructing
the nipple valve: as the bowel is intussuscepted into the reservoir it is
rotated 60° to 90° to separate the
mesenteries of the entering and leav
ing segments. In this new technique the
mesentery of the 8- to 10-cm length of
ileum earmarked for making the nipple
valve is split exactly at its middle (Fig.
10). One or two silk sutures are then
inserted on one side of the bowel
proximally and passed through the
mesenteric gap to be inserted on the
other side distally. Then, as the ileum
of the exit conduit is drawn into the
lumen of the reservoir, these sutures
VOLUME 21, NO. 1, JANUARY 1978
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FIG. 10—Preparation of nipple valve
by technique designed to rotate bowel as
it is intussuscepted and to separate ingoing
and outgoing mesentery. Mesentery cor
responding to 8- to 10-cm segment of
bowel that will be used for manufacturing
valve is divided at its middle. Fine silk
sutures are then inserted in one side of
bowel, proximally, they are passed through
mesenteric gap and are then inserted in
opposite side of bowel, distally.

are tied, the effect being to rotate the
bowel and separate the two portions of
mesentery. Further Lembert sutures of
silk are inserted around the basal part
of the intussuscepted bowel (Fig. 11).
Before the ileum is intussuscepted,
its peritoneal and muscle coats are
scarified by diathermy to encourage
the development of adhesions between
the apposed serosal surfaces after in
tussusception. Kock (personal com
munication, 1976) has recently aban
doned his technique'9 of suturing the
tissues of the nipple valve together
with two or three longitudinal rows of
silk stitches inserted through both
layers of bowel from within the lumen
of the reservoir, because it sometimes
led to the development of a fistula
through the substance of the valve with
nullification of its valvular effect.

Certainly the major difficulty with
the reservoir ileostomy is to provide
an effective valve mechanism that will
endure. It remains to be seen whether
this new technique for manufacture
of the nipple valve will prevent it
prolapsing later, but the experience
with this innovation so far reported by
Kock (personal communication, 1976)
is encouraging, and this method has
given improved results in my own
smaller group of patients, although sub
sequent extrusion of the valve has still
occurred in a few cases.
In this connection it is appropriate
to discuss the legitimate role of the
reservoir ileostomy in the surgical man
agement of colitis. Obviously this pro
cedure, which involves extensive and
complex intestinal suturing, carries
risks of contamination, dehiscence,
leakage and sepsis that do not apply
to a conventional ileostomy operation.
These risks are greatly increased in
patients seriously ill during severe
acute phases of ulcerative colitis;
therefore a reservoir ileostomy is con
traindicated at the time of the initial
excisional surgery unless the disease is
temporarily in full remission. The ideal
candidate for a reservoir ileostomy is,
in my view, one who has already un
dergone proctocolectomy and conven
tional ileostomy but who wishes the
latter to be converted to a reservoir
ileostomy because of persistent prob
lems in the management of the stoma,
or for various deeply felt psychologic
or social reasons. It is certainly im
portant that the patient who wants a
reservoir ileostomy should be firmly
dedicated to this idea, for complications
after this operation are common; even
in very experienced hands at least half
the patients need one or more addition
al operations before a satisfactory con-
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FIG. 11—Preparation of nipple valve by rotation technique. As exit conduit is
drawn into lumen of reservoir, sutures are tied and produce rotation of bowel and
separation of ingoing (A) and outgoing (B) mesentery, best seen in diagrammatic
cross-section.

tinent ileostomy is obtained. A reservoir
ileostomy is generally considered inad
visable in patients undergoing colectomy
for Crohn’s colitis because if the dis
ease recurs the recurrence is most
likely to be located just above the
stoma. In a patient with a reservoir
ileostomy that would mean in the re
servoir itself, and its removal would
thus necessitate sacrifice of a con
siderable segment of precious lower
ileum. Finally the construction of an
efficient reservoir ileostomy is tech
nically a highly demanding operation
and unless the surgeon is engaged in
the exercise fairly frequently, he is un
likely to master its intricacies.
Indications for Surgery
Elective operation.—The common
est indication for elective surgery is
chronic invalidism and the occurrence
of frequent relapses, generally in
patients with radiologic evidence of a
total or subtotal colitis. However,
especially in older patients, a more
limited distal proctocolitis confined to
the rectum and sigmoid colon may
produce enough recurrent problems to
require operation.
A debatable issue is the use of
surgery as a measure of prophylaxis
against the well-recognized risk of car
cinoma of the large bowel in patients
with long-standing and extensive colitis.
Certainly in the past we have advised
ileostomy and complete proctocolec
tomy to patients who have had total
colitis for 10 or more years,16,22 but,
as Svartz and Ernberg23 pointed out,
many of these patients have learned to
handle their disease satisfactorily and
to lead a reasonably normal existence
with relatively few symptoms. Conse
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quently it is often difficult, as I have
found, to induce them to accept an
operation involving an ileostomy, and
I have had the mortifying experience
of seeing several such patients, who
refused operation, return a few years
later with established and sometimes
incurable “colitis carcinoma”. More
recently some clinicians24 have con
sidered the presence of epithelial dys
plasia in rectal biopsy specimens as an
indication for prophylactic operation
in patients with a long history of ex
tensive colitis or, more correctly, the
absence of dysplasia as an indication
that it is safe, so far as risk of devel
opment of a carcinoma is concerned,
to continue with conservative manage
ment for a further period of 6 to 12
months. Just how reliable this plan
may be is questionable,25 but LennardJones and colleagues26 have given an
encouraging account of the conserva
tive management of patients with
ulcerative colitis monitored by rectal
biopsy in this way.
Physical retardation in children with
severe extensive ulcerative colitis is
possibly another indication for resort
ing to elective surgery, which should
always be borne in mind in managing

these young patients. Contrary to ex
pectation, proctocolectomy and ileo
stomy are usually well tolerated by
children.
Arthritis, eye complications and skin
manifestations in association with co
litis often respond well to adequate
medical treatment of the underlying
bowel condition, but troublesome sys
temic and local anorectal complica
tions may necessitate proctocolectomy.
Urgent and emergency operations.—
These are life-saving operations un
dertaken at the height of severe attacks
that have not responded to medical
treatment. Unfortunately they are not
always successful in their objective, for
some of these patients are extremely
ill at the time they undergo operation
and the operative mortality may be
four or five times greater than that
after elective operations (Table I). In
most patients admitted with a severe
attack of colitis it is usual to give a
short course of intensive medical treat
ment with high doses of steroids. If at
any stage during this treatment there
is toxic dilatation or perforation of the
colon, immediate operation is required.
If no such complications occur, the
medical treatment is continued, but if
by the end of about 1 week there are
no unequivocal signs of commencing
remission of the attack, urgent laparo
tomy is advised.
A procedure that has attracted much
attention in recent years for the man
agement of such cases, is that of loop
ileostomy with decompressing trans
verse or sigmoid colostomy, recom
mended by Turnbull and associates27
specifically for patients with toxic me
gacolon. It is particularly suitable for
the management of megacolon when
there is an associated sealed perfora
tion, for, if a colectomy is performed,
the perforation is unsealed and inevi
tably there is a contamination of the
peritoneum by feces. But if there is no
colonic dilatation (and in my experi
ence more than half the patients re
quiring urgent surgery for colitis have
no megacolon), or if there is megacolon
but no sealed perforation is present.
I prefer to perform an ileostomy and
subtotal colectomy or complete procto
colectomy, as I do also for patients with
free perforation into the peritoneal

T a b le 1— O p e r a tiv e M o r t a lit y in U lc e r a tiv e C o litis A c c o rd in g to U rg e n c y o f O p e ra tio n ,
1952 to 1977
N o. of
p a tie n ts

O p e r a tiv e
m o r ta lity (a n d % )

E le c tiv e o p e ra tio n
U r g e n t and e m e rg e n c y o p e ra tio n s

420
135

13 ( 3 )
22 (1 6 )

A ll o p e ra tio n s

555

35 ( 6 )
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cavity. But the results reported by
Turnbull, Weakley and Hawk*8 for
ileostomy with decompressing colos
tomy are challengingly good; there was
only one operative death in 57 patients
so treated.
Crohn’s Disease

Crohn’s disease has a wide distribu
tion in the alimentary tract and occa
sionally occurs elsewhere, but in most
cases the lesions are found in the lower
portion of the small bowel or, increas
ingly in the last 10 to 15 years, in the
large bowel.16 I shall consider only
Crohn’s disease confined mainly or
entirely to the colon and rectum (Fig.
12). Medical measures, as for ulcerative
colitis, with steroids and salicylozosulfapyridine are, in my experience, often
effective in securing a remission of
exacerbations of symptoms, but often
surgical treatment is required eventual
ly. Occasionally, in patients with
localized lesions, this may entail
a restricted colonic resection with
colocolonic or ileocolonic anastomosis,
or an abdominoperineal excision of the
rectum with terminal iliac colostomy,
but far more frequently one of the
standard operations for colitis is needed
— colectomy with ileosigmoid or ileorectal anastomosis, or ileostomy with
subtotal colectomy or complete procto
colectomy. Often these operations must
be combined with resection of a vari
able amount of terminal ileum if there
is associated ileal involvement. One
consequence of this ileal resection is
that the ileostomy tends to be more
active, and antidiarrheal agents such as
codeine phosphate are often required
to make it manageable. The other con
sequence is that owing to disturbance of

T a b le I I — R e c u rre n c e a f t e r L a rg e B o w e l E x c is io n a n d Ile o s to m y o r C o lo s to m y A c c o rd in g
to V a r io u s A u th o r s
C a s es
fo llo w e d

A u th o r
N u g e n t a n d a s s o c ia te s , B o s to n , M A , 197339
R itc h ie a n d L o c k h a r t-M u m m e ry , L o n d o n ,
U K , 197331
S te in b e rg a n d a s s o c ia te s , B irm in g h a m , U K , 197430
K o r e litz a n d a s s o c ia te s , N e w Y o rk , 197240
G o lig h e r, L e e d s , U K , 1 9 7 6 33

the enterohepatic circulation of bile
salts these patients are predisposed to
the development of gallstones.29 The
fact that the rectum (or rectum and
sigmoid) is spared in about 30% of
patients with Crohn’s disease of the
large bowel makes a colectomy with
ileorectal or ileosigmoid anastomosis
fairly frequently a logical and attractive
means of treating this condition. Al
though recurrence, usually just above
the anastomosis or in the rectal stump,
is not uncommon after this opera
tion,11-30'33 a reasonable argument can
be advanced for its use, where feasible,
at any rate as a temporary measure. It
has generally been considered, how
ever, that ileostomy and complete proc
tocolectomy yield superior results with
respect to recurrence in Crohn’s disease
of the rectum and colon. 3435 Indeed,
soon after the pathological and clinical
features of Crohn’s disease affecting
chiefly the large bowel were first clear
ly defined by Lockhart-Mummery and
Morson,38-37 many gastroenterologists
formed the impression that the results
of its surgical treatment, particularly by
ileostomy and complete proctocolec
tomy, would be much better than the
50% 5-year recurrence rate after re
section for Crohn’s disease affecting
mainly the small bowel.34-38 But during
the 15 years that have elapsed several
careful follow-up studies have been
published of the outcome after ileos
tomy and proctocolectomy for Crohn’s
disease, with widely varying findings
(Table II30’31-33-39'40). It is not clear

28

3 .6

80
70
67
167

6.2
3 3 .0
4 6 .0
1 0 .2

why there should be such variations in
the recurrence rate, especially since the
lowest incidence of recurrent disease
was in the study of Nugent and col
leagues,39 which had the longest follow
up (every patient had been operated
on at least 10 years previously). Cer
tainly in my own series the striking
feature was the increasing recurrence
rate as the length of follow-up increased
(Fig. 13). Unfortunately, because the
number of cases available for follow-up
of more than 12 years is small, the
validity of the curve beyond this period
is extremely dubious. By far the most
frequent site for recurrence was imme
diately above the ileostomy (Fig. 14).
It is emphasized, however, that a large
number of patients enjoy freedom from
recurrence for many years, or indef
initely, after ileostomy and proctoco
lectomy and that when recurrence does
take place a second resection and es
tablishment of a new ileostomy can be
followed by further relief of symptoms
for quite long periods.33
While the results of surgical treat
ment for Crohn’s disease of the large
intestine appear to be better than those
of surgery for this condition in the
small intestine, they do not provide any
grounds for complacency. But until
more effective medical treatment is de
veloped the surgeon will continue to

if
FIG. 13— Graph showing cumulative
risk of recurrence after large bowel ex
cision and ileostomy (or colostomy) for
Crohn’s disease.

FIG. 12—Subtotal colectomy specimen
showing typical gross appearance of
Crohn’s disease.
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FIG. 14— Appearance of recurrent
Crohn’s disease just proximal to site of
ileostomy.
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play a m ajor role in the management
of this disease.
Figs. 2, 4, 5 and 6 are reproduced by
permission from G oligher JC: Surgical
treatment, in Colitis Ulcerosa, Kremer
K, K ivelitz H (eds), Stuttgart, Georg
Thieme, 1977, p 87. Fig. 3 is reproduced
by permission from G oligher JC: The
ostomy reconstruction. Br J Surg 50: 259,
1962. Fig. 13 is reproduced by permission
from G oligher JC: Results of resection
for Crohn’s disease. Dis Colon Rectum
19: 584, 1976. Fig. 14 is reproduced by
permission from G oligher JC: Ileal re
currence after ileostomy and excision of
large bowel for Crohn’s disease. Br J Surg
50: 253, 1972.
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Symposium on Carcinoma of Colon and Rectum
1. Results of Standard Surgical Treatment of
Colon and Rectal Carcinomas*
A ndre B. P eloquin ,

A review is presented of 1550 cases
of cancer, 545 of the rectum and 1005
of the colon, treated at Hopital
Notre-Dame, Montreal.
A survey of the patients with rectal
cancer treated during successive periods
shows that over the years there has
been no improvement in survival
after standard surgical treatment.
On the contrary, in patients with colonic
cancer there has been a significant
improvement in the crude survival rate,
from 32.5% to 63.2%. Over the 28-year
period studied, we noted also an
increase in the resectability rate (from
71.8% to 90.4%) and a decline in the
operative mortality rate (from 12.1%
to 2.9% ). Moreover, the number of
patients over 70 years of age tended
to increase. These three factors
combined can explain, at least partly,
the rise in the crude survival rate.
The corrected survival rate excludes
these factors since it is based on only
the resected cases and excludes
postoperative deaths and deaths from
intercurrent disease. Nevertheless we
found an evident improvement in this
survival rate as well, which rose from
46.2% to 75.4%. These gratifying
results can therefore be attributed to
an improvement in surgical technique:
more extensive resection with high
ligation of the pedicle thereby preventing
dissemination of cancer cells.

FAesf

diverses periodes successives, montre
que, au cours des annees, il n’y a eu
aucune amelioration des taux de survie,
suite a la chirurgie conventionnelle.
Au contraire, dans le cas du cancer
du colon, il y a eu une amelioration
significative du taux de survie brut,
celui-ci passant de 32.5% a 63.2%. Au
cours de la periode de 28 ans etudiee,
on a aussi observe une augmentation
de la possibility de resection (le taux
passant de 71.8% a 90.4%) et une
baisse du taux de mortality operatoire
(de 12.1% a 2.9% ). De plus, le nombre
de patients de plus de 70 ans a montre
une tendance a augmenter. L'association
de ces trois facteurs peut expliquer,
au moins en partie, ['amelioration du
taux de survie brut.
Le taux de survie corrige exclut ces
trois facteurs puisqu'il ne tient compte
que des cas ou il y a eu resection
et qu'il elimine les deces postoperatoires
et les morts dues a une maladie
intercurrente. On a neanmoins trouve
une amelioration evidente de ce taux
de survie qui a augmente de 46.2%
a 75.4%. Ces resultats encourageants
peuvent done etre attribues a une
amelioration des techniques
chirurgicales: une resection plus etendue
avec ligature haute du pedicule,
prevenant de la sorte la dissemination
des cellules cancereuses.

From 1942 to 1969 inclusive, carci
noma of the colon or rectum, or both,
was diagnosed and treated in 1550
patients at Hopital Notre-Dame, Mont
real. The author has reviewed person
ally all their records. Only three pa
tients (0.19%) were lost to 5-year
follow-up. The location of the carci
nomas in the large bowel is shown in
Fig. 1. In eight cases it was impossible
to fix the exact location of the tumour
because advanced carcinomatosis was
present; these patients are included in
the group of cancer of the colon. Can
cers of the rectosigmoid treated by
anterior resection are included in the
group of sigmoid cancers.
Staging was by Dukes’ classification,
established on pathological findings.1
Patients who were not operated upon

On presente une revue de 1550 cas
de cancer, dont 545 du rectum et 1005
du colon, qui ont ete traites a I’Hopital
Notre-Dame de Montreal.
Une etude des patients atteints du
cancer du rectum et traites pendant

*Presented at the inaugural meeting of
the Canadian Association o f General
Surgeons, Toronto, Ont., May 11 and
12, 1977
t Attending surgeon, Hopital Notre-Dame,
Montreal, and associate professor of
surgery, University o f Montreal, Montreal,
PQ

Reprint requests to: Dr. A.B. Peloquin,
Departement de chirurgie, Hopital
Notre-Dame, 1560, rue Sherbrooke est,
Montreal, PQ H 2L 4K8
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all had advanced disease with distant
metastases proved either by biopsy or
at autopsy.
Operability refers to the percentage
of patients operated upon, whether the
operation was laparotomy, a bypass
procedure, colostomy or resection. Re
sectability refers to the percentage of
patients operated upon who had a resec
tion. The crude survival rate is based
on the total number of cases. The
corrected survival rate is calculated
from the number of patients in whom
resection was performed. Therefore the
operative deaths, the deaths from inter
current disease and the three patients
lost to 5-year follow-up are excluded
from this figure, as suggested by
Bacon.2 Operative mortality includes ail
deaths occurring before the 30th post
operative day. By obstruction we mean
complete obstruction, and by perfora
tion, those patients with symptomatic
abscess formation or generalized peri
tonitis.3
Global Results

There were 545 patients with cancer
of the rectum. The operability was
94.3% and the resectability of stages
A, B and C was 85.3%. The operative

FIG. 1— Location of tumour in 1550
cases of colorectal carcinoma.
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Table I—Cancer of the Rectum: Crude Survival Rate by Stage for Patients Treated in Each Time Period
1952-1956
1957-1961
1967-1969
1947-1951
1962-1966
1942-1946
(n = 119)
(n = 111)
(n = 99)
(n = 66)
Dukes’ stage
(n = 48)*
(n = 102)
X2
20
(71.4)
14
(48.3)
16
(66.7)
14
(82.3)
8.42
7 (50.0)f
12 (75.0)
A
10 (30.3)
12 (44.4)
10 (47.6)
11 (30.5)
3 (14.3)
B
3 (33.3)
7.119
4.984
0
7 (25.9)
4 (16.7)
2(24.1)
C
2(19-3)
2(23.1)
20 (39.2)
29 (38.1)
36 (45.6)
31 (39.2)
33 (36.3)
4.278
10 (26.3)
Total
'Numbers (n) include patients with stage D cancer (distant metastases) not considered in this table.
fNo. (and %) surviving.
ffNS = not significant.

P valuesff
< 0.2 (NS)
< 0.3 (NS)
< 0.5 (NS)
< 0.7 (NS)

Table II—Cancer of the Rectum: Corrected Survival Rate by Stage For Each Time Period
1942-1946
Dukes' stage
7 (63.6)*
A
1 (33.3)
B
0
C
8 (50.0)
Total
*No. (and %) surviving.

mortality for resection was 10.6%. The
corrected survival rates for stages A,
B and C were 80.2%, 46% and 30.3%,
respectively. For patients with a stage
A, B or C lesion considered as a group,
the corrected survival rate was 53.1%.
There were 1005 patients with cancer
of the colon. The operability was 97%
and the resectability for stages A, B
and C was 85.1%. The operative mor
tality for resection was 6.5%. The cor
rected survival rates for stages A, B
and C were 83.1%, 65% and 37.7%,
respectively. The corrected survival rate
for all patients with stage A, B or C
lesions was 61.7%.
These results of what is termed stand
ard surgical treatment of colorectal car
cinomas are similar to those reported
in the literature.4'8 As in other series,
they apply to a large number of pa
tients treated over a considerable pe
riod.
It is logical to study the outcome in
patients treated at different periods:
accordingly the total period of 28 years
was subdivided into five 5-year periods
and a final one of 3 years. Many fac
tors can influence survival after stand
ard surgical treatment, and in each
period of the study one can notice a
variation in the number of cases, the
age of the patients, the proportion of
cases in each Dukes’ stage, the inci
dence of complications (obstruction or
free perforation), the operability, the
resectability, the operative mortality,
and possibly the surgical technique.
40

1952-1956
20 (90.9)
12 (57.1)
4 (36.4)
36 (66.6)

1947-1951
12 (92.3)
10 (50.0)
J_ (41-2)
29 (58.0)

1957-1961
12 (63.1)
9 (56.2)
7 (31.8)
28 (49.1)

1962-1966
16 (80.0)
11 (40.7)
6 (21.4)
33 (44.0)

Cancer of the Rectum

The crude survival rate on the six
time periods for patients grouped ac
cording to Dukes’ classification is
shown in Table I. The percentage of
lesions belonging to each stage is shown
in Fig. 2. Most of the patients were
aged between 60 and 70 years; in suc
cessive periods we noted a small rise
in the number of patients aged over
70 years.
The operability varied between
90.9% and 95.8% and did not change
%
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34.

14

10 1

l---------------- 1----------------1---------------- 1----------------1----------------1
years 42-46

47-51

5 2 -56

57-61

6 2 -6 6

67 -6 9

1967-1969
14 (87.5)
3 (23.1)
2_(33.3)
20 (52.6)

X2
8.701
5.1
3.118
7.394

P values
< 0.2 (NS)
< 0.5 (NS)
< 0.7 (NS)
< 0.2 (NS)

significantly over the years (x2= 2.703,
P > 0.7).
The resectability for stages A, B and
C rose significantly; in successive pe
riods it was 50%, 84.2%, 88.6%,
87.2%, 94.4% and 87.7% (x2 = 42.98,
P < 0.001).
A considerable decrease in the oper
ative mortality was noted as the series
accumulated. For the various periods
it was 10.5%, 18.3%, 18.9%, 6.8%,
4.5% and 2.2%. This improvement is
statistically significant (y2 = 18.334,
P < 0.01).
In cases of rectal carcinoma the in
cidence of complete obstruction and of
obstruction associated with perforation
has always been low. For the former it
ranged between 4.2% and 0% (x2 ~
4.096, P > 0.5) and for the latter be
tween 2.1% and 0% (x2 = 3.013,
P > 0.5). These variations are not
statistically significant.
At first sight, the crude survival rate
seems to improve with the years, but
neither the variations for the individual
stages nor for the group as a whole are
significant (Table I).
The corrected survival rates for re
sected rectal cancer are set forth in
Table II. Again, the differences in suc
cessive periods were not statistically
significant, whether one considers the
various stages individually or the group
as a whole. We noted for cases of
stages A, B and C a corrected sur
vival rate varying from 63.6% to
87.5%, from 33.3% to 23.1% and

FIG. 2— Carcinoma of rectum: percen
tage of lesions in each stage for each
time period.
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Table III—Cancer of the Colon: Crude Survival Rate by Stage for Patients Treated in Each Time Period
1942-1946
(n = 63)*

1947-1951
(n = 139)

1952-1956
(n = 176)

1957-1961
(n = 183)

A

5 (62.5)f

11 (55.0)

13 (86.6)

B

7 (38.9)

20 (38.5)

1 (7.2)
13 (32.5)

Dukes' stage

C
Total

17 (56.7)

1962-1966
(n = 267)
28 (78.4)

34 (79.1)

34 (58.6)

17 (41.5)

33 (45.8)

36 (66.6)

13.07

_4 (14.3)

2 (6.9)

8 (20.0)

24 (36.9)

16 (41.0)

19.62

< 0.01

35 (35.0)

49 (48.0)

42 (37.8)

86 (49.4)

86 (63.2)

27.747

< 0.001

P values

1967-1969
(n = 177)

X2
9.932

Pvalues
> 0.05 (NS)
< 0.05

*Numbers (n) include patients with stage Dcancer (distant metastases) not considered in this table.
fNo. (and % ) surviving.

Table IV—Cancer of the Colon: Corrected Survival Rate by Stage for Each Time Period
1942-1946

1947-1951

1952-1956

1957-1961

1962-1966

1967-1969

A

Dukes' stage

4 (66.6)*

11 (68.7)

13 (100.0)

17 (G8.0)

29 (96.6)

34 (85.0)

X2
14.22

B

7 (58.3)

’0 (52.6)

34 (69.4)

17 (56.7)

33 (63.5)

36 (80.0)

8.63

C

_1_(12.5)

4 (36.4)

2 (14.3)

8 (25.0)

24 (46.2)

16 (55.2)

12.99

< 0.05

Total

12 (46.2)

35 (52.8)

49 (64.5)

42 (48.3)

86 (64.2);

86 (75.4)

20.72

< 0.001

< 0.02
< 0.2 (NS)

*No. (and % ) surviving.

from 0% to 33.3%, in the first and
final time periods respectively. These
differences also are not significant. To
tally for carcinomas of stages A, B and
C the corrected survival rate, which
was 50% in the first period, was only
52.6% in the last one, a variation that
is not significant.
Even if, over the years, we noted an
improvement in the resectability and
the operative mortality, there was no
change in the duration of survival after
the standard surgical treatment of rectal
cancer. The treatment, namely Miles’
abdominoperineal resection, was the
same throughout the 28 years of our
study.

4-

yeors 42-46

47-51

52-56

57-61

62-66

67-69

FIG. 3—Carcinoma of colon: percen
tage of lesions in each stage for each
time period.
VOLUME 21, NO. 1, JANUARY 1978

/

Cancer of the Colon

The numbers of patients treated in
the six periods of the study are set forth
in Table III where they are grouped
according to the stage of disease. In
each period the distribution of patients
according to age decade was the same.
The incidence was highest in persons
in the seventh decade, but in the latter
years of the study more patients were
aged over 70 years. The percentage of
patients in each stage is indicated in
Fig. 3.
The operability remained fairly con
stant over the years, varying only be
tween 96.6% and 97.3% (y2 = 0.179,
P > 0.8). The resectability, regardless
of stage of disease (A, B or C) changed
significantly. For successive periods it
was 71.8%, 72%, 86.1%, 88.2%,
88.9% and 90.4% (y2 = 24.972,
P < 0.001). We noted also a decrease
in operative mortality after resection of
cancers of the colon, from 12.1% in
the first period to 2.9% in the final
one (y2 = 5.375, P > 0.3).
In cases of colonic carcinoma the in
cidence of complications (complete ob
struction or free perforation, or both)
has always been high. Successively for
each period it was 22.2%, 21.6% ,
19.3%, 15.8%, 18.7% and 17.4%;
these variations are not statistically sig
nificant (y2 = 2.461, P > 0.8).
The crude survival rate showed an
increase in all three stages (Table III).
These improvements are statistically
significant for stages B and C cases.
For the group as a whole the crude
survival rate increased from 32.5% in

the first period to 63.2% in the final
one. This improvement is highly signi
ficant. The corrected survival rate also
increased (Table IV) significantly for
cases belonging to stages A and C. The
increase in the corrected survival rate
for the group as a whole, from 46.2%
to 75.4%, is also significant.

Discussion

Our study of results obtained over a
28-year period demonstrates that, in
the case of rectal cancer, even if we
noted an increase in the resectability
and in the operative mortality, there
was no increase of duration of survival
after standard surgical treatment.
However, when we take account of
the results in our study of cancer of
the colon, we can conclude that both
crude and corrected survival rates have
improved significantly. During the 28
years the resectability improved sig
nificantly (from 71.8% to 90.4%) and
the operative mortality dropped from
12.1% to 2.9%. Both factors can in
fluence the survival rate.
The corrected survival rate, as de
fined by Bacon,2 evaluates more ac
curately than the crude rate the form
of surgical treatment. The former ex
cludes the nonresected cases, and thus
avoids the influence of the resectability
rate. Operative deaths are also excluded
and thus the effect of the variation in
operative mortality rate is eliminated.
The corrected rate also excludes deaths
from intercurrent disease during the
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5-year follow-up and thus it is not in
fluenced by (he age of the patients.9
A definite improvement is evident
over the years. For stages A, B and
C cancers the corrected survival rate
rose from 46.2% to 75.4%. During the
entire 28-year period neither radiation
therapy, nor chemotherapy nor immu
notherapy were ever used as an adjunct
to surgical treatment. None of our sur
geons ever utilized the Turnbull’s no
touch isolation technique. Nevertheless
over the years the surgical technique
was gradually modified. In the final
period covered by our study all sur
geons concerned were performing more
extensive resections with high ligation
of the pedicle. All were following the
practice of Cole intended to prevent
dissemination of cancer cells.10
Our latest results for 5-year survival
in cancer of the colon in stages A, B
and C of 85%, 80% and 55.2%, re
spectively, are comparable to those ob
tained in other centres.11'14 A high
resectability rate, extended resections
and the use of Cole’s measures to pre
vent cancer cell dissemination are, we
believe, common to all series from
which superior results are reported.
We finally suggest that, grosso modo,
the survival figures for standard sur
gical treatment for stages A, B and C
should be 75%, 50% and 25% for

rectal carcinomas, and 90%. 80% and
55% for colonic carcinomas. These re
sults should be the base from which
improvement of survival should be cal
culated in any further investigation or
experiment.
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2. Sphincter-Preserving Operations for Rectal Cancer*
I a n P.

At St. Mark's Hospital in London,
England there has been a steady
improvement over 20 years in the results
of treatm ent of rectal cancer. The
resectability rate has reached 95% and
the overall operative mortality rate has
declined to 2%. The corrected 5-year
survival rate is about 70% for all who
recover from the operation. It is
unlikely that these figures can be

T odd, ms ,

m d ( tor ), frcs

bettered, so attention has been directed
to the use of radiation therapy and
adjuvant cytotoxic therapy, but so far
no firm conclusions are possible on
the benefits of either modality. In
order to spare the patient a colostomy,
local excision of the growth or the
use of a transsphincteric approach can
be considered, but few cases are
suitable for either procedure or their
more radical alternatives.

totale est descendue a 2% . Le taux
corrige de survie a 5 ans est d'environ
70% pour ceux qui survivent a
I'operation. Comme il est quasi
impossible que ces statistiques puissent
etre ameliorees, I’attention s'est
portee vers I’emploi de la radiotherapie
et des agents cytotoxiques d'appoint
mais, jusqu'a maintenant, aucune
conclusion definitive n’est possible
sur les benefices de ces deux modes
de traitement. Dans le but d’eviter
une colostomie, on peut envisager une
excision locale de la tumeur ou le
recours a une voie d'abord a travers
le sphincter, mais peu de cas se
pretent a ces modes operatoires ou
a leurs alternatives plus radicales.

St. M ark’s Hospital de Londres,
*Presented at the inaugural meeting of Au
on a constate, sur une periode de
the Canadian Association of General
Surgeons, Toronto, Out., May 11 and 12, 20 ans, une amelioration constante
1977
des resultats du traitement du cancer
rectal. Le taux des tumeurs operables
Reprint requests to: Mr. Ian P. Todd,
149 Harley St., London W IN 2DE, UK a atteint 95% et la mortality operatoire
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The management of carcinoma of the
rectum has altered slowly but conti
nuously since Dukes1 made the impor
tant observation that spread occurred
primarily upwards towards the inferior
mesenteric pedicle and only later in a
retrograde or lateral direction. This
observation was confirmed by Gilchrist
and David2 and is the basis of surgical
practice today. As a direct outcome of
this teaching, anterior resection and the
modifications of pull-through, sleeve
resection and peranal anastomoses have
evolved. Local operations, such as
peranal and transsphincteric (York
Mason) excisions,3 have gained ground
even more recently, again largely
through application of the original
Dukes’ classification,1 stages A and B,
to clinical practice.
To put into focus the place of the
newer conservative excisions and sphinc
ter-saving procedures in the manage
ment of rectal cancer it is essential to
have some idea of resectability, opera
tive mortality and 5-year survival rates
for routine procedures such as com
bined excision of the rectum and an
terior resection. At St. Mark’s Hospital,
London, England, the resectability rate
for all rectal cancer is around 95%.
The overall operative mortality for
rectal cancer is 2%; it is less than 1%
for combined excision and about 4%
for anterior resection, the principal sur
gical techniques used at this hospital.
The figures for these procedures have
improved steadily over the past 20
years and any further improvement
seems unlikely. Our corrected 5-year
survival rate for patients with cancer
of the rectum is around 70% for all
who recover from the operation. It is
64% when combined excision is per
formed and 80% when anterior resec
tion is selected. To obtain some idea
of the chances for an individual patient
one can break down these figures to
apply to every computation of grade
of malignancy, Dukes’ staging, degree
of local spread and presence or ab
sence of venous involvement.
Since operative mortality and re
sectability figures are unlikely to
change, treatment regimens must be
reconsidered. Can more be done and
can the quality of life be improved?
All major centres in the world are now
concentrating on these issues. Should
preoperative or postoperative radio
therapy be given and in what dosage?
Toronto has been foremost in conduct
ing one of these trials, but there is still
no definite answer. At St. Mark’s we
abandoned, halfway through its course,
a trial of postoperative radical radio
therapy, mainly because of the mor
bidity induced. We still use radio
therapy for young patients when there
is a high grade of malignancy but have
VOLUME 21, NO. 1, JANUARY 1978
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no figures in its support. At present
the British Medical Research Council
is conducting a multicentre controlled
trial of preoperative radiotherapy, but
as yet no figures are available. Three
regimens are being studied: no treat
ment; 850 rads immediately preoperatively (as, I believe, was the practice
in Toronto); and up to 2200 rads over
a 10-day period immediately preoperatively.
Many trials are being conducted of
early cytotoxic adjuvant therapy, but
the results of those reported so far
have been unimpressive. At St. Mark’s
Hospital the trial proposed is con
cerned with the use of neuraminidasetreated cells, but the results will not be
available for several years.
We have therefore to consider im
proving the quality of life. It is un
likely that dramatic changes will be
made in the techniques of combined
excision and anterior resection. We
firmly believe in attention to detail:
careful and early ligation of the pedicle,
gentleness of dissection, painstaking
control of bleeding and, above all,
irrigation of the perineal cavity in the
case of excisions or of the lumen of
the bowel when resection has been
performed. Eighty percent of perineal
wounds are now completely healed in
2 weeks through use of the Shirley
drain and a sump suction apparatus.
We have thus been able to reduce hos
pital stay, expense and morbidity. But
because every patient wants to avoid
having a colostomy we are trying other
restorative procedures.
Certain other operations can be per
formed for tumours very low in the
rectum and for those at that difficult
location, 6 to 8 cm from the anus.
Physical factors have to be taken into
account: size of the patient and whether
he or she is obese, sex, breadth of the
pelvis, size and grading of the tumour,
condition of the blood vessels, presence
of other diseases such as diabetes and
so forth. These are fairly obvious fac
tors that may militate against some
operative procedures.
Local excision is now being done
more often, but figures to some extent
reflect the recent increase in colono
scopic removal of malignant polyps.
We surgeons still take a fairly serious
view of the surgical local excision pro
cedure, even though our peranal tech
niques have improved greatly. Of our
143 patients with colorectal cancer
only 24 had a local excision of a sessile
lesion. In two less than 5 years have
passed since the operations, so they can
not be included in a report. In 6 of the
other 22 the local excision was thought
to be incomplete, so immediate radical
reoperation was undertaken. Two had
a late reoperation (combined excision)

for recurrence and both are well. Only
14 of the 22 have survived 5 years
without further procedures. Our method
of local excision was mainly removal
per anum of a full-thickness wedge
with at least 1 cm clearance, and
closure by direct suture. We have
treated only four patients using the
transsphincteric approach, rediscovered
and popularized by York Mason.3 We
think this operation has little place in
the surgical management of rectal can
cer, though certainly it is useful for
other problems. The selection of pa
tients for local excision depends upon
the presence of certain obvious fea
tures: the tumour must be small (dia
meter, < 2.5 cm), proliferative and
protuberant, not ulcerated, mobile over
the deeper layers and accessible. It
must not be of high grade as determined
from a biopsy. Hence it is not a
common lesion. Clinical selection and
staging can be difficult and mistakes
must be expected.
There are a number of more radical
alternatives: pull-through procedures,
sleeve resection and abdominoperanal
resections where the anastomosis is done
per anum. We have abandoned the old
Bacon-Babcock-Black type of pullthrough procedure and also the Maunsell-Weir or Swenson type of abdominoanal anastomosis. The Kraske proce
dure has been done only once in the
last 10 years but perhaps it has a larger
place. Our own experience with pullthrough operations for rectal cancer is
small, comprising only 32 patients up
to 1967. Of the 23 patients who under
went a radical procedure 15 survived
for 5 years. Only six more procedures
have been done since 1967, of which
five were considered radical and one
palliative. In this small series totalling

Table 1— Selection of Operative Procedure for
Rectal Carcinoma
Height of tumour
from anal margin,
cm
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Preferred operation

13-15

High anterior resection

9-12

Low anterior resection

6-8

Abdominoperineal exci
sion
Anterior resection and
peranal anastomosis
Pull-through
Local excision
Peranal
Transsphincteric
Kraske
Fulguration

3-5

Abdominoperineal exci
sion
Local excision

43

38 patients there were three postoper
ative deaths. Since 1972 there has been
a tendency to treat the smaller rectal
tumours at 6 to 8 cm from the anus
by an abdominoperanal operation. This
is preferred to the abdominotranssphincteric operation or the abdomino-Kraske
procedure or even the Localio opera
tion as being somewhat less dangerous,
less traumatic and providing a more
satisfactory anastomosis. Obviously it
is too early to report results, but we are
reasonably pleased with the procedure.

3.

Table I summarizes our position. Re
member that the grade of malignancy
and the size and type of tumour must
be taken into account whenever a
sphincter-saving operation is undertaken
for cancer of the rectum. At St. Mark’s
Hospital we do not yet feel completely
confident about these newer procedures,
although we are using them to an in
creasing extent. We shall wait until a
larger series provides-us with statistical
ly sound figures before advocating
their general use.

2. G ilchrist RK, D avid VC: Considera
tion of pathological factors influencing
5 year survival in radical resection of
the large bowel and rectum for carci
noma. Ann Surg 126: 421, 1947
3. M ason AY: Trans-sphincteric resec
tion, in Colon, Rectum and Anus
fOperative Surgery Series), R ob C,
Smith R (eds), London, Butterworth,
1977, p 178

Radiation Therapy in Rectal Cancer*
B J . C um m ings ,

In a number of studies preoperative
irradiation of cancer of the rectum has
procured 5-year survival rates higher
than those obtained with conventional
surgical techniques, whether or not
the tumour has spread to lymph nodes.
There appears, as well, to be a lower
rate of local recurrence and possibly
of the development of distant
metastases. Also, some tumours of
questionable operability are reduced
in size to make resection possible.
The effectiveness of postoperative
radiation therapy is not yet firmly
established.
Radiation therapy as the primary
method of treatment of rectal
carcinoma has been used at the Princess
Margaret Hospital in Toronto in 79
patients over a period of 18 years.
The overall 5-year survival rate is 28%;
this rises to 38% when the tumour
is not fixed but falls to half this figure
when fixity of the growth is evident.
These results offer grounds for

*Presented at the inaugural meeting of
the Canadian Association of General
Surgeons, Toronto, Out., May 11 and
12, 1977
t Radiation oncologist, The Princess
Margaret Hospital, Toronto
Reprint requests to: Dr. B.J. Cummings,
The Princess Margaret Hospital, 500
Sherhourne St., Toronto, Out.
M 4X 1K9
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investigating radical radiation therapy
as an alternative to surgical methods
of dealing with low-lying carcinomas
of the rectum.

Dans un certain nombre d'etudes,
I’irradiation preoperatoire dans le cancer
du rectum a procure une survie a
5 ans superieure a celle qui est obtenue
avec les techniques chirurgicales
conventionnelles, qu'il y ait
envahissement des ganglions
lymphatiques ou pas. Egalement, il
semble y avoir un plus faible taux de
recidives locales et une moins grande
possibility d’apparition de metastases
a distance. De plus, quelques tumeurs
difficilement operables sont reduites
de taille, rendant la resection possible.
L'efficacite de la radiotherapie
postoperatoire n'a pas encore ete
parfaitement etablie.
La radiotherapie a ete utilisee au
Princess Margaret Hospital de Toronto
comme traitement primaire du
carcinome rectal chez 79 patients, en
18 ans. La survie a 5 ans a ete de
28%; ce nombre augmente a 38%
lorsque la tumeur n’est pas adherente,
mais il diminue de moitie lorsqu'il y
a fixation evidente de la neoplasie.
Ces resultats offrent des raisons pour
examiner la radiotherapie radicale
comme alternative aux methodes
chirurgicales pour traiter les carcinomes
bas du rectum.
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Survival rates for patients presenting
with carcinoma of the rectum and
treated by surgery alone have not im
proved substantially over the past 20
years.1
Patients rarely present early in the
course of their disease when preserva
tion of the rectum and anal canal by
local excision of the growth might be
possible. Most patients with cancer of
the lower part of the rectum must still
undergo a surgical procedure that re
quires a colostomy. Spread of the
tumour to lymph nodes or through the
bowel wall means that more than half
the patients will die because of their
cancer, and in many a local recurrence
will develop.2 For many years it has
been apparent that better methods of
treatment are needed, not only to im
prove survival rates but also to save
the rectum and anus and thus spare the
patient a colostomy. There is evidence
that radiation therapy may achieve
these aims.
Morson and Bussey3 reported that
80% of local recurrences followed the
removal of tumours of the lower two
thirds of the rectum that had penetrated
the bowel wall or spread to the local
lymph nodes. Their 9.7% overall in
cidence of local recurrence with clin
ical examination is a minimum figure.
This is well below the incidence re
ported in autopsy and surgical series.
For example, Gunderson and Sosin4
found local recurrences in 65% of pa-

THE CANADIAN JOURNAL OF SURGERY

tients undergoing a “second-look” op
eration. The range of these figures
reflects the difficulty of assessing the
pelvic contents by clinical means and
the lack of an accepted definition of
local recurrence.
Radiation therapy has been added to
conventional surgical techniques and
has also been used as the sole treat
ment for rectal carcinoma.
Preoperative Irradiation

The rationale of preoperative irra
diation is based on experimental
evidence that suggests that such treat
ment will reduce the risk of implanta
tion of cells dislodged at surgery,
sterilize unrecognized local tumour ex
tension and reduce the bulk of large
tumours to make resection technically
easier. Comparison between patients
who receive preoperative irradiation
and those who are treated by surgery
alone is made difficult by the lack of
a clinical staging system for carcinoma
of the rectum.
However, all trials of preoperative
irradiation for cancer of the rectum,
with only a single exception, have
brought about improvement in survival,
although not always in the same sub
groups of patients (Table I5’8). A
variety of radiation doses and field
arrangements have been used. In the
retrospective Memorial Hospital study6
a dose of 1000 to 1500 rads was given
to the pelvis, and increased survival
rates were reported at 5 and 10 years
for patients who had involved lymph
nodes. A later nonrandomized study
at Memorial Hospital,9 in which a
dose of 2500 rads was given in
12 days, showed no apparent difference
in survival rates at 5 years. The large
randomized trial conducted by the
Veterans Administration Group7 em
ployed a preoperative dose of 2000 to
2500 rads in 12 days. Their patients
who had abdominoperineal resection
after preoperative irradiation had im

proved 5-year survival. In this trial
patients with and without lymph-node
involvement benefited. In a Toronto
study5 a single dose of 500 rads
was given on the day of operation, and
improved survival was demonstrated in
those who had an abdominoperineal re
section in the presence of positive
lymph nodes. Stevens, Allen and
Fletcher,8 reported increased overall
survival rates with the use of 5000 rads
given over 5*/i weeks to the primary
rectal tumour.
Local recurrence rates after preop
erative irradiation have been lower,
although again not all subgroups seem
to have derived equal benefit. In the
high-dose study of Stevens and col
leagues8 not a single local recurrence
developed in the 40 patients who had
curative resection after 5000 rads.
Studies in which a lower radiation dose
was given suggest a greater benefit
when lymph nodes are positive. How
ever, these are the patients in whom
local recurrence rates are highest, and
it may simply be easier statistically to
detect improved results in this group.
The effect of preoperative irradia
tion on rates of development of distant
metastases is difficult to assess, because
occult metastases may be missed at
surgery. The Veterans Administration
Trial7 does suggest that such rates are
lower in irradiated patients. More ef
fective systemic therapy is needed to
deal with distant metastases, and also
to help improve control rates for local
metastases.
Marginally operable tumours have
been reduced to resectable size in some
studies. Higher dose radiation therapy
in the range 5000 to 6000 rads in 5 to
6 weeks has been used, sometimes with
additional chemotherapy. Stevens and
colleagues8 reported the results of treat
ment of 35 patients with locally fixed
tumours; of the 20 who subsequently
underwent surgery 3 lived longer than
5 years without tumour and 2 others

Table I— Positive Results at 5 Years in Patients w ith Adenocarcinoma
of Rectum, some of whom Received Irradiation Preoperatively
5-year survival following

Preoperative irradiation
Reference
no.
5

Dose, rad
500

Group w ith

RT + surgery

Surgery alone

1

40

10

AP, LN +

Tim e, d

results

6

1000 - 1500

6 -1 2

39

25

LN +

7

2000 - 2500

10

41
47
32

28
34
24

A ll AP
Curative AP
AP, LN +

8

5000

33

53

38

C urative resection,
all stages

RT = preoperative irradiation; AP = abdominoperineal resection, combined resection etc ., but
excluding anterior resection; LN + = lymph nodes involved by tumour.
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died without evidence of tumour activ
ity. Kligerman and Urdaneta-Lafee10
treated 15 patients with fixed tumours;
in 13 the tumour became operable, and
3 of the 9 who subsequently underwent
resection survived 5 years.
Postoperative Irradiation

Postoperative irradiation has been
advocated by those who believe
adjunctive therapy should be offered
only to those with a statistically high
risk of local recurrence. The difficulties
of selecting such patients on the basis
of operative and pathology reports have
been demonstrated.11 Also, on theo
retical grounds, the disturbance to the
pelvic blood supply caused by surgery
might produce areas of local hypoxia
with reduction in the radiosensitivity of
malignant cells. Postoperative irradia
tion cannot affect cells that are not
within the radiation field, and after
surgery the whole abdominal cavity and
perineum become potentially conta
minated. High-dose, wide-field radia
tion therapy carries a risk of irradia
tion-induced small-bowel complications.
None of the preliminary studies have
progressed far enough to provide sig
nificant information as to survival,12
but on clinical grounds local control
rates appear to be improved. Current
trials are also studying combinations
of radiation therapy and chemotherapy
following surgery. The irradiation of
established local recurrences produces
good palliation but few cures.
Primary Curative Irradiation

The use of radiation therapy as a
primary curative method for cancer of
the rectum has been reported in three
widely differing situations. The first
of these is one in which patients re
garded as likely to receive only pallia
tion of their disease have been irradi
ated, and a small percentage has been
cured.13 Also, Papillon14 has demon
strated that, in carefully selected pa
tients, contact radiotherapy or the in
sertion of radioactive implants provides
local tumour control rates similar to
those obtained with local excision or
electrocoagulation.
In the third situation, external su
pervoltage radiation therapy has been
employed as curative treatment for
rectal carcinoma. Results in some series
have been disappointing, with 5-year
survival rates of about 5% ,13 but the
radiation techniques used may have
been inadequate. Studies at the Princess
Margaret Hospital, Toronto, show that
results much better than these can be
achieved with primary curative radia
tion therapy. Seventy-nine patients
were so treated between 1958 and 1975.
Of these, 60 were over 60 years of age,
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and 30 were over 70 years. Most of
these patients had locally advanced
tumours. Those with smaller tumours
had refused abdominoperineal resec
tion or were medically unfit for surgery.
In general, there was only a clinical
search for distant metastases. It is now
recognized that in treating some of
these patients adequate radiation fields
and doses w ere not used. The Princess
Margaret Hospital techniques for irra
diating carcinom a of the rectum are
now standardized as far as possible.
Most of the pelvic contents are irradated to a tum our dose of 4500 to
5000 rads given in 18 to 20 fractions
over a 4-week period using anterior and
posterior opposed fields on a 25 MeV
linear accelerator.
The effect of tum our fixation on
patient survival is shown in Fig. 1. The
5-year survival for patients with tu
mours that were not fixed was 38% .
The results for a comparable group
are not reported in the surgical litera
ture, since tum our spread beyond the
limits of a curative resection cannot be
discovered in those patients treated by
radiation therapy. Those with fixed
tumours had a 5-year survival of 19%.
This figure obtained with radiation
therapy is com parable to published re
sults for extended pelvic resection for
locally advanced tumours, and to the

results obtained from planned highdose preoperative irradiation and sur
gery for marginally operable tumours.
Fig. 2 shows that the overall 5-year
survival rate was 28% and also the
results when patients are grouped ac
cording to the surgical management
they received. Those who had postra
diation surgery did not fare unexpected
ly worse than those who did not; they
include those patients whose tumours
were not controlled by radiation
therapy. They also include a group of
patients who probably underwent un
necessary surgery. An important ob
servation by Rider15 has been that the
rate of regression of some irradiated
adenocarcinomas of the rectum is much
slower than that seen in many other
irradiated tumours, for example, squa
mous cell carcinoma. Of those patients
for whom regression information was
available, in only about 20% had the
rectal carcinoma disappeared clinically
3 months after irradiation, and in 10%
the tum our was still palpable and
visible 12 months or more later.
Neither the slow rate ot regression nor
the finding of morphologically identi
fiable carcinoma cells in the irradiated
areas, is in itself proof of failure of
irradiation. Those patients who under
went radical surgical procedures after
radiation therapy did not appear to
have an unusual incidence of surgical
complications.
C o n clu sio n

FIG . 1— Princess M argaret Hospital
1958 to 1975. Effect of tum our fixation
on actuarial survival of patients with
prim ary carcinom a of rectum. Patients
treated by prim ary radiation therapy.

A practical scheme for the manage
ment of patients with rectal carcinoma
may be developed from the reported
studies. An effective form of systemic
adjuvant therapy has not yet been dis
covered. Preoperative irradiation offers
improved local control and survival
rates, especially if it should be proved
that the patient has involved lymph
nodes or spread of the tumour through
the bowel wall. Postoperative irradia
tion cannot be given in high doses over
a wide abdominal field, and until more
adequate trials are completed it should
be reserved for known residual tumour
or be given only in moderate doses.
The evidence from the Princess
Margaret Hospital experience is that
radical radiation therapy should be
investigated as an alternative to surgical
techniques for low-lying carcinomas of
the rectum that require removal of the
rectum and anal canal. Surgery would
then be used only for locally uncon
trolled tumours.

FIG . 2— Princess M argaret Hospital
1958 to 1975. R esults of treatm ent of
prim ary carcinom a of rectum by radiation
therapy (actuarial survival).
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4. Place des Traitements d’Appoint Complementaires
de la Chirurgie dans les Cancers du Colon et du Rectum
Louis J. D ionne , md , frcs [ c], facs,! A ntoine K ibrite , m d , frcs[c ]|
et

improvements, seems to have reached
its limit; the 5-year survival rate is still
approximately 50%. There is some
hope of curing a patient by surgery if
the cancer is localized. If the condition
is generalized, one must resort to
adjunctive therapy with a view to
improving the effectiveness of
conventional therapy by destroying
residual tumour cells and
micrometastases.
The authors reviewed the literature
pertaining to the prophylactic use of
chemotherapy— thiotepa, 5-fluorouracil
and methylcyclohexyl-chloroethylnitrosurea— and immunosuppressive
therapy— bacille Calmette Guerin
and C orynebacterium parvum— as
surgical adjuvants in the curative
treatment of colonic or rectal cancers.
The results generally are not very
significant and often are contradictory,
but they indicate a trend that requires
confirmation.
Based on their own experience in
the surgical treatment of gastrointestinal
cancers, the authors are at present
engaged in conducting therapeutic
studies under the aegis of recognized
research groups. They urge surgeons
to participate in such studies and
emphasize that the Canadian Association
of General Surgeons must play a role
in promoting Canadian therapeutic trials.

Le traitement chirurgical des cancers
du colon et du rectum, en depit de
certains raffinements techniques, semble
avoir atteint ses limites: le taux de
survie a 5 ans est d'environ 50%. On
ne peut guere esperer guerir
chirurgicalement un patient que si la
maladie cancereuse est locale. Lorsqu'il
y a atteinte generate, il y a lieu de
recourir aux therapies adjuvantes visant
a augmenter I'efficacite du traitement
conventionnel par destruction des
cellules tumorales residuelles et des
micrometastases.
Les auteurs passent en revue les
etudes publiees sur (’utilisation
prophylactique de la chimiotherapie—
thiotepa, 5-fluorouracil et methylcyclohexyl-chloroethyl-nitrosurea—
et de I'immunotherapie— bacille
Calmette Guerin et Corynebacterium
parvum — comme adjuvants de la
chirurgie dans le traitement a visee
curative des cancers colorectaux. Les
resultats sont generalement peu
significatifs et souvent contradictoires,
mais ils indiquent une tendance qu'il
y a lieu de confirmer.
Suite a leur experience personnelle
dans la chirurgie des cancers du tube
digestif les auteurs se sont engages
dans des etudes cliniques sous I'egide
d'organismes reconnus. Ils incitent
les chirurgiens a participer a de telles
etudes et ils soulignent le rdle que
doit jouer (’Association canadienne des
chirurgiens generaux afin de promouvoir
les essais therapeutiques canadiens.

Les traitements chirurgicaux classiques,
tels que pratiques depuis des annees
dans le cancer du colon et du rectum,
semblent avoir atteint leurs limites. Les
divers types de resection decrits depuis
quelques decennies pour radicaliser la
resection colique, n’ont guere ameliore
le pronostic. II en est ainsi des raffine
ments de techniques pour prevenir la
dissemination des cellules cancereuses
lors des manipulations operatoires.1'6
C’est ainsi que Morson et Bussey7
ont remarque, a juste titre, que la
chirurgie ne pouvait apporter plus que
ce qu’elle avait donne. Le raisonnement
qui amene ces auteurs a cette conclu
sion s’appuie sur une revue de plus de
1500 cas de cancers du rectum, traites
chirurgicalement au St. Mark’s Hospital
de Londres.

Surgical treatment of colon and rectal
carcinoma, in spite of technical
*Presente sous le titre “Place for
Chemotherapy and Immunotherapy in
Colorectal Cancer" au congres inaugural
de VAssociation canadienne des chirurgiens
generaux, Toronto, Ont., 11 et 12 mai,
1977
•Chef du service de chirurgie generate,
I'Hotel-Dieu de Quebec, Quebec, PQ
tAssistant du service de chirurgie generate,
VHotel-Dieu de Q uebec
Les demandes de tires-a-part doivent
etre adressees au: D r LJ. Dionne, Service
de chirurgie generate, I’Hotel-Dieu de
Quebec, 11 Cote du Palais, Quebec, PQ
G1R 216
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Une analyse plus approfondie des
causes de deces apres traitement chi
rurgical a visee curative, permet de
poser le probleme et d’illustrer le fondement des therapies d’appoint qui ont
ete, depuis quelques 10 ans, mises de
l’avant pour contrer 1’evolution locale
et generate de la maladie cancereuse.
En effet, pour 100 cancers du rectum
traites dans un but curatif, le taux de
survie a 5 ans est d’environ 5 0% .
Cinquante patients decederont de leur
cancer, dont 10% de dissemination par
vote lymphatique, 20% de recidive
perineale et 70% de metastases visce
rates a distance, principalement hepatiques.8
L’apparition de metastases a distance
presuppose la circulation de cellules
neoplasiques depuis la lesion primaire
jusqu’ au foyer de nidation. L’invasion
veineuse par les cellules tumorales,
souvent visible sur les prelevements,
est un facteur favorisant la presence
de cellules cancereuses dans la circula
tion et implique habituellement un
mauvais pronostic. La presence de cel
lules tumorales dans la circulation
veineuse de drainage et dans la circula
tion peripherique varie selon le temps
operatoire et la technique employee.9
C’est pour prevenir cette dissemina
tion peroperatoire des cellules cance
reuses que Cote, Roberts et Strehl10 ont
recommande certains gestes preventifs
et que Turnbull11 a decrit la “ no touch
isolation technique” . Ackerman19 a re
commande la ligature precoce de l’artere principale et des arteres marginales.
Bien que le but de ces details de tech
nique soit mis en doute par certains,13
il est de bonne pratique de les observer
en cours d’operation.
Si la maladie est locate au moment
du traitement a visee curative, la chi
rurgie seule a d’excellentes chances de
guerir le patient. Par contre, si la
maladie est generate au moment du
traitement primaire, la chirurgie seule
est vouee a l’echec; elle devrait etre
completee d’un traitement a portee ge
nerate, pour prevenir la nidation des
cellules en circulation et leur developpement sous forme de micrometastases.
Schabel14 a precise cette notion de
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micrometastases et a demontre l’importance des cellules residuelles en posttraitement. Pour guerir un cancer, il
faut theoriquement detruire toutes les
cellules cancereuses, puisque une seule
cellule residuelle peut se developper et
donner naissance a des metastases. Un
nodule de 1 mm de diametre peut contenir de 105 a 106 cellules.
Dans les cancers a risque eleve, il
est logique de croire que de multiples
llots de cellules tumorales existent un
pen partout dans l’organisme, sous
forme de micrometastases tel que l’a
decrit Schabel chez l’animal.
Par ailleurs, revolution fatale de la
maladie cancereuse est souvent previsible au moment du traitement a visee
curative. En effet, le pronostic et revo
lution peuvent etre determines par l’examen anatomopathologique et le degre
d’extension de la lesion primaire. Quand
la tumeur penetre les couches de la
paroi, jusqu’a la sereuse et la graisse
pericolique (Astler-Coller stage B2),15 la
survie est d’environ 40%. Quand il
existe une invasion des ganglions
(Dukes’ C), la survie a 5 ans est de
l’ordre de 25%.
Le taux eleve de recidive des cancers
Bz-C suggere la presence de microme
tastases deja existantes au moment de
la chirurgie. C’est dans cette situation,
c’est a dire, lorsque la masse cellulaire
residuelle est minime, que la therapie
d’appoint a de bonnes chances d’etre
efficace.16 En effet, dans le schema de
Schabel, plus la tumeur est petite, plus
la loge A est importante, et plus les
cellules sont actives et attaquables par
les inhibiteurs chimiques specifiques du
cycle cellulaire.
La therapie adjuvante s’appuie sur
l’hypothese que l’efficacite d’un traite
ment conventionnel peut etre augmentee par 1’usage complementaire de sub
stances chimiques, visant a detruire les
cellules tumorales residuelles et les mi
crometastases. Adjuvant se dit d’une
methode qui renforce l’action d’une
autre.
Et comme exemple, il est classique
de mentionner l’experience des tumeurs
de Wilms, traitees conventionnellement
par chirurgie et radiotherapie et dont
le pronostic a ete ameliore par l’usage
de l’actinomycine D en traitement d’ap
point.17
Nous allons essayer de situer la place
de ces methodes, soit la chimiotherapie
et l’immunotherapie, en revoyant quelques etudes publiees. Nous voulons egalement en degager les indications et
finalement nous voulons preciser le role
que doit jouer l’Association canadienne
des chirurgiens generaux dans le domaine des essais therapeutiques.
Chimiotherapie Prophylactique

Pour illustrer le travail fait dans le
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domaine de la chimiotherapie prophy
lactique, l’Union internationale contre
le cancer18 a publie une liste des essais
therapeutiques en voie de realisation.
La plupart ne datent que de 5 ans
et ne sont pas termines; les resultats
publies ne sont que preliminaires et
partiels et ne permettent pas de tirer
de conclusion ferme. Ils illustrent cependant une tendance qui remet en
“question” la place des traitements conventionnels et celle des traitements
d’appoint. La chimiotherapie est utilisee
en phases operatoire et postoperatoire,
sous forme de monochimiotherapie ou
de polychimiotherapie.
Le VA Surgical Cancer Chemother
apy Group19 presente une premiere etu
de de chimiotherapie per- et postopera
toire. La drogue utilisee, le thiotepa, a
ete administree aux patients par diverses voies et la posologie a varie selon
les phases de l’etude. Cette etude ran
domisee ne permet pas de conclusion
positive et il en ressort que le thiotepa,
a la dose employee (dose totale 0.6 a
0.8 mg/kg) n’a apporte aucune amelio
ration du taux de survie a 5 ans.
L’etude de Holden, Dixon et Kuzma20
regroupant 14 hopitaux americains,
porte sur l’usage du thiotepa comme
adjuvant postchirurgical. Sur 693 pa
tients, 337 ont regu la medication. Les
resultats sont complexes mais non concluant: ni le temps de latence ni la
survie ne sont ameliores.
Rousselot,21,22 de St. Vincent’s Hos
pital de New York a, depuis 1960,
utilise la chimiotherapie peroperatoire
comme adjuvant a la chirurgie colorectale.
Dans le but de detruire les cellules
disseminees dans la lumiere colique au
cours de l’intervention, les cellules circulant dans le systeme porte et les
cellules en circulation dans les veines
peripheriques, le 5-fluorouracil (5-FU)
a ete utilise en injection intraluminale
(10 mg/kg) au moment de l’intervention et par voie intraveineuse durant les
2 premiers jours postoperatoires (30
mg/kg).
Il ne s’agit pas d’une etude rando
misee; le controle est historique, par
comparaison avec les resultats du traite
ment chirurgical des cancers du colon
et du rectum traites au St. Vincent’s
Hospital pendant la meme periode et
ceux des statistiques nationales americaines.
Compte tenu de la faible morbidite,
cette etude parait valable et traduit une
tendance vers laquelle la therapeutique
doit s’orienter. Dans les stades III
(Dukes’ C), le 5-FU semble avoir ete
plus efficace, la survie a 5 ans etant
le double de celle de la serie temoin;
apres 8 ans d’observation la difference
se maintient.23
Du Medical College of Virginia une
etude randomisee faite par Lawrence
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et collegues24 de 1968 a 1973, portant
sur une serie de 156 patients dont 80
regurent du 5-FU comme adjuvant
postchirurgie, apporte des conclusions
contraires et negatives. Lawrence utilise
la chimiotherapie peroperatoire en vue
de prevenir la dissemination chirurgicale des cellules cancereuses et com
plete par une chimiotherapie a long
terme par voie buccale, pour prevenir
le developpement des micrometastases
viscerales.
En conclusion, ni l'intervalle libre,
c’est a dire, le temps avant recidive, ni
la survie, n’ont ete ameliores par le
traitement prophylactique. Il n’y a pas
de difference significative dans le taux
de survie a 4 ans, entre le groupe traite
par chirurgie seule et le groupe traite
par chirurgie et 5-FU.
Grage2’ du Central Oncology Group
presente les resultats d’une etude ran
domisee prospective au cours de la
quelle 204 patients sur 372 ont regu
un traitement postoperatoire d’appoint
au 5-FU par voie intraveineuse. Le
protocole est le suivant: 12 mg/kg par
jour, pendant 4 jours, suivi de 6 mg/kg
a tous les 2 jours pendant 5 jours, et
finalement 12 mg/kg par semaine pen
dant 1 annee. La toxicite est rarement
severe et une leucopenie survient chez
50% des patients traites. La majorite
des patients a ete suivie de 6 mois a
3 ans, et la survie a ce jour est a peu
pres identique pour les deux groupes,
soit 68% des patients vivants et sans
signe de maladie apres un traitement
d’appoint par comparaison a 63% de
ceux traites par chirurgie seule.
Li et Ross26 de Californie ont traite
un groupe de 213 patients porteurs de
cancer colorectal, dont 183 etaient aux
stades II et III. La chimiotherapie (5FU) fut administree de la fagon suivante: 1 g de 5-FU par voie intra
veineuse le ler jour, 500 mg les 4
jours suivants, suivi 4 semaines plus
tard d’un second cycle identique de
chimiotherapie. L’amelioration du taux
de survie a 5 ans dans les groupes de
tumeurs classe C est de l’ordre de
33.2%, tandis que pour le groupe de
tumeurs classe B, 1’amelioration du taux
de survie est de 23.1%. L’augmentation
globale de la survie a 5 ans est de
l’ordre de 28.1%. Cette etude n’est pas
randomisee, le groupe temoin est cons
titute de patients traites par chirurgie
seule par l’auteur durant les 5 annees
qui ont precede l’essai. Une chimio
therapie de courte duree, a doses nontoxiques, semble avoir donne des re
sultats tres interessants.
Apres avoir essaye, sans resultats, le
thiotepa et le 5-FU en per- et postope
ratoire, le Veterans Administration Sur
gical Adjuvant Group27 a entrepris deux
autres etudes prospectives, randomisees,
comparant la chirurgie seule et la chi
rurgie plus 5-FU.
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difference statistiquement significative
touchant Tintervalle libre et la survie.
En effet, le temps de recidive et le
pourcentage de survie des cancers
Dukes’ C, traites par chimioimmuno
therapie, semblent rejoindre ceux des
cancers Dukes’ B, traites par chirurgie
seule. D ’apres Mavligit, il semble done
que Timmunotherapie, avec ou sans
chimiotherapie, puisse ameliorer la sur
vie des cancers du colon.
Ce groupe du M.D. Anderson Hos
pital vient de commencer un nouvel
essai therapeutique combinant Timmu
notherapie et la chimiotherapie (5-FU,
Corynebacterium parvum et BCG).
Le BCG seul a ete utilise avec succes en instillation intrapleurale dans les
cancers operables du poumon, par McKneally et Maver35 Falk et collegues35
de Toronto ont utilise le BCG en instil
lation intraperitoneale (2 mg) et par
voie buccale (120 mg) combine avec
chimiotherapie (5-FU et cyclophospha
mide) pour les cancers du tube digestif
en metastase. Les resultats paraissent
valables et permettraient de faire un
essai identique pour les cancers du
colon traites dans un but curatif.

Le principe de Timmunotherapie s’appuie sur la capacite immunitaire antitumorale d’un individu qui, pour une
raison inconnue, serait inefficace ou
faible et qui pourrait etre effectivement
stimulee par des vaccins.28
La maladie cancereuse serait due a
la presence permanente de cellules neoplasiques dans l’organisme. En effet,
11 semble qu’il y aurait constamment
dans 1’organisme des cellules tumorales
en croissance qui seraient regulierement
eliminees soit par un processus de de
fense immunologique de l’hote, soit par
d’autres mecanismes. Le cancer se developpe lorsque cette defense vient a
faire defaut; ce fait peut se verifier
chez les patients cancereux en phase

avancee, dont la plupart montrent une
immunocompetence generale diminuee.
Morton et collegues29 ont fait la
preuve de faction benefique de l’immunotherapie dans les melanomes stade II,
apres excision locale large et lymphadenectomie. Apres deux ans, 70% des
patients ayant eu une immunotherapie
adjuvantielle sont libres de toute mala
die, tandis que 40% seulement du
groupe controle n’ont pas de signe de
maladie.
L’experience de Timmunotherapie
dans le traitement des macrometastases,
c’est a dire, chez les patients ayant un
cancer avance, n’a donne pratiquement
aucun resultat.18 Cependant, Israel30
pretend que Timmunotherapie ne devrait pas etre reservee seulement aux
patients qui n’ont qu’un minimum de
cellules residuelles.
Dans le tableau suivant, on peut
constater que les essais therapeutiques
en immunotherapie31 sont de date recente, que la quantite de patients traites
est faible, que la surveillance est de
courte duree, rendant les resultats difficiles d’interpretation. La majorite uti
lise Timmunotherapie active nonspecifique ou Tassociation chimioimmunotherapie. Certaines etudes ne sont pas
randomisees et utilisent, comme temoins, des controles historiques.
Dix-neuf institutions americaines, regroupees dans le Southwest Oncology
Group,32 ont participe depuis mars 1975
a une etude randomisee comparant la
chimiotherapie et la chimioimmunotherapie dans les cancers localement avances du gros intestin (Dukes’ B2 et C),
recevant un traitement a visee curative.
Tous les patients ont requ du MeCCNU
par la voie orale, et du 5-FU en injec
tion, a toutes les 3 semaines. La moitie
de ce groupe recevait, en plus, du BCG
par voie orale (Connaught bacille Cal
mette Guerin [BCG] 6 x 10s organismes) a toutes les 2 semaines. L’etude,
trop recente, quoique comptant 130
patients, ne nous offre aucune conclu
sion. Elle vise cependant a juger de
Tefficacite de la polychimiotherapie et
de la chimioimmunotherapie.
Mavligit,33,34 du M.D. Anderson Hos
pital, presente Texperience d’une etude
prospective nonrandomisee dans les
cancers colique classe Dukes’ C. Cent
vingt-et-un patients ont ete admis a
l’etude; 52 requrent du BCG en scarifi
cation et 69 une combinaison chimio
immunotherapie de 5-FU et BCG. Le
5-FU (150 mg/m 2, qid) est administre
pendant 5 jours a tous les 28 jours pen
dant 2 ans. Le BCG se donne en scari
fication une fois par semaine pendant
3 mois, puis aux 2 semaines par la
suite.
Utilisant comme temoins des patients
traites par chirurgie seule, au M.D.
Anderson Hospital pendant une periode
de 10 ans, Tauteur rapporte une
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Les 1118 patients furent divises en
trois groupes (A, B et C) selon l’examen
anatomopathologique du specimen chirurgical.
Dans une premiere serie, l’injection
de 5-FU (12 m g/kg'j, iv, pendant 5
jours) se donne aux 2e et 6” semaines
apres l’operation; dans la seconde serie,
le 5-FU se donne en cycles repetes,
durant 18 mois.
Dans tous les groupes, la survie est
meilleure pour les patients qui requrent
du 5-FU, bien que les resultats ne soient
pas statistiquement significatifs.
L’Eastern Cooperative Oncology
Group, du Docteur Paul Carbone, a
propose deux protocoles (2276 et 4276,
non-publies) pour etablir un traitement
d’appoint a la suite d’une resection a
visee curative d’un cancer du colon et
du rectum de type B2 et C. Le traite
ment vise a comparer l’effet du 5-FU
seul (450 mg/m2 iv, id pendant 5 jours
a toutes les 5 semaines) ou du 5-FU
(325 mg/m 2 iv, les lers et 5e jours et
375 m g/m 2 iv, les 36 et 40 jours)
plus
methylcyclohexyl-chloroethyl-nitrosurea (MeCCNU) (130 mg/m 2 per
os, le ler jour seulement a toutes les
10 semaines) pour les cancers situes
au-dessus du repli peritoneal (nonpublie); pour les cancers du rectum la
radiotherapie (de 4500 a 5100 rads)
s’ajoute a la chimiotherapie (nonpublie). Les traitements chimiotherapeutiques doivent se poursuivre pour
un total de 15 cycles avec un intervalle
de 5 semaines entre chaque cycle, pour
ceux qui reqoivent du 5-FU seul, et
pour un total de 8 cycles avec intervalle
de 10 semaines, pour ceux qui reqoivent
du 5-FU et du MeCCNU.
Le but de ces etudes vise principalement I’amelioration du taux de la survie
et de la periode de latence; elles permettront egalement de comparer les
resultats de la monochimiotherapie a
ceux de la bichimiotherapie. Aucun resultat n’est disponible a date, puisque
ces protocoles n’ont pas assez de recul.
Immunotherapie Prophylactique
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Notre Experience

Bien que nous ayons une experience
chirurgicale de longue date dans le
domaine des cancers du tube digestif,
notre interet aux therapies d’appoint est
recente, partielle et sans influence statistique sur nos resultats a date.
Personnellement, c’est depuis 1970
que nous appliquons, pour les patients
subissant une operation dans un but
curatif, une technique adjuvante selon
le protocole de Rousselot, c’est a dire,
le 5-FU en injection intraluminale peroperatoire suivi d’injection intraveineuse les 2 premiers jours postoperatoires.
Les techniques chirurgicales que nous
avons toujours utilisees ont ete classiques et radicales. Pour les adenocarcinomes situes sous le repli peritoneal
(< 10 cm de la marge de l’anus)
nous pratiquons la resection de type
perineoabdominale decrite par LloydDavies37 a deux equipes chirurgicales
qui travaillent simultanement. L a phase
perineale de Toperation est plus radicale
et plus extensive que celui de la resec
tion abdominoperineale de Miles.38
C’est ainsi que Texcision des muscles
releveurs de l’anus se fait tres lateralement et que, chez la femme le septum
rectovaginal est excise.
Les resultats de notre experience
avec les cancers du rectum traites chirurgicalement sont comparables aux
statistiques connues, la survie globale
est a 51%, la mortalite operatoire est
de 2.8% , et le taux de recidive locale
est de 10%. Dans les cancers locale
ment avances, les resultats sont pau49

vres, ce qui met en evidence de fagon
irrefutable l’importance de faire une
therapie adjuvante des cancers de classe
C l et C2.
Voila pourquoi le groupe que nous
dirigeons a l’Hotel-Dieu de Quebec
s’est interesse aux essais therapeutiques
depuis 5 ans. Une centralisation ad
ministrative a permis d’elargir cette
sphere d’activite a plusieurs types de
cancers, a plusieurs hopitaux et a plu
sieurs participants, sous l’egide d’organismes nationaux. C’est ainsi que
nous participons aux essais therapeu
tiques du N ational Surgical Adjuvant
Breast Project et du Institut National
du Cancer du Canada.
Depuis 6 mois, nous avons rejoint
le groupe du Carbone et sommes devenus membres de l’Eastern Cooperative
Oncology Group.

Conclusion
Cette revue de la litterature nous a
permis de faire le point sur les traitements d’appoint dans les cancers coliques et de voir se confirmer ce que
nous avons preconise il y a 10 ans
pour les cancers dont l’examen pathologique laisse supposer un mauvais
pronostic.8
M algre des resultats peu significatifs,
souvent contradictoires, nous croyons
qu’il se degage une tendance qu’il faut
suivre et qui permet de rationaliser
notre therapeutique.
En effet, pour ameliorer le taux de
guerison des patients qui vont eventuellement developper une recidive ou des
metastases, et chez qui, nous pouvons,
au moment du traitement chirurgical
primaire, prevoir cette evolution par
l’examen anatomopathologique, il nous
semble que “l’abstention” soit un cons
tat d’echec. Personnellement, nous ne
pouvons l’accepter.
Quelle devrait etre l’attitude des chirurgiens generaux? Maintenir le statu
quo, c’est a dire, continuer a n ’utiliser
que Fexcision chirurgicale radicale et
n’accepter aucune amelioration du
pourcentage de guerison? Connaissant
les causes d ’echec, ne serait-il pas plus
logique d’essayer de prevenir par des
methodes connues, peu morbides, la
nidation des cellules tumorales en cir
culation et le developpement des micrometastases?
Le stade pathologique de la maladie,
tel que determine par l’examen microscopique du prelevement chirurgical,
fournit les criteres qui permettent de
selectionner les patients pour qui un
traitem ent d’appoint nous parait s’imposer. En effet, le pronostic des adenocarcinomes du colon et du rectum
depend du degre d’extension parietale
et extracolique, du grade histologique,
de l’invasion lymphatique et ganglionnaire et de l’invasion veineuse.
50

L’utilisation des marqueurs39 biochimiques (hydroxyproline urinaire, ferritine) et immunologiques (antigene
carcino-embryonnaire, a-foetoproteine,
et antigenes associes a la tumeur) perm ettraient de bien diviser les cancers
selon leur stade et offriraient une plus
strid e selection. En attendant, il faut
se fier a Fexamen anatomopatholo
gique.
Chez ces patients a risque eleve, il
faudrait done completer Fexcision chi
rurgicale classique radicale par l’une ou
l’autre des methodes d’appoint.
Pour etre pratique cependant, et pour
que toutes ces techniques experimentales d’appoint soient utilisables pour
la majorite des patients a risque eleve,
elles doivent etre simples d’application,
etre faibles en morbidite, sans mortalite
et etre a la portee de tout centre
regional.
P our ce faire, il faut cependant que
les chirurgiens acceptent de participer
a des essais therapeutiques stricts, dont
les indications sont bien specifiques, la
selection des patients honnete et sous
la direction immediate d’un responsable
regional ou d’un organisme provincial
ou national.
C ’est uniquement dans un tel cadre
qu’un chirurgien peut s’aventurer dans
ces types de traitements qui sont avantgardistes et encore experimentaux.
Ainsi, pourra-t-on accumuler dans un
temps relativement court, des donnees
valables statistiquement et fournir des
reponses a toutes ces questions depuis
si longtemps debattues.
E n 1974, l’lnstitut National du Can
cer a tente en vain de mettre en branle
un essai therapeutique pour le cancer
du colon. Tout recemment, un groupe
de travail du Cancer Research Co
ordinating Committee presentait aux
membres participants de l’lnstitut du
Cancer du Canada, un projet d ’essai
therapeutique pour les cancers de classe
B2, C i et C2, traites chirurgicalement.
L’Association canadienne des chirur
giens generaux se doit de faire oeuvre
de pionnier au Canada dans le domaine
des cancers du tube digestif et principalement du colon et du rectum. L’association doit promouvoir les essais
therapeutiques canadiens de concert
avec le Conseil medical de la recherche
du Canada et l’lnstitut du cancer du
Canada.
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DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS

Davis & Geek annually awards $1000.00 to the surgical
resident submitting the best paper on a surgical topic to the
Canadian Journal of Surgery. This award is intended to pro
mote scientific and literary excellence among Canadian sur
geons in training.
The conditions of entry for the 1978 award are the fol
lowing:-—
1. Candidates shall be currently engaged in a recognized
surgical residency program leading to eligibility for the
Fellowship of the Royal College of Physicians and Sur
geons of Canada in one of the surgical specialties (cardio
vascular and thoracic surgery, general surgery, neuro
surgery, obstetrics and gynecology, ophthalmology, oto
laryngology, orthopedic surgery, plastic surgery and
urology).
2. The material to be submitted shall be in the form of a
manuscript relating to work in which a surgical resident
is or has been the prime or major investigator. Prior
oral presentation at a Royal College meeting or a surgical
forum meeting will not be a disqualification, but prior
publication as a formal paper in a journal will. The
paper should relate to any field of surgical interest. The
manuscript must conform to the style requirements of
the Journal and must not exceed 3000 words of text
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and six tables and/or six figures. Coauthors are permitted
on the understanding that the candidate shall be the
first author and that only the first author shall be eligible
for the award.
3. Entries must be received in the office of the Journal no
later than June 30, 1978. Each entry must be submitted
to the editorial office of the Canadian Journal of Sur
gery, PO Box 8650, Ottawa, Ont. K1G 0G8, with a letter
stating that the paper is being submitted as an entry for
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Cana
dian Journal of Surgery unless returned to the author
without publication.
All papers submitted will be judged by an independent
committee comprising at least one member of the editorial
board of the Journal, one fellow of the Royal College of
Physicians and Surgeons of Canada, and one representative
of The Canadian Medical Association, together with other
fellows invited to serve at the discretion of the three perma
nent members of the committee. For the purpose of judging,
the candidates will be anonymous. The judges’ decision shall
be final.
The name of the successful candidate and the title of the
paper will be announced in the November 1978 issue of the
Journal.
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5. Panel Discussion on Carcinoma of the Colon and Rectum
Chairman: E.B. T ovee, md, frcs ( edin ), frcs[c], facs|
Panelists: B.J. C ummings , L.J. D ionne , A.B. Peloquin and I.P. T odd

Dr. Tovee: How do the members of
our panel stage carcinoma of the rec
tum?
Mr. Todd: I think we all recognize that
it is possible to stage only a proportion
of rectal malignant growths. As many
as 50% are not palpable. In addition
there are those that are obviously very
advanced. We are left with quite a
small percentage to which we can as
sign a stage. One must take into
account all the physical findings, and
these include any protuberance as well
as ulceration and mobility. Very rarely
can one feel retrorectal glands. If there
is a palpable retrorectal gland, I know
the case is an advanced one and that
more than local treatment is necessary.
Dr. Tovee: Dr. Cummings, you are at
a disadvantage because you’re not
like the surgeon who can use the knife
to find what the specimen looks like,
and send it to the pathologist for ex
amination. You must have some special
method of staging tumours.
Dr. Cummings: I recognize that it’s im
portant to know the extent of a tumour,
but I wonder if in some tumours we
don’t attach too much importance to
staging. Certainly in regard to rectal
tumours, there is no question that
Dukes’ staging system has been of tre
mendous help in estimating prognosis.
It does not, of course, determine treat
ment. It may affect treatment when we
consider the field of adjuvant therapy,
which today means the field of post
operative adjuvant therapy. Has the
time not come when we must decide
on some form of clinical staging? The
UICC tried to do this some years ago
and, as you are aware, TNM staging
was abandoned in 1967. The difficulty
with clinical staging is that the only
unequivocal finding is the size of the
primary growth, which is quite unre
lated to any other features of the case.
*Conducted at the inaugural meeting of
the Canadian Association of General
Surgeons, Toronto, Ont., May 11 and
12, 1977
■Senior surgeon, Toronto General
Hospital, Toronto
Reprint requests to: Editorial office,
Canadian Journal of Surgery, PO Box
S650, Ottawa, Ont. K1G 0G8
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The techniques that we have been
investigating in a preliminary way at
the Princess Margaret Hospital include
perirectal node scanning, which has
been developed along the same lines
as internal mammary node scanning
used in breast carcinoma. We are also
trying to devise a system similar to
that advocated by Feinstein who de
fined certain clinical markers that en
abled him to venture a vague prognosis
for the patient. As a radiotherapist, I
can tell you how I arrive at a clinical
staging. I can tell whether the tumour
is mobile or not; if it is not, I cannot
be sure whether its fixity is due to an
inflammatory or a malignant process.
With the patient under anesthesia I can
determine whether it infiltrates the
bladder. I can do a liver scan and incur
all the problems that it may involve.
I can do lymphangiography, which will
tell me nothing about the lymph nodes
below the bifurcation of the aorta in
this disease. I can do a bone scan,
which may or may not be useful, al
though it has been advocated in this
disease. I can do a carcinoembryonic
antigen determination which tells me
nothing whatever about the stage of
the disease. I can record a lot of
information, but really we are left
with a clinical decision — “Is this
tumour confined within the pelvis or
not?” And at this stage I don’t think we
have advanced beyond that. I wish we
did have a reliable clinical staging sys
tem because then I could claim that
our 79 cases are as good as, or are
better, or are worse than any other
surgical series, but at the moment I
cannot do that. Neither can I tell you
what happens after high-dose preopera
tive irradiation, because any preopera
tive treatment must alter the stage. It
is wrong to talk about operative staging
without specifying whether the patient
has had preliminary treatment.
Dr. Tovee: Dr. Dionne, what do you
do when confronted with carcinoma of
the rectum in a patient on the operating
table when that patient has gross hepa
tic metastases? Would you do a palli
ative anterior resection, an abdomino
perineal resection or a proximal colos
tomy, or would you do nothing and
treat the patient with chemotherapy?
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Dr. Dionne: I recall reading about a
series of 12 patients who survived 10
years after an abdominoperineal resec
tion, at which time the surgeon noticed
that there were liver secondaries. Mind
you, these were very good surgeons
because they were from St. Mark’s Hos
pital. This report gives me help in an
swering your question. If you are ab
solutely sure that there is a metastasis
in the liver, then the steps you take
depend on how large it is, what the
expectation of life is and the effect
your operation will have on the quality
of life for that individual. If you are
not sure, you think there is a metastasis
but you’re not completely sure, I think
you should excise the lesion.
Dr. Tovee: Any other comments? Dr.
Peloquin?
Dr. Peloquin: I agree entirely that all
the tumours that can be resected must
be excised even in the presence of hepa
tic metastases. When the primary tu
mour either in the rectum or in
the colon was resected, the survival
rate at 2 years was as high as five
times the rate when a resection was
not done. The reason for this is not
understood but it is believed by many
surgeons. Even at the beginning of this
century some surgeons realized that
when you resect the primary tumour
you may arrest or retard the growth of
hepatic metastases.
Dr. Tovee: Mr. Todd, this next ques
tion is directed to you. Are there any
technical problems in performing re
section and anastomosis if the patient
has had preoperative irradiation, espe
cially if this has been administered in
several doses?
Mr. Todd: With the regimen that has
been used in the trials in England, no
problems have arisen from this form
of management. I’m still slightly wor
ried, I must admit, about anterior re
sections, and one of my colleagues at
St. Mark’s won’t allow preoperative
irradiation because he claims he can’t
always decide whether he’s going to
excise the rectum or do an anterior
resection until he has opened the ab
domen and he is worried about break
down of the anastomosis after the ad
ministration of 2000 rads. I personally
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don’t think that we’ve had any serious
problems as a consequence.
Dr. Cummings: May I make a com
ment? In the recorded series where the
dose range has been that used in the
United Kingdom, namely 2000 rads
given over 2 weeks or a single dose of
500 rads, there has been no increase
in the complication rate. One such
randomized series is the Veterans Ad
ministration study in which most pa
tients, it is true, were treated by
abdominoperineal resection; however,
in approximately 200 cases other types
of resection were used and the compli
cation rate was not increased. If as
high a dose as 6000 rads is given over
6 weeks, as reported by Stevens from
Oregon, anterior resection was deliber
ately avoided at first because of fear
about the anastomosis. By now they
have experience of 4 out of 50 cases
in which they have safely done an
anterior resection. In Kligeman’s report
from the southern United States, 4500
rads is given and the type of operation
is left to the discretion of the surgeon;
no problems are recorded with anterior
resection in a relatively small number
of patients. I myself would think that
the dose could safely reach about 4500
to 5000 rads. I would be worried about
levels higher than that.
Dr. Tovee: Mr. Todd, what’s the best
operation for rectal villous adenoma?
Mr. Todd: It depends on where the tu
mour is situated. It’s an almost im
possible question to answer because one
needs to know more details. Is it a
proliferative lesion, is it a carpet type
of lesion, does it extend over a major
part of the circumference of the rec
tum? One has seen some tumours that
cover many square inches, just as a
carpet. I think this is one situation
where a transsphincteric operation has
a place. The proliferative tumours
sometimes may be dealt with by local
excision. On occasions they can even
be snared. Of course if the villous type
of tumour becomes malignant it tends
to be highly malignant and therefore
these patients need to be watched ex
tremely carfeully. My colleague, Mr.
Parks, does sleeve resections for some
of these, which he thinks is a safer
procedure.
Dr. Tovee: Dr. Dionne, do you do
local perfusion of the liver for metastases from carcinoma of the colon and
rectum and what are the indications for
so doing?
Dr. Dionne: I treated some cases of
liver metastases or perineal recurrences
in this way with very poor results. Fol
lowing the trend throughout the world,
I abandoned the procedure completely.
Dr. Tovee: Dr. Cummings, what hap
pens to anal function after curative
irradiation?
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Dr. Cummings: After curative irradia
tion for carcinoma of the rectum
anal function will remain normal unless
the tumour has already infiltrated the
anal sphincter. If that has already hap
pened you proceed to destroy the tu
mour with radiation. Healing will be
by fibrosis, as after any procedure, and
if the patient initially was incontinent
owing to this cause, then he is likely
to remain so. There is no specific effect
of the radiation as we deliver it that
will destroy a normally functioning anal
sphincter.
Dr. Tovee: Would you tell us a little
more about the complication rate from
radiation used in the treatment of carci
noma of the rectum?
Dr. Cummings: With moderate-dose
preoperative irradiation, as commonly
used, complications are probably not
significant. For postoperative irradia
tion, the data are not yet available.
From analogy with the treatment of
other tumours and from reported
studies, it is quite apparent that you
should not give high-dose wide-field ir
radiation to most of the pelvic and ab
dominal contents. A total of about 70
to 80 cases have been recorded in the
literature where high doses, and by that
I mean doses in excess of 5000 rads
in 4 to 5 weeks, have been given to
the whole of the pelvis and lower ab
domen. Follow-up ranges from 12
months to 7 or 8 years. Complications
have developed and there have been
radiation-induced deaths. What I call
acceptable irradiation is a dose of
4500 rads given over 4 weeks, and that
can be given safely to the whole of
the pelvis. In addition, one can give
probably 2000 to 2500 rads to the
whole of the upper abdomen including
the liver, and that is quite tolerable.
We have very wide experience with that
sort of radiation in treating patients
with carcinoma of the ovary and I
think that, provided you control the
dose, it is safe. Higher doses, I think,
are dangerous. After radical irradiation
such as we are using at Princess Mar
garet Hospital for certain patients with
carcinoma of the rectum, there has
been moderate morbidity. I think every
patient had troublesome diarrhea. If
the tumour can be reached by the
examining finger, we now deliberately
irradiate the entire perineum to almost
full dose because we found that
otherwise these tumours recurred
around the anal canal. Patients will
have a moist reaction at the perineum
and most will require bed rest for
perhaps a week, although some of them
in fact continue working. Healing takes
place normally. A small proportion,
about 3%, will have significant smallbowel morbidity. This figure is of the
same order as after irradiation for car

cinoma of the cervix. I can’t be more
precise because a number of these pa
tients die from uncontrolled tumour
and it’s often impossible to distinguish
side effects of irradiation from the ef
fects of uncontrolled tumour. Provided
the dose is controlled and the patient
is watched carefully, the morbidity is
acceptable.
Dr. Tovee: Dr. Peloquin, would you
tell us what you do with the perineum
that won’t heal after an abdomino
perineal resection?
Dr. Peloquin: Usually it does heal, al
though sometimes not very fast. You
must be patient and wait. After a cer
tain length of time one sometimes has
to go back and try to do a second stage
procedure.
Dr. Tovee: Mr. Todd, tell us, then,
what you do for the perineum that
fails to heal.
Mr. Todd: I think the most important
thing is to have very good hemostasis
or what you think is very good hemo
stasis of the perineum before you close
it, or whatever you do with it. Re
cently we have closed the perineum in
the male entirely and we have put in
Shirley sump sucker drainage. I usually
use only a single suction apparatus, but
I have been very surprised that in the
first 24 hours about 500 mL of what
looks like pure blood collects in the
sucker. Hence, no matter how dry you
think you leave it, the perineum is
actually not very dry. This is the first
thing that matters. If you can’t obtain
complete hemostasis, I certainly would
not suture it completely, but would
insert a small piece of corrugated drain
and leave it in situ for 48 hours. I
don’t believe in irrigating the wound
unless a lot of blood collects; then I
sometimes do irrigate it. Usually I do
not use skin grafts for malignant cases.
However, in cases of inflammatory
bowel disease, which I find are prob
ably more difficult to heal, I try to
make the wound into an acceptable
shape and then apply a xenograft and
later a homograft.
Dr. Tovee: Have any of the panelists
any thoughts about the value of the
procedure of enclosing the suture line
of an anterior resection with omentum?
Is it worth while trying?
Mr. Todd: I bring down the omentum
if it can be done easily, but I don’t
make any special effort to mobilize it.
One of the most important things in
an anastomosis is a good blood supply.
We acknowledge this, but a num
ber of surgeons, I think, tie their su
tures far too tightly and cut off the
blood supply. A piece of omentum
whose blood vessels you have tied in
mobilizing it is not in the least helpful.
If you can lay it easily in the neigh
bourhood of the suture line, do so,
otherwise forget it!

THE CANADIAN JOURNAL OF SURGERY

53

Gelfoam
used by a generation of physicians
in hepatic surgery, haemorrhoidectomy,
cholecystectomy and decubitus ulcer

H

still the only absorbable haemostat that meets all these criteria:
absorbed completely in four to six weeks
safe as a permanent packing in any tissue; won’t interfere with bone
regeneration, cause cyst formation or excessive scar tissue
effective dry or moistened with thrombin solution, isotonic
sodium chloride or antibiotic
non-irritating, naturally-occurring, neutral pH; may be cut,
molded, or sutured in place when necessary
stimulates natural clotting and healing of disrupted tissue
7 69

R E G IS T E R E D T R A D E M A R K : G E L F O A M , G E L F IL M

C E 7 7 3 4 .3

Upjohn
THE UPJOHN COMPANY OF CANADA/DON MILLS, ONTARIO

|

P M A C

J

available in a variety of sizes, shapes
and forms for most areas of
surgery where haemostasis is desired
p acking c a v itie s - o b lite ra tin g
dead space

p a ckin g fo r gynae co lo g ic
and rectal surgery

fo r nasal packing

•

H
44

,{.'4
,

S te rile Pack, size 2 cm
40 x 2 cm
box o f six sponges, No. 7871

S te rile Pack, size 6 cm
40 x 6 cm
box of six sponges, No. 7874

S terile S ponge, size 200
80 x 250 x 10 mm
box of six sponges, No. 7862

fo r general surgery

fo r general surgery

sp e cia lly p re p a re d fo r d ry
a p p lica tio n and e m e rg e n cy
haem ostasis

S terile Sponge, size 100
80 x 125 x 10 mm
box o f six sponges, No. 7859

S te rile Sponge, size 50
80 x 62.5 x 10 mm
b o x o f fo u r sponges, No. 7858

S terile C om pressed Sponge
size 100
12.5 x 8 cm
box o f six sponges, No. 7865

fo r general and n e u ro lo g ica l
surgery

fo r general and n e u ro lo g ica l
surgery

prom ote healing in c h ro n ic
leg u lc e r
::

If}/
S terife Sponge, size 1 2 -3 mm
20 x 60 x 3 mm
box o f fo u r sponges, No. 7852

non-haem ostatic
fo r o c u la r surgery

' \

\
V

O p hthalm ic S terile G elfilm
25 x 50 mm
box o f 6, No. 7844

S te rile Sponge, size 1 2 -7 mm
20 x 60 x 7 mm
box o f fo u r sponges, No. 7853
ja r of fo u r sponges, No. 7854

,
-

'
I
.4,- , ,*444

S terile P ow der
ja r co n ta in in g 1 g, No. 7876

Precautions
Gelfoam and G elfilm are sim ple to use, and w ith conscientious observance of certa in
precautions satisfactory results may g e nerally be expected where th e ir use is ind icate d .
1. Gelfoam should be used d iscrim in a te ly in arterial bleeding because o f the in tra arterial pressure. It is advisable to suture and reinforce where possible.
2. Although Gelfoam generally serves its purpose well in the presence of haem orrhagic
blood dyscrasias, it should not be relied upon as the sole m ethod of haem ostasis in
such conditions.
3. Gelfoam should not be used to stop m enstrual bleeding. In postpartum and m enorrhagic bleeding it serves only as a tem porary vaginal tampon.
4. Gelfoam must be in snug co n ta ct w ith the bleeding surface in o rd e r to be effective.
5. Use Gelfoam as sparingly as possible in o rd e r to m inim ise the am ount of im planted
foreign material.
6. Do not overfill cavities with G elfoam .

CE 7 7 3 4 .3

Upjohn

7. Do not use Gelfoam in grossly contam inated wounds which are so deep that d ra in 
age is interfered with. However, it may be used for tem porary haem ostasis in more
superficial contam inated wounds, provided it is removed after it has served its haem o
static purpose.
8. Avoid prolonged exposure of G elfoam to contam inated air.

Detailed information available on request.

Symposium on Pancreatitis
1. Conservative Management of Acute Pancreatitis*
R oger G. K eith ,

Acute pancreatitis may present as the
mild edematous type or the more rare
and dangerous hemorrhagic form. The
effects of the latter are believed
to be due to the activation of pancreatic
enzymes, notably trypsin. Therefore
attempts are being directed towards
suppression of pancreatic enzyme
activation in the management of the
condition. Aprotinin and glucagon are
the agents for this purpose that have
received most attention.
Patients with acute hemorrhagic
pancreatitis are subject to respiratory
failure, which is not detectable early
by clinical evidence, so that early
monitoring of pulmonary function by
the determination of arterial blood-gas
pressures is desirable. This is borne
out by the findings in six fatal cases.
La pancreatite aigue peut etre du type
oedemateux benin, ou prendre la forme
hemorragique, dangereuse et plus
rare. Dans ce dernier cas, les effets
sont possiblement dus a I’activation des
enzymes pancreatiques et, notamment,
de la trypsine. Dans le traitement de
cette affection, on essaie done de
supprimer I'activation des enzymes
pancreatiques. L'aprotinin et le glucagon
sont les produits utilises a cette fin
ayant recu le plus d’attention.
Les patients souffrant de pancreatite
hemorragique sont sujets a une
insuffisance respiratoire qui ne peut
decelee tot a partir du tableau clinique.
Une surveillance precoce de la
fonction pulmonaire par la mesure des
pressions gazeuses du sang arteriel
est done souhaitable. Ceci est continue
par les observations faites dans six
cas mortels.

The Marseilles classification of pan*Presented at the inaugural meeting of
the Canadian Association of General
Surgeons, Toronto, Ont., May 11 and 12,
1977
Reprint requests to: Dr. Roger G. Keith,
Department of surgery, Sunnybrook
Medical Centre, 2075 Bayview Ave.,
Toronto, Ont. M4N 3M5
56

md, frcs[c], frcs, facs

creatitis correlates the clinical and pa
thological aspects of acute and chronic
forms of the condition.1 Beyond that
classification two forms of acute pan
creatitis are recognized. Acute edemat
ous pancreatitis, so called to indicate
the pathologic state, is the mild form
of the disease, which comprises about
80% of all cases of acute pancreatitis.8,3
Acute hemorrhagic pancreatitis, char
acterized by parenchymal necrosis and
hemorrhage, presents the risk of major
complications and death.4-6 Clinical dif
ferentiation between the two states at
initial presentation is usually impos
sible; the distinction is evident only in
retrospect.
Acute hemorrhagic pancreatitis is a
dynamic condition that may progress
to a state of irreversible shock and
organ failure through three major
mechanisms. Hemorrhage occurs early
and is usually restricted to the local
peripancreatic tissues. Elastase plays a
major role in the small vessel disrup
tion implicated in this process. Retroperitonitis with peritonitis and paralytic
ileus also characterize the early phase
of the disease. Subsequent third-space
losses account for the extracellular fluid
deficits, which range up to 10 L in the
initial 24 to 36 hours. Pancreatic en
zyme activation, absorption and disse
mination account for additional microcirculatory insufficiency and specific
organ failure occurring from 48 hours
onward. Current observations support
the theories that trypsin activation pre
cedes activation of other proteases and
initiates activation of the kinin system,
other vasoactive peptides, the coagula
tion sequence and the platelet release
phenomena.6'8 Using pH electrophoretic
gel diffusion techniques, White has iso
lated 22 pancreatic enzymes. In addi
tion to lipase and phospholipase, there
are 3 to 6 amylases and 15 proteases.®
Trypsin is capable of activating the
majority of the proteases as well as
phospholipase and converts kallikreinogen present in pancreatic tissue to kallikrein, thereby activating the kinin sys
tem.10 Thus, indirectly and directly,
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through activation of the Hageman fac
tor the coagulation cascade is initiated,
as are platelet aggregation and release.
It has been suggested that trypsin acting
through phospholipase is capable of
disrupting surfactant.11 The duration of
free trypsin stability in the plasma is
less than 30 seconds and measurement
of circulating levels of this unbound
enzyme in patients with pancreatitis is
difficult. As well, two trypsin inhibitors
have been identified. These are parti
cularly potent in the intraductal inac
tivation of trypsin.18,13
Recently Allan, Tournut and White13
were able to obtain evidence of the con
version of trypsinogen to trypsin in the
intraductal secretions of the human
pancreas during the spontaneous devel
opment of pancreatitis. This is the first
direct observation to support theories
of the basic mechanism leading to the
development of the proteolytic holo
caust that results in the enzyme shock
associated with acute hemorrhagic pan
creatitis.
Current advances in conservative
management of acute pancreatitis have
been directed towards suppression of
pancreatic secretory activity or inac
tivation of pancreatic proteases. In
1950 in Germany, Frey, Kraut and
Werle14 isolated a trypsin and kallikrein
inhibitor from beef salivary glands.
Subsequent experimental and clinical
trials using this trypsin inhibitor sug
gested improved morbidity and mortal
ity. However, controlled experimental
trials with Trasylol (aprotinin) showed
significant improvement from the use
of this agent only when it was given
prophylactically before the induction of
pancreatitis in an experimental model.
Many controlled clinical trials failed to
show that Trasylol brought about sub
stantial improvement when given in a
dosage of 200 000 units/24 h.15'19 In
1974 Trapnell and colleagues80 reported
a controlled trial in which the patients
treated with Trasylol received a dosage
of 800 000 units/24 h; the mortality
rate was substantially lower in the
treated group. This report was criticized
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on the basis of the exclusion from the
series of cases of alcoholic and post
operative pancreatitis, and the control
group may have been unduly weighted
with cases of severe pancreatitis. The
multicentre study conducted by the
Medical Research Council in the
United Kingdom prospectively com
pared the effects of Trasylol and gluca
gon in a controlled double-blind proto
col; the mortality rate in patients treat
ed with either agent was approximately
the same as in the controls. Imrie (per
sonal communication, 1977) prospec
tively compared the outcome in pa
tients treated with Trasylol in high
dosage with that in controls in one
institution over 2 years. In this series
of 150 patients no significant difference
in the mortality rate was noted between
the two groups.
Glucagon, the hormone produced by
the a cells of the pancreatic islets, has
primary glycogenolytic and gluconeo
genic activity in the liver. Because of
its positive inotropic and chronotropic
action, glucagon has been used in the
shock syndrome of myocardial dis
ease.21 Pharmacologic doses of exo
genous glucagon suppress pancreatic
secretion.22,2'1 Hyperglucagonemia has
been reported in bacterial infection,24
shock25 and pancreatitis.26 Knight, Con
don and Day26 observed a rapid fall of
elevated plasma glucagon values, corre
lating with onset of shock in a fatal
experimental model of pancreatitis. Ex
trapolating from this observation, they
suggested that infusion of exogenous
glucagon might further suppress pan
creatic activity and reduce mortality.
The animals treated with glucagon had
a prolonged survival. Uncontrolled
clinical experience has suggested that
morbidity and mortality are reduced
in patients with acute pancreatitis
treated with glucagon.27
However, controlled studies using a
number of pancreatitis models have
failed to demonstrate prolonged surv
ival in glucagon-treated animals.28 At
the cellular level glucagon is believed
to act at the cell membrane, activating
adenyl cyclase at a specific receptor
site with resultant subsequent cyclic
AMP activity. Using histochemical
techniques, Fodor and colleagues29
were unable to identify glucagon re
ceptor sites in pancreatic acinar tissue.
Controlled clinical trials have failed to
document improved survival in gluca
gon-treated patients (Imrie CW: Per
sonal communication, 1977).10
Recent reports that describe the
mode of death in patients with acute
hemorrhagic pancreatitis indicate a
high incidence of respiratory failure.31
This develops in the early phase of the
disease, is usually unrecognized and
may progress rapidly to sudden death.
VOLUME 21, NO. 1, JANU ARY 1978

/

Since 1974 we have assessed the res
piratory function of 50 patients suf
fering from acute pancreatitis. Arterial
blood-gas measurements made 48
hours after establishment of the diag
nosis illustrated hypoxia in six cases
that subsequently proved fatal. At this
stage of disease the patients had limited
clinical evidence of respiratory insuf
ficiency. The chest roentgenograms
were usually normal. None of the pa
tients had persistent hypotension or
shock. Coagulation studies showed
thrombocytopenia but no evidence of
disseminated intravascular coagulation
(Table I). Minimal hypoxia is observed
in some nonfatal cases of pancreatitis.
Sustained hypoxia in the first 48 hours
despite oxygen administration during
spontaneous respiration should be con
sidered to indicate a grave prognosis
and should provoke consideration of
early aggressive ventilatory support.
The respiratory failure of acute pan
creatitis probably represents organ fail
ure specifically related to an enzymemediated effect on pulmonary arte
rioles and the alveolar capillary mem
brane. Halmagyi and colleagues32 dem
onstrated normal cardiac output and
normal pulmonary wedge pressures,
thus negating the theory of acute left
heart failure. They also demonstrated
increased pulmonary arteriolar pres
sure. Warshaw and associates33 were
unable to confirm pulmonary hyper
tension and proposed as the site of
injury the alveolar capillary mem
brane. Imrie has shown a right-toleft cardiac shunt of up to 15%, a
restricted ventilatory defect and evid
ence of disseminated intravascular
coagulation.8'34 Such changes in the
lung are similar to those seen in the
adult respiratory distress syndrome or
shock lung; the term “pancreatitis
lung” has been coined for this situa
tion.
If we consider the principles for
current management, it is possibly suf
ficient in the majority of cases of acute
edematous pancreatitis to replace fluid
deficit, relieve pain with appropriate
analgesics and treat the ileus as well as
suppress pancreatic stimulation by
means of nasogastric decompression.
However, evidence of progressive clin

ical deterioration with associated tissue
hypoperfusion may indicate acute hem
orrhagic pancreatitis. In such cases
fluid losses will be more extensive and
requirements may include albumin,
plasma, or blood in addition to bal
anced electrolyte solution. The role of
glucagon and Trasylol is still in doubt.
In early conservative management of
acute pancreatitis attention must be di
rected to the respiratory system. Early
assessment of pulmonary function by
determination of arterial blood—gas
pressures is mandatory. Hypoxia, with
failure of prompt response to oxygen
administered by mask, should indicate
the need for endotracheal intubation
and positive-pressure ventilation. Im 
proved mortality rates in prospective
trials support this therapeutic ap
proach.20,33,35
Many problems exist in the overall
management of acute pancreatitis.
Awaiting definition through research
are such tools as the biochemical char
acteristics that will quickly distinguish
edematous from hemorrhagic pancrea
titis and the development of an effec
tive protease inhibitor or blocker of
vasoactive peptides. In spite of the ex
cellence of conservative management,
occasional patients fail to respond. In
this situation, highly selective and welldefined surgical treatment will con
tinue to have a place in the manage
ment of acute pancreatitis.
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2. Surgical Management of Acute Pancreatitis*
P aul P o n c e l e t , m d , f r c s [c ]

While there is general agreement on
the indications for surgery in acute
pancreatitis, the preferred operation is
controversial and the approach ranges
from one that is very conservative
to one that is extremely aggressive.
The author believes that in all cases
the gallbladder should be opened
to permit exploration and that
cholangiography should be performed.
If gallstones are discovered they should
be removed and the organ drained;
cholecystectomy is advised if the
procedure is at all feasible. In a
personal series of 50 cases of acute
pancreatitis, 10 patients had early
operation and 19 surgical procedures
were performed.

Alors qu'il y a generalement accord
sur les indications de la chirurgie
dans la pancreatite aigue, I'unanimite
n’est pas faite sur I’operation de choix,
I'abord etant ou bien tres conservateur
ou extremement agressif. L'auteur croit
pour sa part que la vesicule biliaire
doit etre ouverte dans tous les cas
pour en permettre I’exploration, et qu'on
doit effectuer une cholangiographie.
Les calculs decouverts doivent etre
enleves et I’organe draine; lorsqu'elle
est possible, la cholecystectomie est
recommandee. Dans une serie de 50
cas de pancreatite aigue, 10 patients
ont ete soumis a une operation precoce
et 19 interventions chirurgicales ont
ete realises.
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Most cases of acute pancreatitis are
best treated conservatively and only
5% to 10% should be operated upon
during the acute stage of the disease.1,2
There is no consensus on the best tim 
ing for surgical exploration in these
patients, but most surgeons3-5 agree that
the indications for operation are:
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1. When diagnosis is uncertain.
2. When persistent jaundice devel
ops.
3. When the general condition of the
patient deteriorates despite adequate
medical treatment.
4. When a complication such as an
abscess, pseudocyst, or hemorrhage
supervenes.
What should be done at the time of
operation is much more controversial.
Some surgeons close the abdomen
without doing anything. In such cases
the mortality remains the same; you do
the patient no harm but you do not
help him very much.
The most widely accepted practice
today in North America is to drain
widely the pancreatic area and to per
form a cholecystostomy, gastrostomy
and feeding jejunostomy.2,4,6 Some sur
geons also establish a peritoneal
dialysis around the pancreatic area1 or
drain the thoracic duct.7 Cholecystos-
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tomy is probably unnecessary when the
biliary tract is norm al and some sur
geons do not drain the gallbladder in
such cases.6 The problem here is that,
although the biliary tract may look
normal, there can be small stones in
the gallbladder or common bile duct.
We strongly believe that in all cases
the gallbladder should not only be pal
pated but opened. Routine cholangio
graphy should be performed and then
the surgeon can decide whether or not
to drain the biliary tree.
Other surgeons advocate a more ag
gressive attitude.8'11 Hollender of Stras
bourg performs pancreatectomy as
early as 12 hours after the onset of
the illness and sometimes removes as
much as 95% of the pancreas.10,12 It is
obvious that such an approach is too
aggressive since at this stage necrosis
is not always well defined and large
parts of viable pancreas will be re
moved, even if frozen sections are used
to determine which portion should be
left and which resected.
Still other surgeons, such as Edelmann in Paris, are more conservative
and wait 8 to 10 days. By this time
necrosis is well defined and a subcapsular sequestrectomy can be performed
with surprisingly good results and few
complications.6,13'15
W hat should be done with the gall
bladder and common bile duct when
pancreatitis is due to biliary tract dis
ease? If there are gallstones, the least
that should be done is to remove them
and drain the gallbladder through a
cholecystostomy after performing chol
angiography to make sure there are no
stones in the common bile duct. If
technically feasible, a cholecystectomy
should be done at this stage since no
further operation would be needed.
If stones are demonstrated in the
common bile duct, most authors agree
they should be removed.5,16 Some sur
geons perform a transduodenal sphinc
terotomy if there is no other way to
dislodge the stones, and their results
are good;12’17 others claim that the
sphincter should always be left alone
at this stage and that drainage of the
common bile duct is sufficient.5,16
We are able to report briefly our
personal experience with such cases.
Of 50 patients with acute pancreatitis,
10 were operated upon early (12 hours
to 10 days after onset). Nineteen opera
tive procedures were performed at this
stage: total pancreatectomy (1 case),
left pancreatectomy (4 cases), seques
trectomy (2 cases), cholecystectomy (7
cases), sphincteroplasty (3 cases), and
cystoduodenostomy with vagotomy and
subtotal gastrectomy (1 case).
One patient died from acute myo
cardial infarction with septic shock 12
hours after the operation. Four patients
had a minor pancreatic fistula that

closed spontaneously. One patient bled
from an acute gastric erosion and was
treated conservatively. Five patients be
came infected and two of these had
septic shock, but all recovered after
treatment with antibiotics. One episode
of minor pulmonary embolism was ob
served.
In conclusion, we believe that two
principles should govern our attitude
to the surgical management of acute
pancreatitis:
1. Necrotic tissue should be removed
if possible or at least widely drained if
resection is not technically feasible.
2. The primary cause of the disease
should be treated at the same time
whenever possible.
Bearing these principles in mind,
early surgery is recommended in cases
of gallstone pancreatitis—as soon as
possible if diagnosis is established and
the treatment should be definitive if
possible.1,12,17,18 Early operation is ad
vised also in severe cases of alcoholic
pancreatitis when there has been im
provement after 24 to 48 hours of
intensive medical treatment.
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3. Diagnostic Tools in the Management of
Chronic Pancreatitis*
J.E. M ullens ,

The chief diagnostic tools used in
planning the management of chronic
pancreatitis require close collaboration
of the surgeon and radiologist. Barium
meal, endoscopic retrograde
cholangiopancreatography (ERCP),
ultrasonography and angiography are
the most useful procedures. The barium
meal is the initial screening procedure.
Ultrasonography should follow if there
is suspicion of a pseudocyst or
pancreatic abscess. It also may be of
value in demonstrating localized
chronic pancreatitis. The most useful
of all the tests is ERCP. This shows
the pancreatic duct, the common bile
duct, or both ducts, so that the surgeon
may avoid operation where there is
no defect to correct, or it may guide
him in selecting an operation that is
designed to correct the anatomical
abnormalities of either duct. Angiography
is occasionally of use when the
foregoing procedures have not provided
enough information. In over 80% of
patients it is possible for the surgeon
to undertake an operation with
foreknowledge of the pancreas that
will help him select the correct
procedure to alleviate the patient's
symptoms.
Les principaux moyens de diagnostic
servant a planifier le traitement de la
pancreatite chronique exigent la
collaboration etroite du chirurgien et
du radiologiste. La radiographie
apres repas baryte, la cholangiopancreatographie endoscopique
retrograde (CPER), I’ultrasonographie
et I’angiographie sont les techniques
les plus utiles. Le repas baryte est la
technique initiate de depistage.
L’ultrasonographie vient en second
lorsqu'il y a suspicion de pseudo-kyste
ou d'abses pancreatiques. Elle peut
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and McMaster University, Hamilton,
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egalement etre utile pour demontrer
une pancreatite chronique localisee.
L'epreuve la plus utile est la CPER. Elle
met en evidence le canal pancreatique,
le canal biliaire, ou les deux canaux,
de sorte que le chirurgien peut eviter
I'operation lorsqu'il n'y a pas de
defaut a corriger, ou elle peut le
guider dans le choix d’une operation
destinee a corriger les anomalies
anatomiques de I'un ou I’autre des
deux canaux. A I'occasion, I'angiographie
est utilisee quand les renseignements
fournis par les methodes precedentes
sont insuffisants. Chez plus de 80%
des patients, le chirurgien peut
entreprendre un operation avec une
bonne connaissance du pancreas ce
qui I'aidera a choisir le mode operatoire
approprie pour soulager les symptomes
du patient.

Until recently, dependable evaluation
of the chronically inflamed pancreas
was virtually impossible without resort
ing to laparotomy. Now technologic
advances in radiology have made
it possible to assess the condition of
the pancreas without operation in a
large proportion of patients. In those
patients with chronic pancreatitis one
can distinguish abnormalities that can
be corrected by operation from those
that cannot.
There are four procedures that are

FIG. I—Pancreatic pscudocyst (p) dis
placing stomach (s).

VOLUME 21, NO. 1, JANU ARY 1978

/

md

particularly helpful and complemen
tary, and since more than one will be
required to establish a diagnosis, the
radiologist should be involved in the
selection of the techniques. He will be
able to choose the technique that is
appropriate and he can give a reliable
interpretation of the films if he is in
formed of the patient’s history and of
the presence or absence of pain, al
coholism, diabetes mellitus, biochemical
abnormalities such as an abnormal glu
cose tolerance curve, pancreatic steator
rhea and significant changes in urinary
and serum amylase concentrations.
The four most useful procedures
are:
1. Barium meal.
2. Endoscopic retrograde cholangio
pancreatography (ERCP).
3. Grey-scale ultrasonography.
4. Angiography.
Barium Meal
A well-performed barium meal will
often disclose swelling of the inflamed
pancreas. Swelling is most easily de
tected if the head of the pancreas is
affected; in this case hypotonic duode
nography may better demonstrate the
swelling. Fig. 1 shows displacement
of the stomach due to pancreatic
swelling and Fig. 2 shows a swelling of

FIG. 2—Pancreatic pseudocyst (P) en
croaching upon gastric antrum (ga).
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the head of the pancreas indenting
the greater curve of the stomach.
In both instances the lesions proved
to be pancreatic pseudocysts. How
ever, one cannot expect displace
ment of the stomach or duodenum in
all cases of enlargement of the pan
creas, and this is especially true if the
swelling lies in the tail of the pancreas.
ERCP

This is the most informative of the
procedures available to assess the pan
creas.1'9 The findings of critical im
portance in planning the management
of patients with pancreatitis are listed
and illustrated as follows:
Z. The Normal Pancreas
Fig. 3 shows a normal pancreatic
duct and common bile duct in a patient
in whom the diagnosis was chronic pan
creatitis. Clearly, it is important to the
surgeon to know that the patient’s
symptoms cannot be relieved by an
operation on these normal ducts.
2. Papillary Stenosis
Fig. 4 shows a dilated common bile
duct and dilated pancreatic duct. There
is an organic or functional obstruction
at the papilla, and a sphincteroplasty
may relieve the patient’s symptoms.
3. Strictures of the Pancreatic Duct
Fig. 5 is the roentgenogram of a
patient with chronic alcoholism and
recurrent attacks of pancreatitis; there
are multiple strictures of the pancreatic
duct and irregular duct ectasia. The
operative procedure selected to over
come this problem must be one that
drains the pancreas distal to the stric
tures. This is the ideal type of case
for retrograde drainage of the pancre
atic duct into a Roux-en-Y loop anas
tomosed to the opened pancreatic duct.
4. Obstruction of the Pancreatic
Duct

tion of the pancreatic duct. This find
ing can be caused by carcinoma of the
pancreas, but when there is a long
history of attacks of pancreatitis one
can usually be confident of relieving
the condition by surgery. This type of
abnormality usually can be managed
by distal pancreatectomy.
5. Tortuous or Irregular Ducts
If there is a tortuous or irregular
duct that extends from the head of the
pancreas out to the tail it is difficult
to provide adequate retrograde drain
age. A subtotal pancreatectomy may be
the best operation in this situation.
6. Small, Attenuated or Sclerotic
Ducts
If the pancreatic duct is thin and
sclerotic there is no operation short of
subtotal pancreatectomy or total pan
createctomy that is likely to alleviate
the patient’s symptoms.10
7. Stones in the Pancreatic Duct or
the Common Bile Duct
Fig. 6 shows stones in a dilated pan
creatic duct. The operation selected for
such a patient must be designed to
remove the stones and provide drain
age. Retrograde drainage with a Rouxen-Y loop to the opened pancreatic
duct may suffice, but if the stones ex
tend into the head of the pancreas it
may be necessary to perform sphincte
roplasty in addition.
One may find stones in the common
bile duct in the absence of any ab
normality in the pancreatic duct. Their
removal may be sufficient to prevent
further attacks of pancreatitis, but a
sphincteroplasty may be required as
well. An intravenous cholangiogram
also may show stones in the common
bile duct, but it does not give informa
tion on the pancreatic duct, and it is
a great advantage to possess this in-

formation, if at all possible, before
undertaking operation.
8. Stricture of the Lower End o f the
Common Bile Duct
Chronic pancreatitis may cause a
stricture of the retropancreatic portion
of the common bile duct. The stricture
may be of such a degree as to cause
obstruction of the duct, and this prob
lem should be anticipated before under
taking operation to relieve chronic pan
creatitis.11 Fig. 7 shows a stricture at
the lower end of the common bile duct
in a patient with pancreatitis. The su
praduodenal portion of the duct should
be anastomosed to the intestine in such
cases, either by a choledochoduodenostomy or a choledochojejunostomy
Roux-en-Y.

FIG. 5— Pancreatic duct ectasia with
multiple strictures.

ERCP may show a complete obstruc-

FIG. 3— Normal pancreatic duct and
bile ducts.
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FIG. 4— Papillary stenosis.
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FIG. 6— Stones in pancreatic duct.
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by operation or by external needle
biopsy. If these examinations are not
conclusive ERCP will provide the sur
geon with additional evidence that may
help him decide the management of the
lesion.
Ultrasonography

Grey-scale ultrasonography demon
strates the pancreas in 70% to 80%
of patients and is particularly helpful
in diagnosing pancreatic pseudocysts
and abscesses (Fig. 9).13*15 It also may
be of help in diagnosing carcinoma of
the pancreas, but it cannot distinguish
localized chronic pancreatitis from car
cinoma because both lesions may pro
duce a circumscribed solid-appearing
mass on the ultrasonogram. Chronic
pancreatitis may cause a uniform en
largement of the pancreas, which is
unusual in carcinoma. Ultrasonography
cannot demonstrate atrophy of the
pancreas.
Angiography

FIG. 7—Stricture of pancreatic portion of common bile duct.

9. Pseudocysts
In the opinion of some endoscopists
it is unsafe to perform ERCP on pa
tients with a pancreatic pseudocyst, but
the hazards are not formidable if the
pseudocyst is not overfilled with con
trast medium. The pancreatic duct com
municates with the pseudocyst in 60%
of cases. Sometimes ERCP shows pseu
docysts where none were suspected
(Fig. 8). Ultrasonography is excellent
for demonstrating pseudocysts, but it

It is not always easy to distinguish
carcinoma of the pancreas from chronic
pancreatitis, especially if the history is
atypical. If carcinoma is present ERCP
will often demonstrate it, but the ap
pearance is seldom pathognomonic and
the diagnosis may have to be established

FIG. 8— Pseudocyst of pancreas.

FIG. 9— Ultrasonogram showing pseu
docyst (c) of pancreas: upper portion,
transverse section; lower portion, sagittal
section.
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is not infallible. In particular, it has
shown only one pseudocyst where more
than one has actually been present.12
10. Carcinoma of the Pancreas
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Fig. 10 is the arteriogram from a
patient with two pseudocysts of the
pancreas. Only one of these lesions had
been disclosed by the other forms of
radiologic examination. Angiography
may also show obstruction of the
splenic artery or the portal vein by
pancreatic inflammation or neoplasm,
but this may be of little help in plan
ning management. Angiography cannot
readily distinguish pancreatic inflam
mation from neoplasia except in the
presence of an endocrine neoplasm of
the pancreas.

FIG. 10— Arteriogram outlining pan
creatic pseudocyst.
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The procedure should be used selec
tively on those patients in whom there
is appreciable doubt about the patho
logic process. In such patients it may
provide additional information for
planning the operation.

Endoscopic pancreatocholangiography.
II. The pathological endoscopic pan
creatocholangiogram. Ibid, p 227
5. R obbins AH, M essian RA, W idrich

6.

References
1. Anacker H, W eiss HD, K ramann B,
et al: Experience with endoscopic re
trograde pancreatography. Am J
Roentgenol Radium Ther Nucl Med
122: 375, 1974
2. C otton PB, Beales JSM: Endoscopic
pancreatography in the management
of relapsing acute pancreatitis. Br Med
J 1: 608, 1974
3. K asugai T, K uno N, K obayashi S, et
al: Endoscopic pancreatocholangiography. I. The normal endoscopic
pancreatocholangiogram. Gastroenter
ology 63: 217, 1972
4. K asugai T, K uno N, K izu M, et al:

7.

8.

9.

WC, et al: Endoscopic pancreato
graphy: an analysis of the radiologic
findings in pancreatitis. Radiology
113: 293, 1974
R ohrmann CA, Silvis SE, V ennes
JA: Evaluation of the endoscopic pan
creatogram. Ibid, p 297
Safrany L: Diagnosis of pancreatic
diseases by endoscopic retrograde pan
creatography. Acta Cliir Ital 29: 349,
1973
Sugawa C, R aouf R, B radley V,
et al: Peroral endoscopic cholangio
graphy and pancreatography. The sur
geon’s helper. Arch Surg 109: 231,
1974
Zimmon
DS, F alkenstein DB,
A brams RM, et al: Endoscopic
retrograde cholangiopancreatography
(ERCP) in the diagnosis of pancreatic
inflammatory disease. Radiology 113:
287, 1974

10. G r o d in sk y C, S c h u m a n BM, B lo c k
MA: Absence of pancreatic duct dila
tion in chronic pancreatitis—surgical
significance. Arch Surg 112: 444, 1977
11. W a r sh a w AL, S ch a pir o RH, F e r r u c c i JT j r , et al: Persistent obstructive
cholangitis, and biliary cirrhosis due
to common bile duct stenosis in
chronic pancreatitis. Gastroenterology
70: 562, 1976
12. A n d e r s e n BN, H ancke S, N ie l s e n
SAD, et al: The diagnosis of pancrea
tic cyst by endoscopic retrograde pan
creatography and ultrasonic scanning.
Ann Surg 185: 286, 1977
13. F er r u c c i JT: Radiology of pancreas,
1976—sonography and ductography.
Radiol Clin North Am 14: 543, 1976
14. H a ber K, F r e im a n is AK, A sh e r
WM: Demonstration and dimensional
analysis of the normal pancreas with
gray-scale echography. Am J Roent
genol Radium Ther Nucl Med 126:
624, 1976
15. L e o p o l d GR: Echographic study of
the pancreas. JAMA 232: 287, 1975

4. Surgery in Chronic Pancreatitis*
Frank W. T urner ,

il est logique de choisir un traitem ent
chirurgical destine a soulager
I’obstruction tout en conservant le plus
possible de la glande. Un certain nombre
de cas sont decrits afin d'illustrer les
diverses interventions disponibles
et pour indiquer les caracteristiques
qui determinent le choix de I'operation
la plus appropriee a un patient.
Les operations comprennent la
pancreatectomie partielle, la pancreatojejunostomie de Roux-en-Y et la
pancreatojejunostomie longitudinale;
celles-ci peuvent etre modifiees pour
convenir aux circonstances particulieres
d'un cas donne.

When the pain associated with
chronic pancreatitis is due to ductal
obstruction, it is logical that surgical
management should be designed to
relieve that obstruction while preserving
as much of the functioning gland as
possible. A number of cases are
described to illustrate the various
procedures available and to indicate
the features that govern the selection
of the one most appropriate for a
particular patient. The operations include
partial pancreatectomy, Roux-en-Y
pancreaticojejunostomy and longitudinal
pancreaticojejunostomy; these can be
modified to suit the peculiar
circumstances of a given case.

Despite the many studies of chronic
pancreatitis, there has never been a
controlled clinical trial to compare the
results of one form of surgery with
those of another or, indeed, to compare
the results of surgery with those of
nonoperative treatment. Therefore, the
surgical management of this condition
continues to be based on the opinions
of individual surgeons, often supported
at best by retrospective analyses of
disparate series of patients. Having
done nothing to improve this sad state
of affairs, I can only present yet an

Quand la douleur associee a une
pancreatite chronique est causee par
une obstruction du canal pancreatique,

*From the department of surgery,
University of Alberta, Edmonton, Alta.
Presented at the inaugural meeting of
the Canadian Association of Genera1
Surgeons, Toronto, Ont., May 11 and 12,
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other prejudiced opinion in the hope
of stimulating debate.
By definition, this discussion will
be concerned with the relief of symp
toms resulting from permanent and
progressive alteration in both structure
and function of the pancreas.1 In fact,
we are really discussing the manage
ment of pain, because to restore lost
endocrine and exocrine function is at
present beyond our surgical capability.
The exact cause of pain in chronic
pancreatitis is unclear, but there can
be little doubt that in most patients
with ductal obstruction, relief of that
obstruction brings about relief of pain.
Unfortunately not all patients have
major ductal obstruction, and in these
it is postulated that a more diffuse
obstruction in the smallest duct radicals
is responsible.
Some advantage derives from the al
tered nature of the chronically inflamed
gland, in that it permits surgical assault
in ways that would never be tolerated
by the healthy gland with its propensity
to acute inflammatory change on the
least provocation. It is truly amazing
how much battering the hard, fibrotic
gland of chronic pancreatitis will with
stand.
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University of Alberta Hospital
Experience, 1970 to 1976

A review of local experience served
to indicate the scope of the subject
and the relative uselessness of such re
views. Endoscopic retrograde cholan
giopancreatography (ERCP) was in
troduced midway through the survey
in mid-1973 and produced a notable
improvement in the recognition and
management of chronic pancreatitis,
particularly in patients in whom radiologic calcification of the gland was
absent. Moreover, preoperative delinea
tion of altered ductal morphology al
lowed better selection of patients for
surgery.
The causes of clinically recognized
chronic pancreatitis in 53 patients are
listed in Table I; not included in the
analysis are the many cases of upper
abdominal pain attributed to chronic
pancreatitis but lacking documentation
of pancreatic disease other than by
exclusion. Radiologic evidence of calci
fication was present in 28 (53%).
Of the total group, 28 eventually
underwent surgery for relief of pain.
Table II lists the 34 procedures per
formed on these patients, the diversity
illustrating a nice lack of rigidity among
the operating surgeons. The term “ductoplasty” is used to describe plastic pro

cedures on the pancreatic ducts them
selves (either of Wirsung or Santorini)
as differentiated from a sphinctero
plasty, which only promotes drainage
of the common bile duct. The one
Whipple procedure was done in the
belief that an occult malignant growth
was responsible for the changes of
chronic pancreatitis.

The Logical Surgical Approach

FIG. 1—Case 1. Distal pancreatic duct
with cystic dilatation in tail.

In patients with demonstrable ductal
abnormalities, the procedure selected
must surely be that which will most
easily overcome the problem while pre
serving whatever pancreatic function
remains. Assuming that ductal disten
sion distal to a zone of obstruction is
the major cause of pain in chronic
pancreatitis,2 then relief of that obstruc
tion by ductal decompression is all
that is required. The logic of perform
ing 95% resection of the gland as the
initial procedure in such patients is
hard to understand; not only is it tech
nically more difficult, but it guarantees
that those fortunate enough to survive
the operation will suffer from both
diarrhea and diabetes.
In patients in whom macroscopic
ductal changes are absent and who,
presumably, have diffuse disease, there
may be no recourse other than per
formance of a major resection, but, as
illustrated below (case 8), ductal

FIG. 2— Case 2. Large cyst in cominu
nication with distal pancreatic duct.

FIG. 3— Case 2. Normal pancreatic
duct 1 year after resection of tail.
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T a b le I — C a u s e s of C h r o n ic P a n c r e a titis in
53 P a t ie n ts T r e a te d a t U n iv e r s it y o f A lb e rta
H o s p ita l, 1970 to 1976
Cause

N o . o f p a tie n ts

A lc o h o l
G a lls to n e s
F a m ilia l fa c to r s
H y p e r lip id e m ia
T ra u m a
Unknow n

37
3
2
1
1
9

4

4

T a b le I I — O p e ra tio n s P e r fo r m e d on 28 P a 
t ie n t s w it h S y m p to m a tic C h ro n ic P a n c r e a titis
P ro c e d u re
“ D u c to p la s ty "
D is ta l p a n c re a te c to m y w ith o u t
d r a in a g e
D is ta l p a n c re a te c to m y w ith
d r a in a g e ( D u v a l)
S id e - to -s id e p a n c r e a tic o je ju n o s to m y
L o n g it u d in a l p a n c r e a tic o je ju n o s to m y (P u e s to w )
N e a r - t o t a l p a n c re a te c to m y
P a n c re a tic o d u o d e n e c to m y
(W h ip p le )
D r a in a g e o f re te n tio n c y s t
B io p s y a lo n e
P ro c e d u r e s o n com m on b ile d u c t*
T o ta l

Num ber
3
3
2
3
8
2

A

1
4
1
7
34

i n c l u d e s s p h in c te ro to m y , s p h in c te ro p la s ty
a n d c h o le d o c h o d u o d e n o s to m y .

FIG. 4— Case 3. Narrowed supra-ampullary segment (arrows) with dilatation above.
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FIG. 5— Distal Roux-en-Y pancreaticojejunostomy (Duval).
FIG. 6— Case 4. Narrowed supra-ampullary segment with tortuous widely dilated
duct above.

FIG. 7— Longitudinal pancreaticojejunostomy of Puestow. Incision into duct is
usually carried further into head than
illustrated here.

FIG. 8— Case 5. Multiple strictures with
intervening areas of dilatation (“chain-oflakes”).

VOLUME 21, NO. 1, JAN U ARY 1978

changes permitting a lesser procedure
may eventually develop even in these
patients.
The presence of retention cysts is
readily recognized with ERCP. These
vary in size from relatively small fusi
form dilatations of the duct to large
cysts frequently misinterpreted as post
necrotic pseudocysts because, like pseu
docysts, they may lack a recognizable
lining epithelium. Retention cysts are
always intrapancreatic and communi
cate with a major duct. They represent
cystic dilatation of the duct distal to
a point of obstruction and usually de
velop slowly without any precipitating
episode of pancreatic necrosis. Their
management depends upon their size
and position, as illustrated below.
Finally, the surgeon must be con
vinced that the patient’s symptoms are
indeed attributable to pancreatitis; drug
addiction is not uncommon in this dis
ease and even the most skilful surgery

may fail to quench the demand for
drugs.
Illustrative C ases

Case 1.—A 27-year-old alcoholic man
had a 5-year history of recurrent chronic
pancreatitis. ERCP demonstrated a norma1
proximal duct but a 2 X 1 cm cys' .c
dilatation in the tail (Fig. 1). Quite illogically the procedure selected was sphinc
teroplasty, from which no benefit was
derived. A distal pancreatectomy would
have been a better choice.
Case 2 .—This 32-year-old woman had
documented chronic pancreatitis of un
known etiology. ERCP, 2 years after the
diagnosis had been established, demon
strated a 3 X 4 cm cavity in the tail of
the pancreas associated with a normal
proximal duct (Fig. 2). A distal pancrea
tectomy completely relieved her symptoms
and follow-up ERCP 1 year later (Fig. 3)
confirmed the unchanged status of the
remaining pancreas. It is of interest that

FIG. 9— Case 6. Operative pancreatogram demonstrating large cyst in head of
pancreas associated with narrowing and elongation of proximal duct with distal
dilatation.
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there was an unusual foreign-body giant
cell reaction around eosinophilic foreign
material in the wall of the cyst; the nature
of this material was never determined.
Case 3.—In a 59-year-old alcoholic man
with long-standing disease ERCP demon
strated a narrowed, supra-ampullary seg
ment (length, 6 cm) with dilatation beyond
(Fig. 4). Multiple biopsies ruled out a
malignant condition and a Roux-en-Y pancreaticojejunostomy (Fig. 5) provided com
plete relief of his symptoms.
Case 4.—This 23-year-old alcoholic man
was becoming dependent on narcotics.
ERCP demonstrated a hugely dilated and
tortuous duct with a narrowed supraampullary segment (Fig. 6). A longitudinal
pancreaticojejunostomy (Fig. 7) provided
dramatic relief of pain. At discharge 10
days later he was not using any analgesics.
Case 5.—This 36-year-old male alco
holic was addicted to narcotics. Increasing
severity of pain and a 20-kg weight loss
over 3 months precipitated reinvestigation.
ERCP revealed a characteristic “chainof-lakes” deformity as well as narrowing
of the distal common bile duct (Fig. 8);
the pancreatic duct was packed full of
calculi. A Puestow longitudinal pancreati-

cojejunostomy was performed together
with a choledochoduodenostomy to relieve
the common-duct obstruction. Postoperatively, although readily admitting that his
back pain had gone, his addiction to nar
cotics continued.
Case 6.—A 41-year-old male alcoholic
with increasing pain and a recent weight
loss of 10 kg had a mass in the right
upper abdominal quadrant. ERCP was
unsuccessful. At exploration a large cystic
mass was found in the posterior part of
the head of the pancreas. A widely dilated
duct was easily palpable in the body of
the gland; after its injection with contrast
medium a pancreatogram was obtained
(Fig. 9). A Roux-en-Y loop was used to
drain the cyst and was anastomosed sideto-side to the main pancreatic duct (Fig.
10). The patient was completely relieved
of his symptoms.

tial ERCPs 6 months apart demonstrated
an increasingly narrow stricture of the
duct (Fig. 11) with multiple calculi. A
near-total pancreatectomy was followed by
a difficult postoperative course during
which the coexisting problems of diabetes,
diarrhea, subnutrition, wound infection
and pancreatic fistula were successfully
managed.
Case 8.—This 32-year-old man, prob
ably alcoholic, presented with a 3-year
history of chronic pancreatitis. Initial
ERCP demonstrated a normal duct (Fig.
12). Near-total pancreatectomy was of
fered at that time, but was refused. ERCP
repeated 1 year later revealed a stricture
of the main duct with cystic dilatation
in the tail (Fig. 13). A Puestow procedure
provided a good early result.
L ongitudinal P ancreaticojejunostom y

Case 7.—In a 46-year-old male alco
holic with type IV hyperlipidemia sequen

This procedure was introduced by

FIG. 12— Case 8. Initial ERCP demonstrating normal duct.

FIG. 11— Case 7. Proximal stricture
(arrow) with wide dilatation above.
66

FIG. 13— Case 8. Repeat ERCP, 1 year later. Stricture and dilatation are now
evident.
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in all but the thinnest patients, it is
necessary to mobilize the pancreas to
be able to work comfortably upon the
duct. Inserting the entire body and tail
into the Roux-en-Y loop is also attrac
tive, being much less likely to be fol
lowed by fistula formation or loop
separation. The latter has been de
scribed as a late complication of the
Thai operation (Trapnell JE: Personal
communication, 1976).
Results and Conclusions

FIG. 14—Longitudinal pancreaticojejunostomy as modified by Thai.

Puestow and Gillesby in 1958s as a
means of dividing all strictures and re
moving calculi from the pancreatic
duct. Because it can occasionally be
difficult, modifications to avoid mobil
izing the spleen and tail of the pancreas
such as that suggested by Thai (Fig.
14) have been widely adopted. How
ever, it has been my experience that,

There is general agreement that ap
propriate drainage procedures will pro
vide good long-term relief of pain in
75% of patients with ductal abnormali
ties,4 an experience that is confirmed
in our own series. In such patients
immediate near-total pancreatectomy,
which has a higher operative mortality
rate and postoperative morbidity,5 is
not justified. In patients with severe
symptoms and normal major ducts,
there may be no alternative to resection.
Occasionally a simple plastic proce
dure carried out on the termination of
the pancreatic duct (“ductoplasty”) will
suffice if that is the only level of ob
struction; the classic sphincteroplasty is
of use only for stenosis of the sphincter
of Oddi, which rarely is the obstructing
lesion responsible for alcohol-related

chronic pancreatitis. It is generally ac
cepted that attempts to relieve pain by
splanchnicectomy or destruction of the
celiac ganglia are of little or no value.6
Finally, the best results are obtained
in patients who will abstain from al
cohol. Resumption of drinking usually
reactivates the disease, perhaps modi
fied to consist of recurrent bouts of
acute pancreatitis rather than the pre
vious chronic form.
The help of Dr. Lambros Costopoulos
in reviewing the roentgenograms and of
Mr. Ralph McNabb in preparing the il
lustrations is gratefully acknowledged.
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5. Panel Discussion on Pancreatitis*
Chairman: A.G. T hompson , md, frcs [c], FACsf
Panelists: R.G. K eith , J.E. M ullens , P. Poncelet and, F.W. T urner

that the questioning of the panel mem
bers be on a practical basis. We have
listened to a number of presentations
that have been both interesting and
informative, but most of us would like
to hear more about the actual details
of treatment of patients with acute or
chronic pancreatitis.
Most patients with acute pancreatitis
suffer from the mild form of the dis
ease and will recover on routine “suck
and drip therapy” (i.e., nasogastric
suction and intravenous fluids), to
gether with suitable analgesia. How

Dr. Thompson: I would like to suggest

*Conducted at the inaugural meeting of
the Canadian Association of General
Surgeons, Toronto, Ont., May 11 and 12,
1977
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ever, approximately 20% of patients
with severe pancreatitis require inten
sive care and management, which call
for the participation of various groups
of specialists. It is in relation to this
group of seriously ill patients that I
would like to ask the panel for direc
tion. Dr. Poncelet, in his presentation,
briefly mentioned intravenous hyper
alimentation (IVH) as an important
part of the treatment of the patient
with acute pancreatitis. Dr. Keith, do
you think this is true? Do you use
IVH?
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Dr. Keith: I agree and I disagree. I
don’t think that in the first 48 to 72
hours of the acute fulminant process
IVH will do anything to reverse or
reduce the severity of the disease.
Later, when one is faced with com
plications of the acute process, I cer
tainly think it is of great value. I agree
that both IVH and oral alimentation
with elemental diets have little stimulat
ing effect on the pancreas, which is
in their favour for the management
of this disease.
Dr. Thompson: Do any of you have
strong beliefs on the use or the nonuse
of antibiotics in the severe form of
acute pancreatitis?
Dr. Poncelet: I use antibiotics in gall
stone pancreatitis because most samples
of bile from these cases show enteric
bacteria. But antibiotics are only a
part of the treatment. If there is pus
in the gallbladder it is obvious that the
organ should be removed as soon as
possible; antibiotics alone are not going
to cure this patient.
Dr. Mullens: I think that antibiotics
should be reserved for the complica
tions of pancreatitis. We don’t use them
routinely.
Dr. Keith: I would like to remark that
recently a report of a controlled clin
ical trial was published demonstrating
that antibiotics (1 think that ampicillin
and cephalothin were used) had no
effect whatever on the outcome of the
acute form, so I do not use them.
Dr. Thompson: We would probably all
agree, however, that in the complicated
case, when the patient has infection or
is suspected to have infection, anti
biotics are indicated. Dr. Mullens, how
do you diagnose a pancreatic abscess
or an acute pseudocyst in these pa
tients?
Dr. Mullens: I think that first of all
radiology is a great help. The two
initial procedures in the investigation
of a pancreatic mass are ultrasono
graphy and roentgenographic barium
studies, followed when necessary by
ERCP (endoscopic retrograde cholan
giopancreatography).
Dr. Thompson: The patient in the in
tensive care unit suffering from severe
pancreatitis is extremely ill and prob
ably can be subjected to no more than
an ultrasonic B scan. This examination
during the course of acute pancreatitis
can be very helpful indeed.
Dr. Mullens: It is also very easy to do.
Dr. Thompson: Agreed. It is noninvasive and can help you diagnose the
early abscess or acute pseudocyst. If
repeated on a daily basis it can indicate
whether the abscess or cyst is changing
in size.
Is there any place for steroids in the
treatment of acute pancreatitis? Dr.
Keith?
68

Dr. Keith: No.
Dr. Thompson: Anybody else? Every
one agrees that there is no place for
steroids! How about the prevention and
treatment of the respiratory complica
tions that probably occur in most pa
tients with severe pancreatitis, at least
in most of the ones I see? Very many of
them go into respiratory failure. Dr.
Turner, have you any views on this
subject?
Dr. Turner: The only comment I would
make is that operating on patients with
acute pancreatitis tends to increase the
likelihood of respiratory complications.
I would like to know what Dr. Keith
thinks.
Dr. Thompson: Dr. Keith, are many of
the respiratory complications iatro
genic?
Dr. Keith: That’s an important ques
tion. Are we overloading these patients?
Are we projecting them into pulmo
nary edema or is the pancreatitis the
sole cause? Some reports suggest the
former, since patients improve with
massive doses of diuretics and albumin
given in an attempt to draw fluid back
into the intravascular compartment.
The data available would indicate that
there is a primary end-organ effect in
this disease and that we must replace
fluid losses. We have to use colloid for
the purpose and must be careful not
to overload the patient. But there is
also an acute pulmonary problem for
which the specific therapy is mechan
ically assisted ventilation. By this I
mean high-volume ventilation with posi
tive end-expiratory pressure. Frequently
respiratory failure is not recognized
early enough and when it is, the revers
ible stage of the disease has passed. The
onus is on us to look for it earlier and
to treat it aggressively. We will find, as
Imrie in Scotland is finding, that the
survival rate will be increased even in
patients otherwise left untreated.
Dr. Mullens: I also firmly believe that
the management of the pulmonary
problem, as Dr. Keith has just said,
should begin early in the course of
the disease. I think it is very important
to recognize the case of high-risk acute
pancreatitis. This patient should also
be treated with peritoneal dialysis; it
is well established now that, when a
patient has a low serum calcium value,
a high leukocyte count, low Po2, high
BUN concentration, reduced urinary
output and is delirious, the institution
of peritoneal dialysis can work miracles.
Dr. Thompson: What fluid do you use
for lavage?
Dr. Mullens: We use Ringer’s lactate
solution, the same that the nephrol
ogists use for peritoneal lavage except
that we add a little potassium chloride
to make it more efficient.
Dr. Thompson: One more word on
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respiratory failure. Do any of the panel
ists depend on pulmonary wedge pres
sures in monitoring fluid therapy? Dr.
Poncelet, do you feel these are superior
to central venous pressures?
Dr. Poncelet: Yes. In most patients we
use a Swan-Ganz catheter in the post
operative period for 3 to 4 days.
Dr. Thompson: Is this a difficult pro
cedure to carry out?
Dr. Poncelet: No, not for us because
the anesthetist introduces them.
Dr. Thompson: I mean, can a measure
ment of pulmonary wedge pressures by
means of a Swan-Ganz catheter be car
ried out only in a high-level university
hospital or can this procedure be used
by those of us who are working in
smaller hospitals?
Dr. Poncelet: It should be available in
any intensive care unit.
Dr. Thompson: We found pulmonary
wedge pressures very useful to indicate
whether the patient is being overloaded.
The procedure is simple and it gives
more reliable information than the cen
tral venous pressure.
Would the panelists comment on the
treatment of pancreatitis after biliary
tract surgery or gastric surgery? Do any
of you ever meet this postoperative
complication?
Dr. Mullens: Postoperative pancreatitis
is a serious condition associated with
a high mortality rate. One must be
aware of the possibility of its devel
opment and institute early treatment.
Not only can it follow biliary tract or
pancreatic surgery but also operations
on the bowel. These patients should
have peritoneal lavage.
Dr. Thompson: Dr. Keith, should Trasylol (aprotinin) be used prophylactically when there is a possibility of
damage to the pancreas during, say,
duodenal dissection or common-bileduct exploration?
Dr. Keith: We haven’t used Trasylol
but we have used glucagon. If glucagon
has any place at all it is its prophylactic
use when there has been dissection
around the pancreas or biliary tract.
Unfortunately, we have done no con
trolled study so I cannot be specific
about its value.
Dr. Thompson: Is glucagon available
to the average surgeon?
Dr. Mullens: I am told its production
is now limited. There has been such
a demand for glucagon that I have had
to stop using it in ERCP; the radiol
ogists have a limited supply and they
require it for hypotonic duodenography.
Dr. Thompson: If it were readily avail
able, is there any place for glucagon
in the treatment of acute pancreatitis?
Dr. Keith: Again, I can only refer back
to what’s been reported. I think that
once the disease is established this agent
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has little effect and that it probably Dr. Turner: I am not sure and that’s
has more value when given prophylac- why I’m asking about it. There are
reports that if the stools of such pa
tically.
Dr. Thompson: Could we consider the tients are filtered, a stone will be found
management of the patient with acute in a very high percentage of them.
gallstone pancreatitis? By some means Presumably it is the actual passage of
or other we have found out that a the stone through the sphincter that
patient who is suffering from acute causes the trouble rather than the mere
pancreatitis has gallstones. When should presence of a stone in the common bile
one operate to remove the gallstones? duct.
Dr. Poncelet, I believe it is your Dr. Poncelet: But sometimes there is
opinion that this should be done as just one big stone in the gallbladder
soon as possible after the onset of the and the patient has pancreatitis.
episode and as soon as the diagnosis Dr. Turner: That just means that you
has been made. If the patient has gall have missed the one that has gone
stone pancreatitis, should he be oper through.
ated upon?
Dr. Turner: I don’t really have any Dr. Thompson: This is certainly a moot
strong views, but it would seem reason point. Perhaps we can move on to
able if the patient is improving not to another area and I would like to pose
do anything about the gallstones at that the question, What should be done if
time. I would allow the patient to re one happens to operate on a patient
cover and bring him back in approxi with acute pancreatitis? Not all of us
mately 6 weeks for an elective chole are as enthusiastic as Dr. Poncelet, but
would somebody like to outline their
cystectomy.
Dr. Keith: I think, Dr. Turner, you indications for operation in the course
may find that in the 6 weeks the pa of acute pancreatitis. Dr. Keith, you
tient may have more attacks of pan tend to treat these patients more con
creatitis? Have you not had this ex servatively than Dr. Poncelet. Do you
perience? I agree with Dr. Poncelet believe there are indications for surgery
that early operation is indicated, but during the course of acute pancreatitis?
I would like him to tell us how he Dr. Keith: I think it will be simpler to
knows which patient has gallstones un discuss alcoholic pancreatitis and then
less there has been a previous workup we can set aside the question of what
is to be done about gallstones. If a
indicating their presence?
Dr. Poncelet: In most cases of gall patient is not responding to conserva
stone pancreatitis my knowledge of the tive measures, are we going to con
primary cause is based on a previous sider surgery? I believe the answer
workup. Sometimes my diagnosis is on is yes. There are about 5% of patients
a clinical basis, for example, the patient whose condition, in spite of the most
does not drink alcohol or is a 40-year- aggressive nonoperative management,
old fat lady; in such instances one can excluding peritoneal lavage, will con
be almost certain that the patient has tinue to deteriorate, and this is the
patient who needs an operation. I have
gallstones.
Dr. Mullens: I would like to make a no personal experience with acute pan
plea for ultrasonography — it will show creatic debridement or sequestrectomy
for a totally necrotic gland other than
gallstones in many cases.
Dr. Thompson: Sometimes the ultra- as an observer in France. I was im
sonographer is a little overenthusiastic pressed at that time by the ease of
removal of the dead black pancreas, but
but usually he is pretty reliable.
I
was also impressed by the comments
In the case of a patient with acute
pancreatitis as a result of gallstones, of the men who worked under Holprobably most of us would prefer to lender that these patients had 100%
operate during the same admission. Per mortality; about 5 days later they either
sonally I like to let the patient recover, bled to death or were overcome with
but before he or she goes home 3 to 4 sepsis.
weeks later to perform an elective chole Dr. Turner: I have tried this procedure
cystectomy with operative cholangio in the acute stage and had great dif
graphy to make sure that there are no ficulty in recognizing whether the pan
creas was actually necrotic or not.
stones in the common duct.
Dr. Turner: I would ask the other Dr. Thompson: What might one do
panelists whether they believe that at the time of operation short of pan
stones within the gallbladder or a stone createctomy or sequestrectomy, if we
passing into the common duct and accept the fact that most of us are a
through the sphincter causes the pan little hesitant about resecting the acute
creatitis? It seems to me that if the ly inflamed pancreas? What else can be
stone that has caused the trouble has done at the time of operation? Dr.
already passed, then there is not much Poncelet, you mentioned cholecystostomy or drainage of the biliary tract.
urgency to take out the gallbladder.
Dr. Poncelet: How can you be sure that Do you feel that this is important?
Dr. Poncelet: If there are gallstones
the stone has already passed?
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present, then I strongly believe that the
biliary tract should be drained and,
if possible, through the common bile
duct. I think this is a better drainage
procedure than a cholecystostomy. With
respect to pancreatectomy, I disagree
with Hollender, who proposes early
operation within 12 hours, and I agree
with Edelman that after 8 to 10 days
is the optimal time to consider opera
tion in these patients. Necrosis is then
well defined and it is much easier to
determine what part of the pancreas
has to be resected and what can be
left in place.
Dr. Thompson: Do you use drains in
these patients?
Dr. Poncelet: Yes, the pancreatic area
is widely drained and peritoneal lavage
is carried out postoperatively.
Dr. Thompson: I think that many of
these patients come to operation be
cause of a misdiagnosis. We think
we’re probably operating on a patient
with acute cholecystitis and at opera
tion, to our horror, we find the patient
has active acute pancreatitis. What
should one do then? Usually it is an
acute, edematous type of pancreatitis
and I believe that in such instances the
less one does the better. These patients
are going to recover as long as we
don’t interfere with them too much,
and I agree with Dr. Poncelet that if
there is any evidence of biliary tract
disease one should drain the biliary
tract but not do much more than that.
Let us move on to a consideration
of chronic pancreatic disease. Dr.
Poncelet, would you like to comment
on the easiest and best method of drain
ing the average pseudocyst?
Dr. Poncelet: If possible, I drain them
through the stomach after waiting 5 to
6 weeks to be sure that there are good
adhesions present. If one is forced to
operate early during the acute phase
of the cyst development, then external
drainage is advisable. A pancreatic fis
tula may follow but this can be dealt
with at a later date. Sometimes a small
cyst lying adjacent to the duodenum
can be drained into this structure.
Dr. Turner: I would agree completely
with Dr. Poncelet, although I am not
sure what the average pseudocyst is.
Dr. Thompson: The average pseudocyst
is one that is well formed, easily identi
fiable, has a thick fibrous wall and is
not friable; in other words it can easily
be sutured to stomach or bowel. Do
complications ever follow drainage into
the stomach?
Dr. Mullens: Not all pseudocysts re
quire treatment; some of them subside
spontaneously and we should not be
too hasty in operating on these patients.
Dr. Thompson: This is where ultrasonic
B scanning has helped in allowing us
to follow the course of the so-called
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acute pseudocyst, many of which do
subside, as we now realize. In answer
to the enquiry about complications
from draining a pseudocyst into the
stomach, I have encountered a few
myself.
Dr. Mullens: What were they?
Dr. Thompson: Hemorrhage. If there
is a highly alkaline fluid in the pseudo
cyst and you drain it into the stomach,
multiple bleeding ulcers can develop in
the gastric mucosa and these can create
quite a situation. I agree that this is a
rare occurrence and that drainage into
the stomach is the easiest and safest
way of draining most cysts when they
lie in the lesser sac. I, myself, prefer
to drain them into the jejunum but
most surgeons consider cyst-gastros
tomy as the treatment of choice. How
about the small pseudocyst in the tail
of the pancreas?
Dr. Mullens: I was going to remark that
there is sometimes more than one
pseudocyst, and that these can be easi
ly overlooked, especially one that is in
the tail region of the pancreas.
Dr. Thompson: What would you do
with such a one, Dr. Mullens?
Dr. Mullens: Excise the tail of the pan
creas along with the spleen. With re
gard to the stump of the pancreas, I
would remind you of the little trick
about the pancreatic duct that Sir Rod
ney Smith taught. Sir Rodney advised
that if you can see the duct in the
stump of the pancreas, you should put
a tube into the duct, attach the stump
to the back of the stomach and bring
the tube out through both walls of the
stomach and the abdominal wall. This
works very well.
Dr. Thompson: Dr. Turner, you have
used the Puestow procedure in a num
ber of patients with chronic pancrea
titis. Were your results always good if
ductal obstruction was present?
Dr. Turner: So far, yes, and this is in
agreement with the reported results

of other surgeons. Several long-term
studies have been recorded now. Jordan
has 30 patients he has observed over
15 years and White has patients who
are doing well in the long term. Both
of these investigators report good long
term results, meaning freedom from
pain, in 70% to 75% of patients.
Dr. Thompson: In performing a Pues
tow or similar procedure, is a mucosato-mucosa apposition necessary?
Dr. Turner: I do not think so. Jordan
doesn’t carry out such mucosa-tomucosa apposition because he believes
this may obstruct small radicles drain
ing into the main duct. I don’t know
how he avoids this because when you
split the pancreas open it bleeds so
much from the edges that, in my ex
perience, the edges must be oversewn
anyway. I have never carried out a
formal mucosa-to-mucosa apposition in
performing various pancreatic ductal
drainage procedures.
Dr. Thompson: What suture material
do you use when you are working on
the pancreas?
Dr. Turner: I use silk routinely.
Dr. Thompson: Does anyone use ab
sorbable sutures? No. How about the
technique for closing the proximal
stump after distal pancreatectomy?
Dr. Turner: I don’t think there is any
thing special about this. I try to identify
the duct and close it separately and
then I simply use mattress sutures of
silk for the end. Sometimes one can
wedge the stump a little to get a better
closure.
Dr. Mullens: You don’t need to do this
if you use the Rodney Smith procedure
I mentioned previously.
Dr. Keith: My only other comment is
that if the stump is to be oversewn
without draining it you must be sure
that the sphincteric duodenal end is
patent. This can easily be determined
by sliding a small no. 5 esophageal
feeding catheter along the pancreatic

Critique of Item 600 (SESAP II)
Pseudomonas aeruginosa grows very well under conditions of moisture
and alkalinity. Urethral catheter drainage, when improperly managed,
is an ideal situation for such infections since both conditions exist. The
water trap used in mechanical ventilators to increase the water content
of inspired gases provides the best environment for the growth of
Pseudomonas. Although infection of the central venous catheters used
either for recording of pressure or for hyperalimentation is an important
complication, Candida albicans is the most frequent microorganism to
appear in this situation; Pseudomonas aeruginosa is cultured infrequently.
References
600 / 1 . Polk HC Jr, Borden S, Aldrete JA: Prevention of pseudomonas
respiratory infection in a surgical intensive care unit. Ann Surg 177:607615, 1973
600 / 2 . Ashcraft KW, Leape LL: Candida sepsis complicating parenteral
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duct; it should fall in the duodenum
quite easily.
Dr. Thompson: Dr. Turner, you have
mentioned a patient with chronic pan
creatitis and a very normal-looking
small duct; you stated there is no place
for ductal drainage in this type of case.
Then what would you do?
Dr. Turner: I am not altogether certain
whether a patient with chronic pan
creatitis but having a normal duct
should actually have a pancreatectomy
as the primary procedure. Perhaps it
would be advisable to wait a few years
and then operate on the duct after it
has become dilated for then it will be
more adaptable to a drainage proce
dure.
Dr. Thompson: Dr. Mullens, should we
all be doing ERCP? Are there any com
plications from putting a little tube into
the pancreatic and biliary duct systems?
Dr. Mullens: It takes quite a time to
develop the necessary skill and I think
the performance of this procedure
should be reserved for a few individuals
so that they can get the practice neces
sary to obtain dependable results con
sistently. Our results are successful in
approximately 90% of instances at the
present time, but only after a great
deal of practice on my part.
The complication I would like to
mention first is the transmission of in
fection when a patient with infectious
hepatitis is being investigated. Obvious
ly the instrument should be carefully
sterilized before it is used in another
patient. The practical rule is that if no
cause for the patient’s jaundice is found
at the time of ERCP, the scope should
be sterilized in a gas autoclave. There
is also the complication of sepsis, either
cholangitis or pancreatic abscess, but
as long as one is aware of the possibil
ity, treatment with antibiotics can be
instituted if these seem indicated. Third
ly, pancreatitis can develop if one in
jects the pancreatic duct at too high a
pressure. Many patients do have a
transient elevation of serum amylase.
I have had two such cases but in both
instances the disease process was short
lived and of no great consequence.
Dr. Thompson: Do you find the socalled common channel in all patients
whom you intubate?
Dr. Mullens: Oh no. In only about
60%; in the other 40% the common
bile duct and main pancreatic duct
have to be cannulated separately. This
means they have separate openings, but
usually both are located in the same
area.
Dr. Thompson: I would like to thank
the members of the panel for their par
ticipation and also the members of the
audience who submitted many of the
questions. It has been a most interest
ing discussion.
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Monitoring of the Critically III Surgical Patient*

Y *

D.B. A llardyce ,

The skill and experience of the medical
and nursing staff are the factors that
have the greatest impact on the quality
of monitoring and treatment of the
critically ill surgical patient. Basic
determinations at the bedside together
with periodic evaluation of the whole
patient by the medical staff may, in
selected cases, be supplemented
usefully by more invasive monitoring
techniques. The specific complications
and technical pitfalls of these techniques
should be known, and caution should
always be exercised that the values
provided are not misinterpreted. A
critical care area serving a major
tertiary referral hospital should be able
to measure pulmonary capillary wedge
pressure and cardiac output. Mixed
venous oxygen content and arterial
lactate concentration, as indices of
oxygen delivery, are also useful
measures.
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L'habilite et ('experience du personnel
medical et infirmier sont les facteurs
qui influencent le plus la qualite de la
surveillance et du traitement du patient
de chirurgie dont I'etat est critique.
Les principales determinations relevees
au lit du malade associees a une
evaluation periodique complete du
patient par le personnel medical peut,
dans des cas choisis, etre completees
par des techniques de surveillance
plus envahissantes. Les complications
specifiques de ces techniques et leurs
ecueils techniques doivent etre connus,
et (’interpretation des valeurs obtenues
doit toujours etre faite avec
circonspection. Un poste de soins pour
malades critiques attache a un grand
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hopital de consultation devrait pouvoir
mesurer la pression capillaire
pulmonaire et le debit cardiaque. La
concentration veineuse mixte en oxygene
et la concentration arterielle en lactate
utilisees comme indices du transport
d'oxygene sont aussi utiles.

Monitoring in its broadest sense refers
to the surveillance, by whatever means,
of either a static situation or an on
going series of events, so as to detect
change. When a patient is “monitored”
this term is frequently interpreted as
referring to various forms of electrical
surveillance, but in this discussion the
broader definition of the concept of
monitoring will be used.
Many surgical patients require “in
tensive” care, but are not critically ill.
Individuals who have suffered major
trauma or who have undergone a major
surgical procedure require intensive
monitoring, but this need not normally
be carried out in a critical care unit.
These patients can be cared for on a
surgical ward where there is provision
for continuous surveillance by experi
enced nursing personnel. This need
may usually be satisfied by a six- to
eight-bed unit that is part of the surgi
cal ward. As long as the individual
sustains vital organ function, without
need for major or continuous interven
tion, while he remains a “major” sur
gical case, he is not critically ill and
does not require admission to a critical
care unit.
Critical Care Units

Whether this is a medical, surgical,
or combined unit, such an area should
always be constructed in a manner that
provides easy continuous observation
by the nurses and physicians available.
The collection and recording of basic
physiologic variables (such as tempera
ture, pulse and blood pressure) by the
nursing personnel, although important,
serve the additional and perhaps more
important function of bringing the
nurse or physician to the patient’s bed

side at regular and frequent intervals.
A current and somewhat alarming trend
is to provide a unit that is designed to
remove the nurse from the bedside and
to carry out multiple-patient, remote
monitoring by television or digital dis
play.1 Only the human mind has the
capacity to recognize patterns in illness;
there are many developments in the
course of critical illness that are infre
quent or unpredictable, and no trans
ducer or electronic device has been yet
devised that will warn of such events.
The colour of the patient’s skin, an
increase in his respiratory effort, a
change in his pain pattern, impairment
of cerebration, development of abdom
inal distension, or discharge from a
wound can only be observed, and their
significance assessed, by an experienced
nurse or physician.
Experienced nurses are a vital link
in the monitoring of the critically ill
patient. A critical care unit must have
such a nursing staff, and must provide
for their continuous instruction and
updating of their knowledge and skills.
Nursing staff should be alert to, and
recognize the significance of, trends
in vital functions. They must recognize
changes in respiratory parameters in
ventilated patients and be able to iden
tify important changes in cardiac
rhythm. They must understand the sup
portive or monitoring equipment and
be capable of carrying out cardiopul
monary resuscitation.
In order that the critical care unit
may function well, there should be a
full-time director who has responsibility
for the performance and training of his
nursing and medical staff, who also
administers the unit and is responsible
for the maintenance of instrumentation
and other supportive equipment.
If the medical staff is composed par
tially of residents, they should be of
sufficient seniority (3rd or 4th year) to
assure good management during the
times when they are the only respon
sible physicians present. Because res
idents “rotate”, staggering of rotations
is desirable, and the director of the
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unit must be sure that new staff are
fully oriented to procedures and equip
ment.
Although the construction of the unit
and the skill and experience of the
staff may seem rather basic considera
tions, they are the factors in critical
care that will have the greatest impact
upon the quality of monitoring and
treatment.
For the majority of patients, even in
a critical care unit, sufficient monitor
ing can be provided by an experienced
nurse, who determines at frequent in
tervals and records on an appropriate
chart the blood pressure (taken with a
cuff sphygmomanometer), pulse rate
and urine volumes, together with a
medical staff to carry out periodic
evaluation of the patient, and supple
mented by the necessary biochemical,
hematologic and radiologic examina
tions.
Failure of adequate oxygen delivery
to the body cell mass must be detected
and corrected as early as possible in
order to prevent secondary deteriora
tion of hepatic, renal and cerebral
function; therefore, the adequacy of
cardiac and respiratory function is the
major priority in monitoring. Oxygen
delivery may also be impaired at the
microcirculatory or cellular level, but
these problems are less common and
their impact on oxygen delivery prob
ably less significant than a serious
deterioration of blood flow or arterial
oxygen tension.
Monitoring Oxygen Transport

Pulse Rate and Electrical Activity
of the Heart
In a patient who has had a sufficient
ly severe dislocation of his vital func
tions to justify admission to a critical
care unit, such a simple and useful
device as a three-lead cardiac monitor
should obviously be employed. In the
management of myocardial infarction
this form of inexpensive, noninvasive
monitoring is extremely valuable, in
that ventricular arrythmias are quickly
detected and more serious problems
thus averted. It should be recognized,
however, that surgical patients, in
whom myocardial disease is not the
primary disorder, may have suffered
cellular hypoxia for some time before
cardiac arrythmias appear.
Radial Arterial Cannula
Insertion of a radial arterial cannula
with continuous monitoring of blood
pressure should be available in a critical
care area but should seldom be re
quired. This procedure is of low prior
ity in initial management but is essen
tial when drugs and anesthetic tech
niques intended to lower peripheral
76

vascular resistance are used. It should
be kept in mind that gangrene of the
hand after such cannulation continues
to be reported sporadically. Cannula
tion of the radial or ulnar artery for
the purpose of collecting arterial blood
for blood-gas determinations is unnec
essary, as multiple needle punctures
are well tolerated.
Urine Volume
Insertion of a Foley catheter and
recording of urine volume are a basic
monitoring requirement not to be
omitted in any critically ill patient. A
falling hourly urine volume, showing a
clear trend over a period of a few
hours, warns of unfavourable changes
in blood flow, usually on the basis of
a contraction of blood volume, or a
redistribution of flow in response to
increasing metabolic demands (e.g.,
sepsis).
Central Venous Pressure
An adequate evaluation of the cen
tral venous pressure (CVP) can some
times be obtained by examination of
the external jugular veins. In the crit
ically ill patient it is seldom possible
to base important therapeutic decisions
on such an estimate of central venous
pressures. For dependable CVP de
terminations a catheter must be placed
with its tip located in the superior
vena cava. Respiratory fluctuation of
the column must be evident, and the
position of the catheter must be veri
fied by roentgenography. The meas
urement of CVP with a simple water
manometer brings the technique within
the scope of any small hospital. A CVP
catheter also provides central venous
access for the administration of drugs
and fluids.
Central venous pressure does not
measure blood volume but is an indi
cator of the competence of the right
ventricle in expelling the blood being
returned to it. Venous tone and, parti
cularly, intrathoracic pressures also af
fect CVP levels. The CPV may be use
ful in the diagnosis of a low-flow state,
or, more importantly, a series of meas
urements exhibiting a trend will act as
a guide of blood volume expansion in
the management of a low-flow state.
In most patients the CVP, as a meas
ure of right heart filling pressures, may
be titrated against hourly urine vol
umes, and blood volume expansion be
continued on the assumption that filling
pressures in the right heart reflect those
in the left heart.
Expansion of blood volume is the
cornerstone of therapy in low-flow
states, and can be most effectively and
quickly accomplished by the infusion
of a colloid; CVP will then be a re
liable indicator of cardiac filling pres
sures on both sides of the heart, and
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ineffective and poorly sustained expan
sion of blood volume with accumula
tion of salt and water in the interstitium
will be avoided.2
Therapeutic decisions based on a low
CVP in an oliguric or hypotensive pa
tient are usually correct, and the CVP
is useful in diagnosis of hypovolemia
and in guiding colloid infusion. In
creased intrathoracic pressures, loss of
right ventricular compliance, or outflow
tract obstruction and increased pulmo
nary vascular resistance can cause
elevation of the initial CVP and may
lead to erroneous conclusions and mis
directed therapy.
Pulmonary Capillary Wedge
Pressures
Pulmonary hypertension, right ven
tricular hypertrophy, or significant dis
crepancies in function between the left
and right ventricles are uncommon co
existent problems in patients whose pri
mary disease or injury is in another
system. If they are present, however,
it is not possible on the basis of CVP
to make reliable estimates of, or to
predict changes in, left atrial pressures.
These deficiencies have led to the
development of flotation catheters and
the measurement of pulmonary artery
and pulmonary capillary wedge pres
sures in selected patients. The indica
tions for insertion of Swan-Ganz cath
eters appear to be broadening as ex
perience and confidence with the tech
nique and instrumentation are gained.
In our institution, at present, if the
measured CVP is low and the clinical
picture is compatible with hypovolemia,
blood volume expansion can be carried
out with the guidance of a CVP cath
eter, and pulmonary capillary wedge
pressures are not required.
In the event that the CVP is elevated
or rises quickly with a volume chal
lenge, without satisfactory evidence of
improved cardiac output, subsequent
therapy will have to be guided by
knowledge of the left atrial pressures
as indicated by pulmonary capillary
wedge pressure.3 In these instances
knowledge of the full clinical picture
will usually suggest the factors that are
making CVP an unreliable guide to
volume expansion. In addition, some
patients will be encountered where
CVP is low, yet there are clinical or
radiologic indications of cardiac failure.
It is not possible to proceed with ex
pansion of blood volume in these in
dividuals without knowledge of left
atrial pressures. It must be recalled,
however, that monitoring of pulmonary
capillary wedge pressure does not as
sure that pulmonary edema will not
develop or progress, because there are
two other critical variables, plasma
oncotic pressure and pulmonary capil
lary permeability. There is no means
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of direct evaluation of pulmonary per
meability.
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Cardiac Output
The development of the triple-lumen
balloon flotation catheter, incorporating
a thermistor probe 4 cm from the cath
eter tip, has greatly facilitated meas
urement of cardiac output by the
thermodilution technique. Electronic
computation devices are required to
allow the on-line determination of car
diac output. Thermodilution now ap
pears to be the method of choice for
determining cardiac output. The in
dicator (5% glucose) is inexpensive, no
withdrawal of blood samples is re
quired, and measurements can be ob
tained at short intervals.
A unit that selectively employs pul
monary capillary wedge pressure for
diagnosis and monitoring should also
be capable of determining cardiac out
put. It is a major advantage in some
cases to be able to construct a Starling
curve for a patient on the basis of
direct measurement of left atrial pres
sures and cardiac output by thermo
dilution.
The determination of cardiac output
and derived values of ventricular func
tion have found application in the diag
nosis and management of patients with
severe sepsis and septic shock, where
physical examination may be mislead
ing in so far as establishing a hemo
dynamic diagnosis is concerned. In
dividuals in respiratory failure and re
quiring positive end-expiratory ventila
tion may require cardiac output deter
minations to assure that increases in
positive end-expiratory pressure (PEEP)
are not actually reducing oxygen de
livery. Serial determinations of cardiac
output may guide the use of vaso
active or cardiotonic drugs when these
are indicated.4
Mixed Venous Oxygen Content

W

A flow-directed catheter in the pul
monary artery allows sampling of true
mixed venous blood and the determina
tion of mixed venous oxygen content.
The gradient of arteriovenous oxygen
content can be calculated. This value
will normally approximate 4.1 vol%.
Narrow differences will correlate rea
sonably with high cardiac output, and
wider differences with low-flow states.
In a unit where flow-directed catheters
are used but the instrumentation for
cardiac output is not available, this
value may indicate those individuals
with high cardiac output and poor oxy
gen extraction, a common development
in sepsis, which may not be appreciated
on the basis of bedside evaluation.
Arterial Lactate
Arterial lactate concentrations are
still valuable as prognostic indicators,
VOLUME 21, NO. 1, JANUARY 1978

and also serve as an additional detector
of inadequate oxygen delivery or util
ization. Microcirculatory or cellular
disturbances associated with severe
sepsis may be indicated by lactic acid
osis, where cardiac output is normal or
elevated and arterial oxygen tensions
are in a satisfactory range. Bicarbonate
concentrations are derived from direct
measurements of pH and carbon di
oxide pressure (Pco2), and may be de
pressed by the accumulation of fixed
acids other than lactate. Arterial lactate
values therefore are a more direct
measure of oxygen utilization at the
cellular level than bicarbonate.
Severe lactic acidosis is not a con
sistent finding in septic or hypovolemic
shock, and bicarbonate should not be
administered without the guidance of
blood-gas determinations. Therapy
should be directed towards correction
of the primary disorder of oxygen de
livery. One should be aware that transi
ent increases in lactate concentra
tion occur during resuscitation as a
result of the “flush” phenomenon in
hypoxic peripheral vascular beds.
Monitoring of Oxygenation
and Ventilation

In the unassisted patient, measure
ment of Pco2 and arterial oxygen ten
sion (Pao2), respiratory rate and vital
capacity should assure that adequate
arterial oxygenation and ventilation are
possible, without undue elevation of
respiratory rate and effort. Arterial
oxygenation can be supported by in
creasing the inspired oxygen concentra
tion up to 60%. Respiratory rates
greater than 35 /min suggest that the
effort of ventilation is excessive, and
a vital capacity less than 15 m L/kg
body weight suggests that the individ
ual’s ventilatory reserves are limited.
Where the full clinical picture indi
cates that the disorder impairing
oxygenation or ventilation will be pro
gressive and not quickly reversible,
endotracheal intubation and assisted
ventilation will be required. No arbi
trary figure can be the sole indication
for ventilatory assistance; all the con
tingencies of the case must be con
sidered.
Once mechanical ventilation has been
established, tidal volume, rate and min
ute ventilation will be controlled, and
can be adjusted and monitored with
the volume-cycled respirator. Mon
itoring of the inspired oxygen tension,
Pao2 and Pco2 should continue at in
tervals as frequent as other clinical
factors indicate. In our experience,
needle puncture of the radial artery
may be repeated as often as necessary
and insertion of a cannula is not in
dicated solely for the purpose of
sampling arterial blood.

Failure to maintain a Pao2 over 60
mm Hg with an inspired oxygen
concentration of 60% is usually an
indication for PEEP. The response to
PEEP is not always predictable, and
estimations of arterial blood gases must
be repeated as end-expiratory pressures
are increased in small increments. With
a PEEP, a fall in cardiac output should
be anticipated.
A measure of compliance can be
derived from peak inspiratory pressures
and tidal volume. This value may assist
in quantitating the course of the dis
ease and predicting the response to
increments of PEEP. During weaning
from assisted ventilation, inspiratory
force measurement may assist in pre
dicting or monitoring progress.
Body Temperature

Monitoring of body temperature is
of particular importance in the period
immediately following major trauma
or extended surgical intervention. The
system utilized should be capable of
detecting temperatures at the lowest
range. Hypothermia is very common
under these circumstances and may
have a considerable effect on visceral
function as well as on the interpretation
of results (e.g., arterial blood gases).
Conclusions

Every critical care area servicing a
major tertiary referral hospital should
have the capacity to perform the in
vasive monitoring techniques described
above. Each of these techniques has
specific complications and technical
pitfalls. The worst complication of in
vasive monitoring is misinterpretation
of the results. Because such techniques
provide figures, there is often an un
fortunate tendency to attach undue im
portance to a number, and to disregard
or overlook important clinical observa
tions.
Caution must be exercised at all
times to be certain that the placement
of invasive monitoring devices and the
determination of baseline values do not
delay urgent resuscitative measures.
Frequently, simple bedside observations
will indicate the appropriate therapy.
It is wrong in these instances to delay
such measures pending introduction of
various monitoring devices and cath
eters.
Once a monitoring catheter has been
introduced and data are being obtained
there is sometimes a reluctance to dis
turb the collection of data by moving
or examining the patient. Necessary
examinations or treatment may thus
be omitted in the interest of the mon
itoring device.
An array of transducers and elec
tronic devices may produce a mass of
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data, which is returned in a form that
makes meaningful interpretation dif
ficult. It is now possible to process
the data and present the information
as a “physiologic profile” on a pre
printed format; the data are available
within 1 hour and are presented in a
way that facilitates interpretation and
assists in therapeutic decision-making.5
All techniques and devices used in criti
cal care monitoring should be under
continuous review to ensure that the
risks and expense are justified by the
collection of data that can be inter

preted in time to be of value in making
therapeutic decisions.
In the presence of good indications
and an awareness of the hazards and
pitfalls of interpretation, however, the
advances in monitoring techniques will
usefully supplement physical examina
tion, laboratory and roentgenographic
data and other components of the
standard clinical record.
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2. Infection Control in the
Surgical intensive Care Unit*
J onathan L. M eakins ,

Control of infection in the surgical
intensive care unit demands unfailing
attention to three distinct areas:
a) The bacteria responsible may be
endogenous or exogenous. The effects
of the former can be limited by careful
surgical techniques and judicious use
of antibiotics, of the latter by the
practice of asepsis and antisepsis,
essentially of scrupulous cleanliness.
b) The environment o f infection
concerns the support of natural barriers
to infection (notably the integrity of
the skin and the adequate drainage of
the pulmonary system), and the
sterility and appropriate care and use
of the many invasive devices currently
available, c) The patient’s natural
defence mechanisms show considerable
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variation, and those at increased risk
can be detected by skin-testing with a
number of antigens as well as by
recognized clinical features. It is in
these patients with anergy and abnormal
natural defences that total parenteral
nutrition can be of the greatest value.

presentent un risque augmente peuvent
etre identifies par cutireaction avec
un certain nombres d'antigenes ainsi
que par des caracteristiques cliniques.
La nutrition parenterale totale s'avere
tres benefique chez les patients
anergiques.

Le controle des infections dans I'unite
chirurgicale de soins intensifs exige une
attention constante sur trois points
precis: a) la bacterie responsable peut
etre d'origine endogene ou exogene.
Dans le premier cas, les effets peuvent
etre circonscrits par des techniques
chirurgicales soigneuses et une
utilisation judicieuse des antibiotiques;
dans le second cas, on recourra a la
pratique de I'asepsie, de I'antisepsie
et, essentieilement, d’une proprete
absolue. b) L’envirormement, ou le
m ilieu responsable de Tinfection,
suppose le maintien des barrieres
naturelles (particulierement, I'integrite
de la peau et un drainage adequat du
systeme pulmonaire) et la sterilite
ainsi que la manipulation et I’usage
appropries des divers dispositifs
d'utilisation courante destines a penetrer
I'organisme. c) Les mecanismes naturels
de defense des patients montrent des
variations considerables. Ceux qui

Infection control in a surgical intensive
care unit (SICU) is an ongoing and
difficult job. In this population sepsis
continues to be either the major cause
of death or a major contributing factor
to organ failure and subsequent mor
tality. Control of infection is directed
practically and philosophically against
the three determinants that are inti
mately involved with the development
and evolution of each septic process.
These are: bacteria, which cause the
infection; the environment or local
area, where the infection develops; and
host defence mechanisms, which are
systemic reactions to the developing in
fectious process, that are to contain and
ultimately resolve the infection.
The SICU patient is at particular
risk in all of these areas. There is
exposure to bacterial flora, which has
usually demonstrated pathogenicity and
increased resistance to antibiotics. These
are patients in whom the environment
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simplest factor in the control of in
fection in an ICU area, is a zeal for
cleanliness and good technique on the
part of personnel in their approach to
the patient. The approach to control
of exogenous bacteria is in many ways
similar to control of the environment
of infection and reflects attitudes and
techniques that date back to Semmelweiss, Lister and Halsted and were
designed to keep bacteria from the
locale of potential infection: lungs,
wounds, venepuncture sites, etc. Asep
sis and antisepsis are the keystone of
control.

of potential infection is altered by their
disease or by their treatment; specif
ically, invasive devices, inability to
clear secretions, the presence of wounds
and fistulas, and previous surgery all
contribute to potential infection. Lastly,
host defence mechanisms can be dem
onstrated to be altered in the majority
of these patients.1
Bacteria

The infecting organisms to which the
SICU patient is exposed are endo
genous or exogenous. Endogenous or
ganisms are the patient’s normal flora,
that is, commensal flora of the skin,
mouth and nasopharynx and gastro
intestinal tract. These organisms are
usually susceptible to antibiotics and
have modest pathogenicity, and their
identity may to some extent be pre
dicted by site. The normal flora does
change in hospital so that autochthon
ous organisms are replaced by hospital
flora, making infections caused by en
dogenous bacteria more difficult to
treat. In time, endogenous flora becomes
exogenous. Exogenous flora comprises
those organisms that flourish in the area
where the patient is being treated. In
an intensive care unit these organisms
tend to have considerable pathogenicity
and resistance to antibiotics.
Control of endogenous and exogen
ous bacteria is different. The removal
of endogenous flora is clearly impos
sible. There have been attempts, par
ticularly in burn centres and centres
administering the chemotherapy of ad
vanced neoplasia with associated com
plications of bone marrow aplasia, to
use life islands and intensive antibiotic
treatment to alter or obliterate the pa
tient’s normal flora and isolate the
patient from contact with the outside
world. These attempts have been suc
cessful on occasion but are, however,
extraordinarily expensive and not justi
fied in the SICU. The exposure of the
patient to his or her own endogenous
flora is usually greatest at the time of
surgery, and control of infection relates
particularly to surgical technique, to the
judicious use of preoperative antibio
tics, and to subsequent careful wound
and dressing management with optimal
technique. Critical selection of anti
biotics in the SICU, that is, prescription
only for demonstrable infection, as dis
tinct from colonization, can prevent
overgrowth of normal flora with re
sistant bacteria and fungi.
Control of exogenous bacteria pre
sents different issues. The development
of resistant flora in any area, but par
ticularly in an ICU, is frequently the
product of antibiotic pressures, and
therefore judicious use of antibiotics is
critical. The second feature, perhaps
the most important and certainly the
VOLUME 21, NO. 1, JANUARY 1978

Environment of Infection
(Local Factors)

The environment relates to the area
of the patient that is to become in
fected, or that is indeed infected. Fea
tures of control are maximization of
the local factors to prevent lodgement
of bacteria in a potentially infected
focus. In the SICU the support of these
natural barriers is largely attitudinal
and technical. Specifically there are
mechanical, chemical and bacteriologic
barriers to colonization, lodgement and
subsequent development of bacteria.2
Maintenance of the integrity of the
skin is perhaps a simple example but
nevertheless makes the point. The skin
is an obvious mechanical barrier to
the invasion of bacteria and in addition
its fatty acids have major chemical
bactericidal properties. With normal
cutaneous integrity, bacteria that are
potentially invasive are in these settings
kept on the outside. The problems in
infection control in thermal injuries
bear this out. More pertinent is the
development of a decubitus ulcer (a
problem for which SICU patients are
at risk), presenting an environment for
the growth of bacteria that is most
appealing and therefore representing a
very real risk of systemic sepsis to the
patient. Prevention is the key to con
trol. The pulmonary system, another
area in which infection is common in
the surgical intensive care patient, re
quires constant attention. In uncon
scious patients control of bronchopul
monary secretions is difficult and naso
tracheal or oral-tracheal suction and
promotion of drainage are critical. In
those patients who are able to cough,
the clearing of their own secretions is
equally important and the patients
must continually be urged to do so.
While these two examples may ap
pear somewhat simple they make the
point that constant vigilance and atten
tion to the minutiae of care are critical
in order that infection may be pre
vented and thereby controlled. In both,
it is the control of the environment of
potential infection that reduces in
fection.
/

Invasive devices, some of which are
listed in Table I, present the other large
area of environmental control. Intra
venous catheters both central and peri
pheral, bladder catheters, endotracheal
tubes and arterial lines have all been
a major source of local infection as
well as systemic sepsis in this patient
population. In addition, the equipment
associated with these devices, such as
transducers, respirators and nebulizers,
is a documented source of potential in
fection. Care must be taken to ensure
that these items do not become con
taminated and a source of sepsis. The
control of infection from these devices
is largely a function of attention to
detail and the belief on the part of
personnel responsible for their use that
these devices upon which we have come
to depend so greatly for their monitor
ing and therapeutic benefits must also
be controlled to cause a minimal
amount of harm. It is my belief that
we have too many invasive lines, which
not only detract from our willingness
to examine the patient but which also
remain in place overlong and are prone
to infection. The technology for the
management of intravascular, intra
vesical and endotracheal intubation is
well known. The problem in reality is
the difficulty of maintaining constant
vigilance. It is never adequate to have
solved the problem once. These devices
remain an issue that is a constant
thorn in the side of managing physi
cians in intensive care and if they are
not attended to in a meticulous manner,
major infectious complications inev
itably follow.
The most obvious example is the
sepsis that is associated with hyper
alimentation or total parenteral nutri
tion and central lines. Depending on
the studies reported it is clear that the
infection rate can range from 5% to
33%. The major difference in the in
cidence of sepsis in these patient popu
lations and the type of organisms that

Ta b le 1— In v a s iv e

D e v ic e s

V a s c u la r
P e rip h e ra l v e n o u s c a th e te r
C e n tra l v e n o u s ca th e te r
m o n ito rin g
n u tritio n
A rte ria l lin e s
S w a n -G a n z cath e te r
R e sp ira to ry
En d o trac h e a l tube
n a sa l
oral
C h e st tube
U r in a ry
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B la d d e r ca th e te r
u re th ra l
s u p ra p u b ic
N e p h ro sto m y
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are responsible stems from the attitude
of the personnel looking after these
lines and the technical attention paid to
their management. In control of both
the bacteria and the patient’s envir
onment or local areas of infection, atti
tudes, techniques and attention to detail
are more important than any other
factors.3
Host Defence Mechanisms
(Systemic Factors)

Surgeons have long believed that in
spite of good surgical technique and ex
cellent pre- and postoperative care, some
patients have major septic complica
tions that can only be ascribed to some
intrinsic host defect. The demonstration
of such defects in general surgical pa
tients has been very difficult. However,
in the case of burn injury, consistently
the most severe form of trauma, it has
been shown that major abnormalities
of neutrophil function, cell-mediated
immunity, and complement and hu
moral responses develop, and that these
abnormalities are associated with septic
episodes.4,5 Other forms of trauma have
been shown periodically to be accom
panied by defects in some aspects of
host defence, but none that could be
related to clinical course or outcome.
In other branches of surgery, investiga
tions have been less informative.
Identification of the patient at risk for
sepsis because of abnormal host defence
mechanisms has been an elusive goal.
There are now data to show that the
results of a procedure as simple as skin
testing with five antigens — mumps,
varidase, Candida, purified protein
derivative and trichophyton — can
identify those patients at increased risk
for sepsis and mortality.1'6,7 In 320
patients skin-tested prior to surgery, 42
had abnormal responses with 21.4%
demonstrating sepsis and a 33.3% post
operative mortality rate compared with

4.6% and 4.3%, respectively, in those
who reacted normally. In the context
of the intensive care unit, 115 have
been studied and results are shown in
Table II. There was no difference be
tween those who were anergic and
those who were relatively anergic. As ex
pected, in the SICU there was an in
creased number of patients with altered
skin tests. The sepsis rate in all groups
was increased, consistent with the
severity of the disease processes for
which patients were admitted to the
SICU, but it was significantly greater
in those with altered responses. It is of
interest that the mortality rates in ICU
patients with altered or normal re
sponses were identical to those in pa
tients with similar responses studied
preoperatively.
Skin-test responses are related to the
process of delayed hypersensitivity and
as such are thought to be a reflection
of cell-mediated immunity, that branch
of the immune response associated with
reaction to tumours, organ transplants
and infections from a variety of viruses,
fungi and other intracellular parasites
such as Salmonella, Listeria monocyto
genes and Mycobacterium tuberculosis.
None of these organisms are common
pathogens in the SICU. In a study we
conducted of this subject, all the infec
tions were caused by common gram
positive cocci or gram-negative rods.7
This indicates that if there were de
fects in host defence, they were not
cell-mediated. Extensive in vitro studies
of lymphocytes in mixed leukocyte
culture from anergic patients, cellmediated lympholysis, ability to gen
erate blastogenic factor and response
to various mitogens were all normal.
There were some lymphocyte abnor
malities; resetting of lymphocytes with
sheep erythrocytes was abnormal and
was associated with a serum factor
that inhibited resetting of normal lym

Table I I — Outcome in 115 Patients in an Intensive Care U nit after Operation or Traum a, According
to Response to Skin Testing
Outcome, % *
Response to skin testing
A nergy or relative anergy, n = 96
N orm al, n = 19

Sepsis

Death

61.5
26.3

31.3
5.3

•D ifferences in outcome according to response to skin testing are significant a t P < 0.001.

Table II I — Outcome in 178 Patients According to Results of Serial Skin Testing
Outcome, %
R esult of skin testing
N orm al, n = 76
Im proved, n = 59
F a ilu re to improve, n = 43

Sepsis

Death

6.6
42.4
65.0

0
5.1
74.4
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phocytes, indicating a change in cell
surface characteristics. The resetting
abnormality and normal lymphocyte
function were not associated with the
demonstrated increase in sepsis in the
anergic patients.
Neutrophil function was also as
sessed. We found that neutrophil pha
gocytic and bactericidal function was
often abnormal6 but did not correlate
with sepsis in the SICU patient as has
been shown for the burn injury.4
Neutrophil chemotaxis was examined
and found to be abnormal in patients
with altered skin-test responses. This
abnormality was no longer evident
when cutaneous responses were re
stored, an indication that host defences
could improve. Similarly anergic serum
contained a factor that inhibited chem
otaxis in normal neutrophils as well as
in anergic neutrophils. This factor
disappeared if the anergic state re
turned to normal cutaneous reactivity.
This improvement correlates clinic
ally with skin testing as a measure of
host defence (Table III). The mortality
rate in those patients whose skin-test
responses improved was much lower
than in those whose responses and pre
sumably host defence remained ab
normal.
Skin testing identifies those patients
who are at increased risk for sepsis
and mortality, whether they are studied
preoperatively or seen in the SICU.
We have identified a number of clinical
features commonly associated with
anergy. These are age over 80 years,
major trauma, sepsis, shock related to
hemorrhage and malnutrition. Surgical
principles, well founded in practice,
address themselves to resolution of
trauma, drainage of infected sites and
restoration of blood volume. None of
these measures can be considered as
immunotherapy, nevertheless they ap
pear to be so. Shizgal and his group,
using body composition studies, have
clearly demonstrated that in anergic
patients there is an erosion of body
cell mass and that restoration of the
body cell mass is associated with return
to normal of cutaneous responses.8
However, in many patients total
parenteral nutrition given over periods
of between 2 and 3 weeks does not
correct the contraction of body cell
mass or the abnormal ratio of total
exchangeable sodium to total exchange
able potassium. In these particular cases
skin reactivity also remains abnormal
and the prognosis is poor. Correction
of protein-calorie malnutrition by total
parenteral nutrition is likely to fail if
this treatment is delayed until after a
septic complication has developed.
Anergy is often a reversible state, but
the aggressive early use of total parent
eral nutrition is essential in the treat
ment of these patients.
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proached through attitudes and tech
niques of asepsis and antisepsis. Host
defence may be bolstered by resolution
of those factors that are responsible
for its diminution, particularly by the
early use of total parenteral or enteric
nutrition.

In practical terms the presence of
anergy alerts the surgeon to the ac
quired defects in host defence in a
patient who requires alert anticipatory
care, possibly drainage of an infection
and certainly total parenteral nutrition.
The restoration of cutaneous responses
allows some relaxation of vigilance as
the patient is then usually on his way
to recovery.
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Upper Gastrointestinal Bleeding in
the Intensive Care Unit*
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such agents will obviate the necessity
of total gastrectomy in the occasional
resistant cases in favour of conservative
surgery.

Bleeding from hemorrhagic erosions in
the stomach or duodenum of seriously
ill patients is associated with a high
mortality. While the pathogenesis of
such lesions is by no means certain,
it is known that they are universal
after shock, sepsis or severe burns.
Fiberoptic endoscopy has become the
most valuable means of diagnosis. This
should be preceded by gastric irrigation,
which usually suffices to control
bleeding caused by acetylsalicylic acid
or alcohol, or both. Neutralization of
gastric acidity is essential. The
histamine H2-receptor antagonist,
cimetidine, was used in 27 patients
with erosive gastritis, and bleeding
ceased in 24. There is a prospect that

Chez les patients gravement malades,
le saignement provoque par I'erosion
hemorragique de I’estomac et du
duodenum est associe a un taux de
mortality eleve. Bien que la pathogenie
de ces lesions demeure inconnue, on
les retrouve de faqon constante apres
un choc, une septicemie ou des brulures
graves. La fibroscopie est devenue
une methode diagnostique des plus
precieuses. Elle devrait etre precedee
d'une irrigation gastrique qui suffit
habituellement a controler le
saignement cause par I'acide
acetylsalicylique ou I'alcool. La
neutralisation de I'acidite gastrique est
essentielle. La cimetidine, un antagoniste
des recepteurs histaminiques H2, a
ete utilisee chez 27 patients souffrant
de gastrite erosive et le saignement
a cesse chez 24. On peut entrevoir
que de tels agents therapeutiques
puissent obvier a la necessity d'une

*From the departments of surgery and
medicine, Dalhousie University, Victoria
General Hospital, Halifax, NS
I’resented at the inaugural meeting of the
Canadian Association of General Surgeons,
Toronto, Ont., May 11 and 12, 1977
Reprint requests to: Dr. Allan S.
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5849 University Ave., Halifax, NS
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gastrectomie totale dans les cas
resistants occasionnels, laissant la
place a une chirurgie conservatrice.

It is unfortunate but true that in those
seriously ill patients who can withstand
them least, hemorrhagic erosions are
most likely to develop in the stomach
or duodenum. It is therefore not sur
prising that the mortality rate from this
condition is distressingly high, from
20% to 60% in reported series.1’6 At
the Victoria General Hospital, Halifax,
in only 15% of cases of hemorrhagic
gastritis induced by alcohol or acetyl
salicylic acid in otherwise fit individuals
does the bleeding fail to stop spon
taneously and in those few requiring
operation the mortality rate is less than
3%. But in patients who require ad
mission into an intensive care unit
(ICU), bleeding erosions are often the
final straw that determines a fatal
outcome.
Pathogenesis

There has not been a single report
of bleeding erosions of the stomach or
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duodenum in an achlorhydric patient.
Therefore it appears that acid is essen
tial for the production of such ulcers.
In experimental animals acid is re
quired, indeed the erosions are difficult
to produce if the gastric luminal pH
is much above 3. On the other hand,
it is also true that there is no increase
in acid production in response to
serious illness; in fact, it often falls.7,8
Although disputed,9 many believe that
an increase in back diffusion of acid
across the gastric mucosa produces the
observed mucosal damage. This implies
a breakdown in mucosal resistance to
acid and an alteration in mucosal per
meability. Agents such as acetylsalicylic
acid,10 bile acids7 and alcohol11 have
been shown to have this effect. The
mechanism by which this occurs in
seriously ill patients is not understood.
Hypovolemic shock is accompanied by
gastrointestinal ischemia and it is not
difficult to visualize how this might
cause focal ischemic necrosis of the
mucosa.12 However, in our experience
most patients in whom these erosions
develop in the intensive care unit have
not experienced hypotensive shock. In
fact, in some groups (e.g., patients in
renal failure) hypervolemia is often
present. The majority of patients who
bleed have sepsis, frequently caused by
gram-negative organisms, but often they
are not in shock. Clinical observations
of alterations in gastric blood flow are
not very convincing. Yet it has been
demonstrated that the appearance of
mucosal ulcerations is almost universal
after shock, sepsis, or severe burns13,14
and the incidence is probably much
higher than suspected in other stressful
conditions. While the ulcerations may
occur universally, bleeding does not.
This is probably due to the tremendous
regenerative capacity of the gastro
intestinal mucosa. Mucosal ulcerations
often disappear within 24 hours or less
despite massive involvement of gastric
fundus and duodenum initially. It is our
belief that what distinguishes the bleed
ers from the nonbleeders or transient
bleeders is continuation of the stressful
situation that led to the erosions.
It is tempting to think that all the
common situations that lead to stress
ulcers have a common pathogenesis.
Yet there are factors that are obviously
more important in one disease than in
another. The common clinical condi
tions we have found to precede erosive
gastritis in our ICU are shock, sepsis,
organ failure (kidney, liver and lung),
drug ingestion (acetylsalicylic acid, al
cohol and corticosteroids) and elevated
intracranial pressure. In the majority
of patients more than one factor has
been implicated. The mechanism by
which sepsis, in the absence of overt
shock, causes erosions in stomach and
duodenum is still a matter of specula
82

tion. In some patients alterations in
liver function are apparent, whereas in
others the lung is affected and hypoxia
is present. Usually there is a high car
diac output. In some patients prolonged
clotting times or depressed platelet
counts are present. In uremic individ
uals there is often interference with nor
mal coagulation as well, as an effect
of uremia on the mucosal barrier. The
incidence of bleeding is exceptionally
high in patients in whom uremia devel
ops as a complication of some other
surgical problem and in our hands the
mortality in those who bleed has been
50% .15 In liver failure bleeding is also
frequent, probably because of the asso
ciated coagulation defects and the ac
companying hyperacidity; an incidence
higher than 50% has been reported and
the mortality is forbidding.' The role
of acetylsalicylic acid or alcohol, or
both, in precipitating erosions is well
recognized. In our experience, in almost
all these patients the bleeding will stop
with very little treatment, unless it has
precipitated other problems such as
liver failure, heart failure etc. The ef
fect of steroids is much less clear cut
and the previously accepted connection
has been challenged.16 The doses of
corticosteroids now used in the treat
ment of shock, adult respiratory distress
syndrome and renal transplant rejection
are much higher than those used for
chronic conditions. However, the very
conditions for which the steroids are
given are those in which bleeding gas
tric erosions are common. The role of
steroids is therefore unproven.
Raised intracranial pressure is asso
ciated with increased vagal tone and
hyperacidity. Frequently in such pa
tients deep penetrating ulcers develop
rather than superficial erosions, al
though the latter do occur.
There are a variety of other condi
tions seen frequently in the intensive
care unit that are associated with bleed
ing erosions. Pancreatic disorders, par
ticularly postoperative resections, are
not rare causes of massive bleeding
from acute erosive gastritis. Here the
concomitants of liver pathology, hypo
volemia and sepsis are presumed to be
responsible. Not infrequently patients
are seen with rebleeding from erosive
gastritis after operations for control of
bleeding duodenal or gastric ulcer, or
even for erosions themselves.
Diagnosis

The hallmark of erosive gastritis is
bleeding, and the mainstay of diagnosis
is fiberoptic endoscopy. Barium con
trast roentgenographic examination is
not helpful because, although it may
show varices or an ulcer, neither one
may cause the bleeding. The superficial
erosions are not deep enough to be
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seen by roentgenography and the bari
um may interfere with subsequent
endoscopy or angiography. Endoscopy
should be done first and the roent
genographic examination reserved for
those patients who stabilize or those
who are being considered for surgery.
Pripr to endoscopy, gastric irrigation
is required, first to confirm that the
origin of the bleeding is indeed prox
imal to the ligament of Treitz, second
to indicate the rate of blood loss, and
third, therapeutically to reduce or stop
the bleeding by the use of iced glucose
or saline solution. This procedure may
be sufficient to stop the bleeding, or at
least to slow it to the point where en
doscopy is feasible. Even if the bleeding
is torrential, endoscopy should be per
formed at least to rule out esophageal
varices as the source.
At endoscopy, early in the course of
illness, one finds numerous punctate
areas of hemorrhage, typically most in
tense along the lesser curvature and
over the posterior wall of the fundus.
The antrum is often spared. The duo
denum may show only erythema al
though often it too has multiple small
bleeding areas. Occasionally only the
duodenum is involved. As the duration
of the illness lengthens, the erosions
tend to enlarge and coalesce, often
forming a long serpiginous shallow ul
cer several centimetres long, which
can be mistaken for a Mallory-Weiss
tear. If the process is allowed to con
tinue, the ulcers begin to deepen, but
reactive granulations are still absent.
This sequence is most likely in those
patients who have irreversible organ
failure with an inevitably fatal out
come. In patients in whom the primary
stress that has produced disease is re
lieved, for example, by surgical drain
age of an intra-abdominal abscess,
the erosions can disappear incredibly
rapidly.
Treatment
Acute hemorrhagic erosive gastritis
as a single disease entity, usually pre
cipitated by acetylsalicylic acid or al
cohol, or both, almost always resolves
with simple lavage of the stomach with
ice water followed by oral antacids.
The same condition occurring in an
otherwise severely ill patient is an
other matter. Results have improved
with the demonstration by Skillman
and Silen17,18 and others19'20 of the bene
ficial effect of neutralizing gastric acid
ity by the use of antacids. A whole
variety of other techniques have been
tried with occasional success, including
intragastric instillation of viper venom
or epinephrine, or both,21 endoscopic
electrocoagulation,22 laser-induced co
agulation,23 selective embolization of
the gastric arteries,24 and percutaneous
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transarterial celiac artery catheteriza
tion and infusion of vasopressin.25 In
our hands the mainstays of therapy
have been ice water lavage, neutraliza
tion of gastric acidity and infusion of
vasopressin by way of the celiac artery.
Where we have differed from others is
in our use of histamine H2-receptor an
tagonists instead of, or in addition to,
intragastric instillation of antacids.26
These new agents are potent inhibitors
of gastric acid secretion,27,28 and have
the advantage of inhibiting histamine
release from mast cells29 and its dam
aging effect on gastric mucosa. In our
first series of patients we used metiamide to treat 17 episodes of bleeding
from erosive gastritis in severely ill
patients. Because of occasional agranu
locytosis metiamide was withdrawn, but
cimetidine, an equally effective agent,
is now available. We have used it in
27 patients with erosive gastritis (Table
I); bleeding ceased in 24. These were
uncontrolled trials and we do not
know if the results represent any im
provement over what could have been
achieved by standard therapy alone.
However, in the majority of instances
we were asked to see the patients after
conventional treatment had failed,
when blood loss had been substantial
and when continued bleeding was an
immediate fatal threat in patients who
were believed to have relative or ab
solute contraindications to surgery. Of
the four in whom bleeding recurred,
all were operated on and three died in
the immediate postoperative period.
Similar good results have been re
ported with antacids only.20 The only
advantage of the H2 blockers, in our
opinion, is the ease and completeness
with which they prevent hydrogen-ion
release and thus elevate the pH to
neutrality. That this will not be suf
ficient for all patients is illustrated by
the report from Dudley, Fielding and
Glazer30 of four consecutive failures
with cimetidine used to manage upper
gastrointestinal bleeding; one of the
cases was certainly, and one probably,
due to stress erosions.
In all four failures in our practice

endoscopic examination had confirmed
the presence of diffuse punctate ero
sions in the gastric fundus. As the con
dition progressed some of these co
alesced into larger erosions. When
cimetidine was started the small ero
sions promptly disappeared, leaving one
to three erosions that continued to
bleed. To one of these patients cime
tidine was given prophylactically fol
lowing a Whipple pancreatectomy, yet
the erosions caused bleeding that ul
timately required total gastrectomy. It
is not clear whether the erosions de
veloped prior to the patient’s Whipple
operation, or while he was on cime
tidine. In this patient, as in many
others, we have been struck by the
marked bile reflux that is apparent at
endoscopy.
We have been most impressed by
the results of controlled trials of his
tamine H2-receptor antagonists for the
prevention of upper gastrointestinal
bleeding in patients in hepatic coma, as
reported by MacDougall, Bailey and
Williams.31,32 Only 1 of 26 patients re
ceiving H 2 blockers bled, while 54%
of their controls did so. The drug ap
pears to be almost completely free of
side effects during short-term usage and
it is our prediction that its routine
prophylactic use in intensive care pa
tients who are at risk will greatly
reduce the problem of erosive gastritis.
There will, however, always be some
patients who fail to stop bleeding de
spite all conservative measures and who
will require operation. The selection of
the procedure to be adopted is a vexing
question. One is equally reluctant to
remove the stomach in a patient who
does not have a long-standing ulcer
diathesis, or to do a lesser procedure
and leave bleeding mucosa behind. A
recent review of the literature by
Moody and Cheung33 shows that only
total gastrectomy, as advocated by
Menguy, Gadacz and Zajtchuk34 is not
associated with substantial rebleeding.
The rebleeding rate for subtotal
gastrectomy is 51%. Using vagotomy
and drainage with suture ligation Men
guy and colleagues had only a 9.5%

Table 1— Results of Treatm ent of Hemorrhagic Erosive Gastritis w ith Cimetidine
No. of patients
Diagnosis
A fter gastric surgery
A fter pancreatic surgery
Cirrhosis
Renal failure
Cardiopulmonary failure
Erosive gastritis only
Other
Total

Total

Stopped
bleeding

5
4
1
1
2
12
2

5
3
1
1
2
10
2

27

24
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Rebied
1
1 (varices)
1
1
4

rebleeding rate, although 24% of their
patients died.
Based on our experiences with meti
amide and cimetidine, we would ad
vocate conservative surgery. In those
who continue to bleed despite the ad
ministration of H 2 blockers, discrete
ulcers are present which can be han
dled by suture ligation or excision,
followed by vagotomy and drainage
and continuous cimetidine therapy un
til the stressful situation has passed.
Only time will tell if this is the correct
recommendation.
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4 . Respiratory Failure*
J o el D. C o o pe r , m d , fr c s [c ]
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Patients requiring respiratory support
may have normal lungs but inadequate
ventilation, or they may suffer from
defective pulmonary gas exchange
despite adequate ventilation. In the first
group some form of mechanical
ventilatory support is called for, either
pressure-cycled or volume-cycled, used
first with an endotracheal tube and
only later with a tracheostomy. Weaning
the patient from the apparatus requires
special care.
In cases of pulmonary insufficiency
the use of positive end-expiratory
pressure has been a major advance.
Hemoglobin concentration, cardiac output
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of thoracic surgery, Toronto General
Hospital, Toronto, Ont.
Presented at the inaugural meeting of
the Canadian Association of General
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and renal function must receive
attention. Open lung biopsy is of the
greatest value when the diagnosis
is open to question. Resort to a
membrane oxygenator to provide
extracorporeal oxygenation of blood
can sustain for a time the patient in
whom hypoxia is critical in degree.
Les patients necessitant une respiration
assistee peuvent avoir des poumons
normaux mais une ventilation inadequate,
ou ils peuvent souffrir d’une anomalie
de I'echange gazeux pulmonaire en
depit d'une ventilation adequate. Dans
le premier groupe, on doit recourir
a une forme quelconque d'assistance
ventilatoire mecanique, a cycle de
pression ou a cycle de volume, par
intubation endotracheale au debut et,
par la suite seulement, a I'aide d'une
tracheotomie. II faut des soins speciaux
pour debrancher le patient de I'appareil.
Dans les cas d'insuffisance
pulmonaire, I'utilisation d'une pression
positive en fin d'expiration a constitue
une amelioration majeure. On doit
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porter attention a I'hemoglobinemie, au
debit cardiaque et a la fonction renale.
Quand le diagnostic est incertain, la
biopsie a poumon ouvert est de premiere
importance. L'emploi d’un oxygenateur
a membrane pour assurer une
oxygenation extracorporelle du sang
peut maintenir, pour un certain temps,
le patient dont le degre d'hypoxie est
devenu critique.

While acute respiratory failure may be
variously defined, it can be considered
the inability to maintain spontaneously
normal arterial oxygen and carbon di
oxide concentrations by an individual
breathing room air and who has not
previously had lung impairment.
Patients requiring respiratory support
fall roughly into two categories: those
with fairly normal lungs but with ina
dequate ventilation, and those in whom
pulmonary gas exchange is defective
even with adequate ventilation. The
management of these two problems is
quite different. Patients suffering from
sedative overdose or from neurologic
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disease by and large require primarily
mechanical ventilatory support and do
not have gas-exchange difficulties.
These patients fall into the first cate
gory. Patients with cardiac and renal
failure, and those with primary pul
monary abnormalities that bring about
defective pulmonary gas exchange be
long to the second category. Patients
with chest injuries and some postopera
tive patients may have features in
common with both groups.
Respiratory units were first devel
oped for the management of patients
primarily requiring mechanical ventila
tory support. The Copenhagen experi
ence with poliomyelitis, in 1952, pro
vided the opportunity for first wide
spread use of positive-pressure ventila
tion, and demonstrated its advantages
over negative-pressure ventilation with
an iron lung or a cuirass. Poliomyelitis
patients and patients with other neuro
muscular disorders such as myotonia,
myasthenia, muscle wasting diseases
and injuries to the central nervous sys
tem provided the stimulus for the devel
opment of specialized respiratory units.

may be comforting to know that this
complication can be successfully man
aged, it is far better to avoid the com
plication by placing the tracheostomy at
the 2nd or 3rd tracheal ring. Even so, a
high-riding innominate artery can still
occasionally be eroded by the elbow of
the tube.
We now know that old fashioned,
high pressure endotracheal and trache
ostomy cuffs can cause considerable
tracheal damage in a short period of
time, due to pressure necrosis at the
cuff site. This causes necrosis and
eventual dissolution of cartilaginous
rings. Healing may be by scar forma
tion with resultant tracheal stenosis.
Pressure necrosis by the cuff can also
lead to erosion through the posterior
wall of the trachea into the esophagus,
or through the anterior wall into the
innominate artery. With the advent of
tracheostomy tubes and endotracheal
tubes fitted with high volume, com
pliant, low pressure cuffs, the problems
of the cuff stenosis and cuff fistula have
been virtually eliminated in those hos
pitals where such cuffs are routinely
used.

Tracheostomy
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Over the years important lessons
have been learned regarding the logis
tics and mechanics of delivering safe
positive-pressure ventilation. In the
early days of such care, emergency
tracheostomies were common and so
were their related problems. These in
cluded local hemorrhage, displacement
or obstruction of the tube, incorrect
placement of the tracheostomy stoma
and difficulties with the management
of secretions. Today there is almost
no place for emergency tracheostomy
other than for acute upper airway ob
struction. Respiratory support is begun
with an endotracheal tube and trache
ostomy is subsequently done on an elec
tive basis, usually 4 to 7 days later.
Elective tracheostomy has not solved
all problems relating to the use of
cuffed tracheostomy tubes. We recently
had experience with three tracheoinnominate fistulas, which were suc
cessfully managed by partial sternotomy
and resection of the innominate artery.
Control of the hemorrhage was by
hyperinflation of the balloon cuff and
forward leverage on the tracheostomy
tube, or, failing this, by endotracheal
intubation, removal of the tracheostomy
tube and digital compression through
the tracheostomy site, by pressing the
innominate artery forward against the
back of the sternum. In two of these
cases the tracheostomy had obviously
been placed much too low, causing the
elbow of the tube to rest against the
back of the innominate artery. In one
case the tracheostomy was situated as
low as the 7th tracheal ring. While it
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Ventilators

Ventilators are available in various
sizes, shapes and complexities. Their
source of power may be electricity or
compressed gas. A cycling mechanism
determines the magnitude of the breath,
a system is provided for determining
the rate of inspiration and the inspired
gas is properly humidified. Based upon
the cycling system, ventilators can be
roughly divided into two groups — the
pressure-cycled ventilators such as the
Bird, and the volume-cycled ventilators
such as the Bennett, Ohio, or Emerson.
The Bird ventilator delivers gas at a
preset flow rate until a predetermined
peak airway pressure is reached, at
which point the ventilator shuts off.
Since the airway pressure depends on
many factors including the patient’s
cooperation, chest wall and pulmonary
compliance, the pressure-cycled venti
lators do not deliver a given vol
ume. The tidal volume must be meas
ured periodically to ensure that the
patient is receiving the desired ventila
tion. Also, the concentration of in
spired oxygen is not accurately con
trolled by the Bird ventilator. A mix
ture of compressed air and oxygen may
be required to give the desired concen
tration of inspired oxygen, and the
oxygen concentration must be frequent
ly checked with an oxygen analyzer.
Volume-cycled ventilators deliver a
preset volume and an accurate concen
tration of inspired oxygen. With the
use of such ventilators these parameters
do not have to be monitored as fre
quently.

Whatever the type of ventilator, it
must be monitored, including the vol
ume and peak of the gas mixture de
livered, the inspired oxygen concentra
tion, and the effects on the patient’s
cardiovascular system and on arterial
blood gases. One of the most important
ventilator safeguards is an alarm system
that sounds in case of a disconnection
or mechanical failure. This may seem
obvious today, but many of us who
have been associated with respiratory
care for a period of time can re
member patients who have been lost in
the past because ventilator disconnec
tions were not discovered in time, in
the absence of an alarm system.
Weaning

Just as there are problems associated
with the use of a ventilator, there are
others posed by weaning a patient from
the ventilator. In this regard, the use
of intermittent mandatory ventilation
(IMV) has been an important recent
advance. Traditionally the patient was
weaned from the ventilator by intermit
tently removing him completely from a
ventilator for progressively longer
periods. With an IMV circuit the
patient can breathe spontaneously
at any rate he wishes and in addition
he receives a fixed number of mech
anical breaths from the ventilator. The
gas inspired in the spontaneous breaths
has the same oxygen concentration as
the gas provided by the ventilator
breaths. Over a period of hours or
days the number of assisted breaths is
gradually reduced, for example from
15/min, to 14/rnin, to 13/min, and so
on, so that the patient is always receiv
ing some assistance and increasingly
does more of the work himself. This
type of weaning is much smoother and
easier for the patient and is useful in
some of the more difficult problems.
Early use of such a circuit, even before
the patient is ready to be weaned, may
be of value in preserving the strength
and coordination of the patient’s res
piratory muscles.
An understanding and familiarity
with the mechanics of ventilatory tech
niques help the surgeon to use ration
ally a form of ventilatory support for
his patients. Certainly some patients
undergoing major surgery appear to do
much better when routinely ventilated
overnight. Thereby some of the com
plications of marginal ventilation in the
early postoperative period are avoided.
As well, the patient may be provided
with needed rest for the first night fol
lowing operation. The surgeon familiar
with ventilator support will consider
its postoperative use, when indicated,
as an important part of his therapy and
not as an undesirable, and all too ob
vious, result of the operation.
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Another example of ventilatory sup
port as an adjunct to surgery is the
case of the patient with an acute gen
eralized empyema such as might result
from a ruptured esophagus. Following
thoracotomy to close the perforation
and to drain the chest, the routine use
of ventilatory support and positive endexpiratory pressure for several days will
maintain a high lung volume, quickly
obliterate the pleural space and avoid
subsequent development of loculated
pleural infection.
Ventilatory Support for Pulmonary
Insufficiency

The second group of patients re
quiring respiratory support, those with
basic pulmonary dysfunction, are far
more difficult to manage. In patients
with pneumonia, chronic lung disease,
aspiration pneumonia, pulmonary ede
ma or one of a host of inflammatory
conditions of the lung, mechanical
ventilatory support may not be enough
and one must try to improve the im
paired pulmonary gas exchange. It is
now known that the pattern of ventila
tion in such patients may be as im
portant as the amount of ventilation
in improving gas exchange. These pa
tients almost always require a volume
ventilator. A ventilator that operates
on a sine wave, such as the Engstrom,
may give better gas exchange than one
operating on square wave cycle. An
inspiratory hold or plateau in the cycle
may also improve gas exchange.
The use of positive end-expiratory
pressure (PEEP) has been a major ad
vance. Its use can be traced back at
least to 1943 when Barach used such a
system for spontaneous ventilation.
With the use of end-expiratory pressure
the lungs are maintained at a higher
volume than otherwise, and in certain
conditions this markedly improves oxy
genation. Usually a pressure of 5 to 15
cm H zO achieves maximum effect. In
some patients, however, even higher
levels, or “super PEEP” may produce
further improvement. In one case, a
patient receiving 100% oxygen had a
partial pressure of oxygen (Po2) of 50
mm Hg when the PEEP was 15 cm
H 20 . The Po2 rose immediately to 150
mm Hg when the PEEP was increased
to 25 cm H 2O. When the PEEP was
raised to 30 cm H 2O no further rise
in P 0 2 was achieved and the cardiac
output began to fall, so the PEEP was
reduced to 25 cm H20 , which was well
tolerated.
When faced with severe hypoxia and
acute respiratory failure, one mani
pulates the entire patient to improve
the oxygen delivery to tissues. Careful
monitoring is important during this
period of active intervention. Pulmon
ary gas exchange is rendered optimal
86

with the use of PEEP and an appropiate ventilatory pattern. The use of
bronchodilators and sedation or bring
ing about paralysis of the patient, when
required, may improve ventilation.
Oxygen delivery to the tissues is a
product of the cardiac output and the
oxygen content of the blood. Hence
maintaining an adequate hemoglobin
concentration and a satisfactory cardiac
output is important. Digitalis, albumin,
inotropic agents and calcium may be
required to maintain adequate cardiac
output in the case of hypoxia. Oxygen
consumption can be reduced by cooling
the patient to as low as 32°C and by
sedating or paralysing the patient to
reduce or eliminate muscle activity.
Increased pulmonary extravascular
water is inevitably present in almost all
patients with acute respiratory failure,
regardless of its cause. Maximum de
hydration by diuretics and correction
of left ventricular failure, when present,
are of the greatest importance. The use
of peritoneal or hemodialysis should be
considered if renal function is impaired,
since reduction of excess body water
is essential.
Emergency Open Lung Biopsy

In cases of acute respiratory failure
if the cause is at all in doubt, a specific
tissue diagnosis is required. Under these
circumstances emergency open lung
biopsy is most helpful. When we re
cently reviewed 28 cases in which
emergency open lung biopsy had been
performed we found that a correct
diagnosis had been made possible in
27 (96%) cases. The clinical diagnosis
prior to biopsy was confirmed in 12
cases but was in error or incomplete
in 15 cases.
The procedure is usually done in the
operating room but can be done at
the bedside. Since a specific diagnosis
in such cases is so important we con
sider there to be very few contraindica
tions to emergency open lung biopsy.
It can be done when the patient is on
a ventilator and even when very high
volumes of PEEP are being used.
Thrombocytopenia is not a contraindi
cation, as a platelet transfusion at the
time of biopsy has, in our experience,
prevented problems of bleeding.
One dramatic example of the
importance of open lung biopsy was
the case of a young woman presenting
with rapidly developing pulmonary in
filtrates and fulminant respiratory fail
ure, several days after a normal de
livery. The clinical diagnosis was amniotic fluid embolism. Emergency open
lung biopsy revealed fulminant tuber
culous pneumonitis. Treatment with
antituberculous drugs in combination
with steroids led to prompt resolution
and complete recovery.
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Controversies in Respiratory Care

Many controversies remain regarding
the management of acute respiratory
failure. For example, how long should
an endotracheal tube be left before
changing over to tracheostomy? The
correct answer is probably 5 to 7 days,
but there are great differences of
opinion. There is a question as to the
significance of pulmonary oxygen toxi
city in humans. If it does exist as a
primary entity, what is the safe con
centration for inspired oxygen? I per
sonally doubt whether oxygen toxicity
is an important clinical problem if
blood gases are monitored, and if one
does not allow arterial oxygen concen
trations to become excessive. Basically,
hypoxia is bad, oxygen is good — but
one should not use more oxygen than
necessary. If there is an alternative to
the use of high oxygen concentrations,
such as the use of PEEP to improve
oxygenation, this should be the first
resort. However, one should not hesi
tate to use even 100% oxygen for
days if required to prevent critical hy
poxia. A number of patients so treated
at high ventilatory pressures continu
ously for 4 and 5 days have made a
complete recovery.
The debate as to whether colloid or
crystalloid should be used for volume
replacement is a continuing one, as
is the use of massive doses of steroids
for specific and nonspecific inflamma
tory conditions of the lung.
Use of Membrane Oxygenator

If all else fails, one can buy addi
tional time with the use of a membrane
oxygenator, a device for extracorporeal
oxygenation of the blood. This device
exchanges gas across a thin silicone
rubber membrane separating the blood
and gas phases. This avoids direct
blood-gas contact and prevents most
of the harmful effects on red cells,
proteins and platelets, which occur after
several hours on a bubble oxygenator.
The membrane oxygenator can be used
for days or even weeks. The longest
documented successful perfusion was
for 10 days and ended with the pa
tient’s complete recovery.
The membrane oxygenator can be
used for acute respiratory failure when
a patient with critical hypoxia has a
disease process presumed reversible; by
this means the physician can sustain
the patient for a few extra days while
waiting for recovery to occur. The per
fusion catheters are inserted up the
femoral vein and artery into the inferior
vena cava and aortic arch, respectively.
A ventilator is still required for part of
the gas exchange requirements. We have
used a membrane oxygenator on six
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patients. One of the patients was re
moved successfully from it after 3 days
of perfusion, but died several weeks
later of bone marrow insufficiency due
to underlying leukemia. Our one long
term success was a 19-year-old girl with
a 3-week history of progressive dyspnea
and cyanosis, and multiple small pul
monary emboli confirmed by lung scan
ning and pulmonary angiography. In
creasing pulmonary edema and respira
tory failure developed and the patient
went into shock with a high pulmonary
artery pressure, a low cardiac output

and anuria. Pulmonary embolectomy
was not believed to be indicated be
cause no central major clots were
identifiable on the pulmonary angio
gram and the patient’s history suggested
that the small peripheral emboli were
up to 3 weeks old. As a last desperate
effort she was connected to a mem
brane oxygenator with a bypass flow
of 3.5 L/m in. This promptly reversed
the shock, the anuria, the hypoxia and
the pulmonary edema. After 35 hours
of perfusion, however, the patient was
still totally dependent on the oxygen

ator and continued to have elevated
pulmonary artery pressures and a low
cardiac output. Selective pulmonary
angiography through a Swan-Ganz
catheter revealed a clot obstructing the
major branch to the right lower lobe.
Peripheral embolectomy of this and
several other smaller vessels was per
formed through a median sternotomy.
There was no immediate improvement
and she required another 35 hours of
membrane oxygenator support before
she could manage without it. She had
an uneventful recovery thereafter.

5. Panel Discussion on Intensive Care*
Chairman: J ohn H. Du f f , md , FRCs[c]f
Panelists: D.B. A llardyce, J.D. Cooper, A.S. M acD onald and J.L. M eakins

Dr. Duff: A number of questions have
been supplied by the audience and I
will assign these to the member of the
panel for whom they seem appropriate.
How do you administer the H2 blockers
metiamide and cimetidine? Dr. Mac
Donald.
Dr. MacDonald: We routinely use
intravenous cimetidine. Metiamide is no
longer available, and at first we used
to give 300 mg q6h. Now we tend to
give it by continuous infusion at the
rate of 300 mg over 6 hours. The ob
jective is to eliminate production of
acid and one can determine one’s suc
cess by measuring intragastric pH. With
cimetidine one can almost invariably
bring the pH to 7.
Dr. Duff: Do you employ the exchange
able sodium to exchangeable potassium
ratio to indicate anergy or do you
routinely do the skin tests to confirm
your diagnosis of anergy and its cor
rection by parenteral nutrition? Dr.
Meakins.
*'Conducted at the inaugural meeting
of the Canadian Association of General
Surgeons, Toronto, Ont., May 11 and 12,
1977
1Chief of general surgery, University
Hospital, University of Western Ontario,
London, Ont.
Reprint requests to: Dr. J.H. Duff,
Department of surgery, University
Hospital, 339 Windermere Rd., London,
Ont. N6A 5A5
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Dr. Meakins: We just use serial skin
testing. Body composition studies do
not rapidly supply the data necessary
and so we use them in clinical practice
only occasionally. As a general rule
skin testing for anergy is done serially
once a week on all patients in the
intensive care unit.
Dr. Duff: Is this your present method
of determining whether or not your
parenteral nutrition is effective?
Dr. Meakins: Yes. And we have no
better method of finding out how the
patient is doing immunologically.
Chemotaxis is accurate but skin testing
is easier.
Dr. Duff: A question on which all the
members of the panel might express an
opinion. When do you decide on hyper
alimentation for patients in the inten
sive care unit?
Dr. Allardyce: We believe that in the
acute situation, for example during the
period of resuscitation from shock,
whether of the septic or hemorrhagic
type, or when major surgery has just
been carried out, total parenteral nutri
tion (TPN) probably complicates the
issue and is not of much value. But as
soon as the patient is stable from a
cardiovascular standpoint, we institute
intravenous feeding. We decide on the
central or peripheral route on the basis
of the expected duration of TPN. If it
is to continue for 3 weeks or longer,
we use the central route. If we think it

will be for only 2 to 3 weeks we choose
the peripheral route.
Dr. Duff: When do you start TPN and
what solution do you give?
Dr. Cooper: When I go 12 hours with
out eating, I get rather hungry and by
the time I have gone 24 hours without
food I am feeling rather weak. It is
definitely my opinion that it is unfair
to put a patient on a ventilator in the
intensive care unit and make him fight
his way without giving him any nutri
tional support. To do so is to add
starvation to his illness. I think nutri
tion is often neglected because we are
so busy taking care of everything else.
Often 5 or 6 days have passed when
we suddenly remember even to do
something so simple as putting in a
nasogastric tube for feeding. By all
means if you anticipate a long course
for the disease you should start feeding
the patient right away. My personal
feeling is that feeding should be given
during the first few days via a stomach
tube if possible, otherwise by the par
enteral route. It should be part of the
early treatment plan to identify the
patient who is likely to require either
TPN or enteric nutritional supplemen
tation. In 1977, this part of surgical
treatment is to be considered, if not
in the emergency room, certainly pretty
soon afterwards.
Dr. Duff: Dr. MacDonald, have you
anything to add?
Dr. MacDonald: Yes, two points. We
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discourage the use of peripheral veins
for TPN. If the patient is going to be
ill and in an intensive care situation for
a long time, you want to have every
peripheral vein available for as long as
possible. The more you spare, the
better. We use central veins early. The
second point is that patients in an in
tensive care unit often have caloric
requirements that are much higher than
can be supplied by peripheral TPN
systems.
Dr. Duff: Dr. MacDonald, one mem
ber of the audience believes your results
with cimetidine are not good because
the patients who received it were
treated with the agent for quite a long
time despite continued bleeding. In
other words, surgery was delayed, and
the questions are, Was surgery delayed
too long in the patients to whom you
gave cimetidine? and, Would an earlier
operation have resulted in a better
salvage rate?
Dr. MacDonald: Those are fair ques
tions. The figures reported here are for
patients from whom surgery was with
held because of prohibitive operative
risk. These patients received cimetidine.
The study showed that those with ero
sive gastritis did well, those with duo
denal or gastric ulcer did not do well.
But they did not die because surgery
was delayed; they died because they
were in severe pulmonary failure, renal
failure, or liver failure.
Dr. Duff: What is your opinion of phy
siologic gastrectomy for acute erosive
gastritis rather than a total gastrectomy
in an old, medically unfit patient?
Dr. MacDonald: Physiologic gastrec
tomy is performed when you give cime
tidine. This drug completely abolishes
gastric acid production and decreases
acid output from pentagastrin stimula
tion by 85%. But in our experience,
patients will still bleed despite complete
inhibition of gastric acid production.
From our gastroscopy findings, I sus
pect that many of these individuals have
a bile gastritis. We have tried cimetidine
in patients who have postgastrectomy
bile gastritis and they obtained no bene
fit. Bile can produce erosions in pa
tients who have a compromised
mucosa.
Dr. Duff: Some surgeons like to have
their patients extubated quickly, others
believe extubation should be delayed.
How do you tell when to extubate a
patient who, say, had been ventilated
overnight?
Dr. Meakins: Adequate oxygenation
must be proven prior to extubation —
a Po2 in the range of 80 to 100 mm Hg,
a normal Pco2 and normal pH. The
breathing should be easy without strain
ing or tachypnea. In the case of a pa
tient who has been on a respirator for
several days, if he is extubated too
quickly he is likely to tire, go into
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respiratory failure and require reintuba
tion. It is much more difficult to get
a patient off the respirator the second
time.
Dr. Duff: Is there a Po2 value that you
will tolerate or below which you will
not extubate?
Dr. Meakins: In a patient without
chronic chest disease who has been on
a respirator, I am very reluctant to ex
tubate that patient if the Po2 is much
under 75 mm Hg.
Dr. Duff: Dr. Cooper, have you any
thing to add on that point?
Dr. Cooper: An endotracheal tube does
prevent coughing, and the normal
negative-pressure inflation of the lungs
is better than positive-pressure infla
tion. Therefore there is reason to ex
tubate the patient as soon as possible.
However, having said that, I would
emphasize that there are very few ha
zards present in well-managed units and
the benefits of that extra time of rest
and adequate mechanical ventilation
may be very important.
Dr. Duff: If a patient has had emer
gency thoracentesis in the emergency
room and then requires positive endexpiratory pressure (PEEP) or mech
anical ventilation, there is the risk of
a sudden pneumothorax. Should such
a patient have a chest tube inserted
prophylactically?
Dr. Allardyce: We have had bad ex
periences with the sudden development
of a tension pneumothorax in the situa
tion you have described. I think you
have to balance the risk of a sudden
pneumothorax and your ability to de
tect it in time against the need for
PEEP.
Dr. Cooper: Yes, the likelihood of
spontaneous pneumothorax is probably
high, so keep the chest tube near the
bedside if you have tapped the patient
with multiple injuries in the emergency
ward. I very often insert a chest tube
as a prophylactic measure in a patient
going to the operating room for an
abdominal procedure who has had mul
tiple injuries and pleural effusions or
rib fractures, even though he has no
pneumothorax.
Dr. Meakins: I really do not like the
concept of a prophylactic chest tube.
All volume-cycle respirators have a
gauge that indicates the pressure re
quired to achieve adequate inspiration.
As a pneumothorax develops, that pres
sure is going to increase. Careful mon
itoring can identify this problem so that
the needless insertion of chest tubes is
avoided.
Dr. Duff: Dr. Meakins, does splenec
tomy affect the cutaneous anergic re
sponse?
Dr. Meakins: Not as far as we know.
Patients who have had splenectomy for
isolated splenic injury have not become
anergic.
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